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ABSTRACT
Fibrinolysis, the proteolytic degradation of the fibrin fibers th a t stabilize blood clots, is 
initiated when tissue-type plasminogen activator (tPA) activates plasminogen to  plasmin, 
the main fibrinolytic enzyme. Many experiments have shown th a t coarse clots made of thick 
fibers lyse more quickly than  fine clots made of th in  fibers, despite the fact th a t individual 
thick fibers lyse more slowly than  individual th in  fibers. O ther experiments show the 
opposite result. Reaction-diffusion models have been the standard  tool for investigating 
fibrinolysis, and have been successful in capturing the wave-like behavior of lysis seen 
in experiments. These previous models trea t the distribution of fibrin w ithin a clot as 
homogeneous, and therefore cannot be used directly to  study lysis of fine and coarse clots. 
We create a model th a t includes a spatially heterogeneous fibrin concentration, as well as a 
more accurate description of the role of fibrin as a cofactor in the activation of plasmin. O ur 
model predicts spatiotem poral protein distributions in reasonable quantitative agreement 
with experim ental data . The model also predicts observed behavior such as a front of lysis 
moving through the clot w ith an accum ulation of lytic proteins a t the front.
In spite of the model improvements, however, we find th a t one-dimensional (1-D) con­
tinuum  models are unable to  accurately describe the observed differences in lysis behavior 
between fine and coarse clots. Hence, we develop a three-dimensional (3-D) stochastic 
multiscale model of fibrinolysis. A microscale model representing a fiber cross section and 
containing detailed biochemical reactions provides information about single fiber lysis times 
and the length of tim e tPA  stays bound to  a given fiber cross section. D ata  from the 
microscale model is used in a macroscale model of the full fibrin clot, from which we obtain 
lysis front velocities and tPA  distributions. We find th a t the num ber of fibers in a clot 
impacts lysis rate, bu t so does the num ber of tPA  molecules relative to  the surface area of 
the clot exposed to  those molecules. Depending on the values of these two quantities (tPA 
num ber and surface area), for given kinetic param eters, the model predicts coarse clots 
lyse faster or slower than  fine clots, thus providing a possible explanation for the divergent 
experim ental observations. We also use the model to  predict values of unm easured reaction 
rates and to  suggest desirable characteristics of fibinolytic drugs. We find th a t a tPA
variant th a t binds less strongly to  fibrin causes faster degradation rates than  normal tPA. 
We conclude by studying the effect of the inhibitors a 2-antiplasm in ( a 2-AP), plasminogen 
activator inhibitor-1 (PAI-1), and throm bin activatable fibrinolysis inhibitor (TAFI) on 
lysis. We find th a t a 2-AP is the stongest inhibitor, bu t lysis is most delayed when a 2-AP 
and TAFI work together.
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Intravascular blood clots (thrombi) are composed of platelets, red blood cells, and a 
stabilizing mesh of fibrin fibers. Fibrinolysis is the proteolytic degradation of fibrin fibers. 
Occlusive throm bi can form if fibrinolysis happens too slowly, causing heart a ttack  or 
stroke. Rapid fibrinolysis impedes form ation of blood clots, leading to  excessive bleeding. 
U nderstanding the tightly  regulated fibrinolytic process is im portant from both  physiological 
and clinical standpoints. Safely and effectively increasing lysis rates therapeutically  is a goal 
of much ongoing research. We develop m athem atical models of the fibrinolytic system to 
explore the underlying mechanisms of fibrinolysis and to  propose potential targets for new 
fibrinolytic therapies.
1.1 Biological background
Plasm in, the main fibrinolytic enzyme, is activated from its inactive precursor plas­
minogen (PLG) by tissue-type plasminogen activator (tPA). tPA  is fibrin-selective and 
preferentially activates fibrin-bound PLG, creating a source of plasmin on the surface of 
fibrin fibers. Plasm in exists in the blood plasm a at extremely low concentration due to 
strong plasmin inhibitors (the most im portant being a 2-antiplasm in), so the local creation 
of plasmin on fibrin fibers is a critical step of fibrinolysis. Once plasmin is formed, it 
degrades the fibrin by cleaving peptide bonds formed by the carboxyl group of lysine. The 
cleavage exposes initially cryptic C-term inal lysines to  which more tPA  and PLG may bind, 
potentially creating a positive feedback for plasmin activation and fibrin degradation (Figure 
1 .1 ).
I t has been shown th a t a therapeutic  bolus of tPA  adm inistered near a clot increases 
the rate  of fibrinolysis in patients [?, ?, ?]. In several experiments mimicking therapeutic  
lysis, a bolus of tPA  is added to  the edge of a fibrin clot in the absence of fluid flow [?, ?, ?]. 
These studies show th a t lysis moves across the clot as a front, w ith a high accum ulation of 
lytic enzymes bound to  fibers at the lysis front.
2Plasma
F ig u re  1.1. C artoon of fibrinolysis (not to  scale). Plasm inogen (PLG) and tPA  diffuse in 
the plasm a and can bind to  fibrin. If tPA  and PLG bind in close proximity to  one another, 
the tPA  can convert the PLG to  plasmin (PLi). PLi then degrades the fibrin by cutting 
across the fiber. New binding sites for tPA  and PLG are exposed as plasmin cleaves fibrin. 
P lasm a concentration of PLG k  2 ^M , and plasm a concentration of tPA  k  70 pM.
Plasm in-m ediated degradation of fibrin fibers seems to  occur by transverse cutting  across 
fibers, ra ther th an  by uniform degradation around fiber diam eters [?, ?, ?]. This is likely 
due to  the fiber configuration, which has binding sites located 6 nm apart transversely, 
and 22.5 nm  apart lengthwise. A single fiber is a lateral aggregation of many two-stranded 
protofibrils (long chains composed of half-staggered 45-nm-long fibrin monomers). The 
protofibrils in a fiber are in register and clear striations across the fiber are seen in electron 
micrographs [?]. This half-staggering distributes binding sites in 22.5 nm intervals along 
a fiber, while lateral aggregation spaces protofibrils about 5-6 nm apart transversely. It 
is hypothesized th a t plasmin can “crawl” to  the transverse binding sites, bu t is unable to 
reach farther away binding sites, which directs degradation across a fiber [?].
Despite the seemingly tight packing of protofibrils into fibers, fibrin fibers are about 20% 
protein and 80% water [?, ?]. Hence, on the scale of a single fiber, it is believed there are 
pores through which small molecules can diffuse [?]. A calculation of protofibril spacing in 
a fibrin fiber suggests th a t the edge-to-edge distance between protofibrils is approxim ately
5 nm , on average (A ppendix A). There is some debate about the size of a PL G  molecule, 
which has been estim ated to  have a diam eter of 9-11 nm  [?], and a radius of gyration 
between 3.05-3.9 nm [?, ?]. All of these estim ates are large enough to  imply th a t PLG 
cannot diffuse through the pores of a single fibrin fiber. However, since PLG  is present in 
the plasm a during fibrin form ation, it is reasonable to  assume th a t PLG can be bound to 
any protofibril in a fiber.
On the clot scale, there are much larger pores between fibers. The structure  of a fibrin 
clot depends on the environment in which it forms. Conditions of high salinity or throm bin 
concentration yield fine clots w ith thin, tightly  packed fibers (sm all pores), while conditions 
of low salinity or throm bin concentration produce coarser clots with thicker fibers and larger 
pores. Despite the fact th a t individual thick fibers lyse more slowly th an  individual th in  
fibers [?, ?], some experiments have shown th a t coarse clots made of thick fibers lyse more 
quickly th an  fine clots made of th in  fibers [?, ?]. However, o ther experiments show fine clots 
lyse faster th an  coarse clots, or show no significant difference in lysis rates [?, ?, ?]. We create 
m athem atical models to  elucidate the factors th a t influence lysis speeds in clots of varying 
structure, in an effort to  suggest targets for the design of new fibrinolysis therapeutics.
1.2 Literature review
The use of continuum  models to  explore fibrinolysis is the prevailing trend in the 
m athem atical modeling literature, w ith many models consisting of one-dimensional (1-D) 
advection-reaction-diffusion equations [?, ?, ?, ?]. All of these models assume th a t initially 
fibrin is d istributed homogeneously throughout the domain. We discuss a few of these 
models to  put our own models in context.
Zidansek and Blinc [?] study the spatial d istribution of plasmin inside clots exposed to 
pressure-driven perm eation of urokinase-type plasminogen activator (uPA). Like tPA, uPA 
converts plasminogen to  plasmin, bu t unlike tPA  it does so in plasma. uPA has no fibrin 
specificity, and therefore the possible positive feedback provided by plasmin exposure of new 
binding sites is absent in situations of uPA-induced lysis. uPA activation of plasmin and 
plasmin inactivation by a 2-antiplasm in are modeled as M ichaelis-Menten reactions. The 
model does not distinguish between plasma-phase and fibrin-bound species. D egradation of 
fibrin is represented by a decrease in the concentration of peptide bonds in the fibrin network 
th a t can be cleaved by plasmin. W hen the proportion of plasmin-susceptible peptide bonds 
falls to  2/3, the clot has dissolved. The clot is a three-dimensional (3-D) uniformly-shaped
3
4semi-infinite circular cylinder which is reduced to  1-D by symmetry. The clot is assumed 
to  be homogeneous, composed of uniform concentrations of fibrin and plasminogen, with 
no uPA present initially. The relative concentrations of uPA and plasmin are calculated 
in a clot experiencing steady-state lysis. The lysis front is found to  move w ith a constant 
velocity. Incorporating advection to  model plasm a flow results in the front moving with the 
same velocity as the flow. In the absence of flow, the diffusion constants of uPA and plasmin 
limit the speed of lysis, leading to  the conclusion th a t perm eation enhances fibrinolysis.
A higher-dimensional model of fibrinolysis was proposed by Zidansek et al. [?]. M agnetic 
resonance imaging shows th a t pressure-driven uPA can generate finger-like patterns of 
degradation w ithin a clot [?, ?]. In developing a two-dimensional (2-D) random  walk model 
to  predict these types of lysing patterns, the authors s ta rt w ith the same M ichaelis-Menten 
kinetics and advection-reaction-diffusion equations as in Zidansek and Blinc [?], but approx­
im ate the effect of the reactions by a single “reaction tim e” , t R. t R represents the tim e lag 
between the arrival of uPA and the actual clot dissolution at a given point, and depends on 
reaction rate  constants, the steady-state concentration of uPA in the blood, and the plasmin 
concentration. The clot is described as a rectangle separated by a sharp boundary from 
the blood. Using t R, the system of reactions is reduced to  a problem of moving boundaries. 
The blood-throm bus interface and the boundary created by the uPA front are tracked. 
The variation in clot porosity is accounted for by solving the Laplace equation for pressure 
with lattice G reen’s functions. The Green’s functions are calculated w ith a random  walk 
simulation, which results in pressure a t a point r  being proportional to  the probability th a t 
r  was visited by a random  walker. The m agnitude of t R affects solutions of the random  
walk model, w ith high t R values resulting in finger-like patterns of lysis. Model solutions 
show “remarkable similarities to  experim ental and clinical observations” of lysis velocity 
and of the dependence of lysis patterns on the enzyme transport param eters, however no 
quantitative comparison between the model and experiments is provided. The authors 
conclude th a t accounting for the random  character of clot porosity results in the model 
equations displaying the ability to  produce the finger-like, drug-induced clot degradation 
patterns observed experimentally.
To date, the most influential modeling paper of fibrinolysis is by Diamond and Anand [?]. 
The authors extend the model of Zidansek and Blinc [?] by accounting for the evolution 
of fiber diam eter, considering reactions under nonequilibrium  conditions, and including 
kinetics of individual reactions. The im pact of diffusion and perm eation on the fibrinolytic
system is studied. 1-D advection-reaction-diffusion equations model lysis and concentration 
profiles of lytic species in a 1 cm long clot. The clot contains fibers w ith time-evolving 
diam eters. Lysis of a fiber is modeled as plasmin-induced degradation from the outside in, 
resulting in a fiber diam eter th a t decreases w ith time. (Since the publication of Diamond 
and A nand's paper, it has been shown th a t lysis proceeds by transverse cu tting  across the 
fiber, ra ther than  by uniform digestion around the fiber [?, ?].) The percentage of lysis at 
a particular location is calculated as the num ber of cuts made by plasmin at th a t location 
divided by the num ber of cuts needed to  degrade one subunit of fibrin. Concentrations 
of free uPA and free and fibrin-bound tPA, PLG, and plasmin are included in the model. 
Proteins are allowed to  bind only to  sterically accessible sites located on the surface of the 
fiber. This is a simplification, because tPA  molecules are small enough to  diffuse through 
pores in the fibrin fibers and are not confined to  the fiber surface. However, most tPA  is 
likely located near the surface of the fiber due to  the strong binding affinity of tPA  to  fibrin.
Results under different flow conditions (i.e., different pressure drops across the clot) all 
show a sharp front of lysis moving across the clot. The faster perm eation velocities generate 
increased lysis front velocities. Concentration profiles for bound and free phase enzymes are 
obtained 15 m inutes after tPA  is introduced, bu t the tim e evolution of these concentrations 
is not presented. The bound plasmin concentration peaks dram atically at the lysis front 
due to  rapid local conversion of PLG  to  plasmin, while the bound tPA  concentration is 
m odestly increased at the front. An increase in free phase PLG  and tPA  is observed near 
the lysis front, due to  the release of bound species from the fully lysed front of the clot.
By changing the fiber radius (from 25-500 nm) while keeping the bulk fibrin concentra­
tion the same, the effects of fiber radius on transport and kinetics can be examined. To 
keep bulk fibrin concentration fixed while increasing fiber radius it is necessary to  decrease 
the concentration of available binding sites on the fiber surface; a lower fraction of the 
fibrin monomers are exposed on the surface of a thick fiber th an  on the surface of a th in  
fiber. Because of this, when the Peclet num ber is held constant (and the pressure drop 
adjusted to  enforce this), fine fibers are lysed faster than  coarse fibers. A constant Peclet 
num ber corrects for the fact th a t clots w ith th in  fibers have a lower specific perm eability 
th an  clots w ith thick fibers. If the pressure drop is held constant, coarse fibers, which 
have enhanced perm eation, lyse faster th an  fine fibers, which have reduced perm eation. 
The authors conclude th a t perm eation is the dom inant mode of transport for lytic species. 
Additionally, by varying kinetic param eters they conclude th a t:  strong binding of tPA  to
5
fibrin slows its penetration into the clot; adjusting the tPA  dissociation constant does not 
cause an increase in lysis rates (the wildtype tPA  dissociation constant is nearly optim al); 
and the concentration of PLG already o n /in  the clot has a strong im pact on lysis rates.
W hile Diamond and A nand’s model [?] is more detailed than  previous fibrinolysis 
models, it omits some essential features of lysis. For instance, we now know th a t lysis occurs 
by transverse cu tting  across fibers, not uniform degradation around the diam eter. Diamond 
and A nand’s definition of lysis, as well as their calculation for the sterically accessible lytic 
protein binding sites, relies on degradation occurring uniformly around the fiber diam eter. 
Also, their model does not account for effects of the plasmin inhibitor a 2-antiplasmin, 
com petition for binding sites between tPA  and PLG, or exposure of new binding sites in 
partially  degraded fibrin. Failing to  account for exposure of new binding sites eliminates 
the possibility of positive feedback.
W ootton et al. [?] modify Diamond and A nand’s model to  account for the effect of 
partial fibrin degradation. They develop a 2-D advection-reaction-diffusion model with 
porous viscous flow, which after scaling is reduced to  a 1-D reaction-diffusion model. The 
model tracks the plasm a-phase and fibrin-bound concentrations of tPA, PLG, and plasmin, 
the plasm a-phase concentration of a 2-antiplasm in, and the fibrin solid volume fraction. It 
is assumed th a t all binding sites are accessible and uniformly distributed throughout the 
domain, and th a t PLG and plasmin com pete for binding sites on fibrin. The authors assume 
th a t partial degradation increases the affinity and binding site density for PLG, but not for 
tPA. Unlike Diamond and Anand, W ootton et al. do not model fiber radius, but rather 
fibrin volume fraction. Consequently, W ootton et al. are be tte r able to  investigate clot lysis 
th an  Diamond and Anand, whose “clot” is one long fiber. The trade off, however, is th a t 
W ootton et al. are unable to  investigate individual fiber lysis.
To achieve lysis, W ootton et al. require higher tPA, PLG, and plasmin binding rates than  
those presented in Diamond and Anand [?]. W ith  the higher binding rates, they find th a t 
lysis occurs more slowly th an  predicted by Diamond and A nand’s model and w ith a much 
larger accum ulation of plasm a-phase tPA, PLG, and plasmin at the lysis front (five times or 
more higher th an  the bulk concentration). Additionally, the lysis front is sharper. The lysis 
front is a zone about 15-30 ^m  thick, in agreement with experim ents [?]. Lysis proceeds 
a t a relatively constant rate  after an initial delay while plasmin is created. W ootton et 
al. do not present any model results pertaining to  distributions or concentrations of bound 
lytic proteins, nor do they discuss the tim e evolution of lytic protein concentrations. The
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7authors prim arily use the model to  complement their experim ental observations of the effect 
of shear stress on fibrinolysis. The experim ents show th a t a t low to  arterial shear stress 
(4 dy n /cm 2 to  18 dy n /cm 2), outer flow slightly accelerates lysis; the average lysis front 
velocities are 1.4 x 10- 5  and 1.5 x 10- 5  cm /s, respectively. In contrast, a t high shear 
stresses (41 dyn /cm 2), lysis is greatly accelerated to  3.1 x 10- 5  cm /s. The model results for 
increasing shear stress show accelerated lysis, bu t the quantitative results are far smaller 
th an  the experim entally m easured values. This suggests th a t increased outer convection 
alone cannot account for the lysis rates observed experim entally a t shear stresses between 
18-40 dyn /cm 2. In fact, the authors suggest th a t outer convection m odulates lysis only at 
shear stresses below 10 dy n /cm 2. They offer no explanation for other mechanisms th a t may 
be responsible for the increased lysis front velocities obtained at increased shear stresses.
More recent models use reaction-diffusion equations to  simulate simultaneous fibrinolysis 
and coagulation [?, ?]. The models include activated and resting platelets, many coagulation 
factors, fibrin, fibrinogen, throm bin, prothrom bin, tPA, PLG, plasmin, and a 2-antiplasmin. 
The models also include blood flow, platelet activation, reactions leading to  clot form ation 
and growth, viscoelastic properties of the clot, and fibrinolysis. In a model w ith so many 
components, it is difficult to  identify subtle influences on the predicted outcomes. The main 
results of these models are predicted tim e courses of fibrin concentration; specific questions 
about fibrinolysis are not addressed.
We have made significant progress in understanding fibrinolysis by creating and ana­
lyzing m athem atical models. In C hapter 2, we discuss our 1-D reaction-diffusion model 
th a t extends the preceding models by considering more detailed reaction chem istry and the 
spatial heterogeneity of fibrin. Our multiscale model, introduced in C hapter 3 and extended 
in Chapters 4 and 5, is the first model of fibrinolysis to  simultaneously include multiple 
dimensions, unbound and bound chemical species, spatial heterogeneity of fibrin, stochastic 
treatm ent of tPA  and plasmin, tPA  and PLG  com petition for binding sites, and the effect 
of partially  degraded fibrin on PLG binding rates. The impact of our m athem atical models 
of fibrinolysis and future work are discussed in C hapter 6 .
CHAPTER 2
ONE-DIMENSIONAL CONTINUUM  
MODEL OF FIBRINOLYSIS
As discussed in C hapter 1 , experiments have shown th a t coarse clots made of thick 
fibers sometimes lyse more quickly th an  fine clots made of th in  fibers, despite the fact th a t 
individual thick fibers lyse more slowly th an  individual th in  fibers. Proposed mechanisms 
for this apparent paradox include enhanced movement of tPA  through coarse clots (and 
therefore earlier activation of PLG ), and lateral transection of fibers by plasmin [?, ?]. If 
degradation occurs by transverse cu tting  across fibers (ra ther than  by uniform digestion 
around fibers) [?, ?, ?], presum ably a coarse clot w ith fewer fibers to  transect might be 
degraded faster than  a fine clot with a higher fiber density. W hile this explanation seems to 
be widely accepted, it is difficult to  confirm experimentally. In this chapter, we aim to  use 
a one-dimensional (1-D) model of fibrinolysis to  elucidate the mechanism by which coarse 
clots lyse more quickly than  fine clots.
The use of continuum  models to  explore fibrinolysis is the prevailing trend in the lit­
erature, w ith many models consisting of 1-D advection-reaction-diffusion equations (Chap­
ter 1 .2 ) [?, ?, ?, ?]. All of these models assume th a t initially fibrin is d istributed homo­
geneously throughout the domain. We create a 1-D continuum  model of the fibrinolytic 
system th a t extends the preceding models in several ways: we allow for tPA  and PLG  to 
compete for newly exposed binding sites; we allow only PLG  th a t is bound to  fibrin in 
close proximity to  bound tPA  to  be converted to  plasmin; and perhaps most im portantly, 
we account for the spatially heterogeneous concentration of fibrin w ithin clots. By treating  
fibrin concentration heterogeneously, we are able to  explore for the first tim e the effects of 
lysis on single fibrin fibers, as well as on fibrin clots of varying structure.
P atien ts w ith blood clots are often trea ted  with a therapeutic  bolus of tPA, which has 
been shown under certain conditions to  increase the rate  of fibrinolysis when adm inistered 
near the clot. We model the experiment by Collet et al., which mimics this clinical situation 
[?]. In the experiment, a bolus of tPA  is added to  the edge of a native plasm a fibrin
9clot in the absence of fluid flow. F irst, we test the model w ith a homogeneous fibrin 
concentration to  verify th a t it produces results similar to  those from previous models [?, ?]. 
Then spatial inhomogeneity is added to  the model (so we can distinguish between fine and 
coarse clots), and the resulting predictions are compared to  published experim ental data. 
We conclude th a t 1-D continuum  models are capable of quantitatively predicting the spatial 
d istribution of lytic enzymes, bu t cannot capture the observed behavior of lysis in clots of 
varying structure. 1-D continuum  models can therefore be used to  answer questions about 
spatiotem poral variation in lytic enzyme concentrations, bu t more sophisticated models are 
necessary to  answer quantitative questions about structu ral aspects of lysis.
2.1 The model
We develop a 1-D reaction-diffusion model to  study the spatiotem poral dynamics of 
lytic protein concentrations. In our model, tPA  and PLG  can each be in one of two states: 
free in solution (where they diffuse), or bound to  fibrin. Because tPA  and PLG m ust be 
bound to  fibrin in proximity to  one another for tPA  to convert PLG  to  plasmin, fibrin is 
represented by binding doublets. Each binding doublet has two sites to  which tPA  and /o r 
plasmin(ogen) may bind and from which they may unbind. If tPA  occupies one site and 
PLG occupies the other, then  PLG may be converted to  plasmin. Such a doubly occupied 
doublet is analogous to  the enzym e-substrate complex in standard  enzyme kinetic models. 
We include binding doublets in an a ttem pt to  incorporate small scale spatial effects in 
the model. Doublets provide us w ith more information about where proteins are located 
on fibrin; if tPA  and PLG  are bound to  the same doublet, the proteins are close enough 
together to  create plasmin. If we model the concentrations of bound enzymes w ithout the 
use of doublets, then  we know only th a t tPA  and PLG  are bound somewhere on fibrin, but 
not how closely located they are to  each other.
There are two types of binding doublets: specific and nonspecific. On a specific binding 
doublet, tPA  may bind only to  the first site, and PL G /plasm in  may bind only to  the second 
(Figure 2.1). For nonspecific doublets, tPA  and PLG can each bind to  either site. Only 
specific binding doublets are available initially, bu t as lysis proceeds, nonspecific binding 
doublets are exposed by plasmin. M ultiple doublets may exist a t the same location.
Next, we describe the term s in the model equations before presenting the full model. 
Two variations of this model are considered, one with a homogeneous concentration of fibrin 
and the o ther with a heterogeneous concentration of fibrin.
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F ig u re  2.1. Reaction diagram  for specific binding doublets. tPA  may only bind to  the 
gray sites and PLG and plasmin (PLi) may only bind to  the white sites.
2.1.1 M odel variables
We track the concentrations of free tPA  and PLG (denoted a and p, respectively), as 
well as the concentrations of all possible configurations of binding doublets (e.g., a specific 
doublet w ith tPA  bound but no PLG ). represents a specific binding doublet with index 
i describing tPA  (i =  0 if tPA  is not bound, i =  1 if tPA  is bound), and w ith index j  
describing plasmin(ogen) ( j =  0 if neither PLG nor plasmin are bound, j  =  2 if PLG is 
bound, and j  =  3 if plasmin is bound) (Table 2.1 and Figure 2.1). n i,j is the concentration 
of a nonspecific binding doublet with indices i, j  =  0,1, 2, or 3. For example, n 2,3 refers to 
nonspecific doublets with PLG bound to  the first site and plasmin bound to  the second. 
Due to  high concentrations of plasmin inhibitors, the plasm a concentration of plasmin is 
effectively zero. Consequently, we neglect free plasmin. If plasmin unbinds from fibrin, it is 
assumed to  be instantaneously inhibited and is removed from the model. The final variable 
is n, the concentration of the pool of initially unexposed binding sites th a t can be exposed 
by plasmin.
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T a b le  2.1. Continuum  model notation.




i or j  =  0 
i or j  =  1 
i or j  =  2 
i or j  =  3
specific binding doublet concentration
nonspecific binding doublet concentration





2.1.2 B ind ing and unbinding
Free tPA  and PLG  can diffuse and interact w ith fibrin, but once bound to  a doublet, 




ka,0,3 0,3 ,a ,1,3 „i,3 ki,1,3 s1,3 +
kon as koff s koff s +
tp T^bind? j tPA (1st term) or PLiwith PLi already bound \  , . , . ,(2nd term) unbind
These are basic term s obtained from reaction diagram s like Figure 2.1. is the forward
rate for species q binding to  doublet su,v or n u,v, and k l^U',v is the reverse rate  for species q 
unbinding from doublet su,v or n u,v, for q =  a,p, or i (plasmin), and u ,v  =  0,1, 2, or 3.
2.1 .3  D egradation
The term s for plasm in-m ediated degradation of fibrin are derived using a quasi-steady 
sta te  analysis for two substrates com peting for one enzyme. Unexposed nonspecific sites, 
n, and exposed sites, doublets, com pete for plasmin. The concentration of plasmin is a  =  
s0,3 +  s 1,3 +  n 0,3 +  n 1,3 +  n 2,3 +  2n3,3. Quasi-steady sta te  analysis gives differential equations 
for degradation products created from doublets (pd), and for degradation products created 
from n  (pn ):
dpd kcata doublets
dt K m +  doublets +  n  
dPn kcata n
VM
dt KM +  n  +  Kn doublets
where the to ta l concentration of doublets is
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doublets =  s0’0 +  s0’2 +  s0’3 +  s 1 ’0 +  s 1 ’2 +  s 1 ’3 +  n 0’0 +  n 1 ’0 +  n 0’2 
+  n 1 ’ 1 +  n 1 ’2 +  n 2’2 +  n 1 ’3 +  n 2’3 +  n 0’3 +  n 3’3.
The catalytic rates and Michaelis-Menten constants are kcat, K M for plasmin degradation 
of exposed sites, and knat, KM for plasmin “degradation” (i.e., exposure) of unexposed sites. 
Assuming th a t each fibrin species (e.g., s 1’3) is degraded in proportion to  its fraction of the 
to ta l am ount of exposed binding sites, and th a t plasmin can degrade any doublet a t the 
same location (not ju st the doublet to  which it is bound), the degradation term s take the 
form:
d s 1’3 /  s 1’3 \  I — kcatadoublets
dt \  doublets J  I K m  +  doublets +  kM n  \  k m
=  _  fccat^s1 ’3_______ +___
Km +  doublets +  Kmm nKM
The other degradation term , obtained similarly, describes the conversion of unexposed sites, 
n, to  exposed sites, n 0’0:
dn kcat ^ n
dt KM +  n  +  Kn doublets
W hen fibrin is degraded by plasmin, the binding doublets (and any bound plasmin) disap­
pear, and the bound tPA  and PLG  are released into the solution.
2.1 .4  M oving p lasm in
Based on the observation th a t plasmin inhibitors have high concentration in plasma, 
plasmin in solution is ignored. Plasm in, however, can move between binding sites a t the 
same spatial location. W ith  the param eter values used in this model (Table 2.2), plasmin 
does not unbind from doublets -  it is only released by degradation of the doublet to  which 
it is bound. Consequently, the tPA  molecule th a t created the plasmin is inhibited from 
producing more plasmin until it unbinds and rebinds elsewhere; it cannot encounter PLG 
while bound to  a doublet occupied by plasmin. Allowing plasmin to  move locally (where it 
is protected from plasmin inhibitors), frees up the binding site for PLG, which can then be 
converted to  plasmin.
Of all the doublets th a t contain plasmin, s 1’3 and n 1 ’3 are most abundant. For simplicity, 
we assume th a t only plasmin from these doublets can move, and th a t plasmin may move
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T a b le  2.2. 1-D model param eter values. References for param eter values are as follows: 
*[?, ?], +[?], *[?], *[?], §[?].
D e s c r ip t io n  (units) N o ta t io n V alu e
tPA  diffusion coefficient (cm2s-1 ) D tPA 5 x 10- 7
PLG diffusion coefficient (cm2s-1 ) D PLG 5 x 10- 7
tPA  dissociation constant in absence of P L G /P L i (^M)
sQk 0.36 *
tPA  dissociation constant in presence of P L G /P L i (^M)
aQk 0.02  +
tPA  binding rate (^M- 1s-1 )
egk 1 .0
tPA  unbinding ra te  (s-1 ) kakoff ka ka kDkon
PLG dissociation constant (^M) kD 38.0 *
PLG binding rate (^M - 1  s-1 ) a
p
ok 0 .1  *
PLG unbinding rate  (s-1 ) k ff kp kp kDkon
PLi unbinding ra te  (s-1 ) koff 0.0
rate  constant for conversion of PLG  to PLi by tPA  (s-1 ) kapkcat 50
rate constant for PLi digestion of activated doublets (s-1 ) kcat 01
constant for enzymatic digestion of activated doublets (^M) kM 0 .1
rate  constant for activation of un-activated doublets (s-1 ) knkcat 50
constant for enzymatic digestion of un-activated doublets (^M) nM 0 .1
only to  the most common doublets, s 0,0 and n 0,0. Movement is modeled as a reaction. For 
example, the reactions
s i,3 +  s °,° s 1,0 +  s0,3,
S1,3 +  n 0,0 —°ve s 1 ,0 +  n 0,3
give term s
d s 1 ,3
=  -  kmove(s1,3s0,0 +  2 s 1 ,3n 0,0) +  ••• .
The factor of 2 arises because plasmin can move to  either of the two available binding sites 
on nonspecific doublet n 0,0.
2.1.5 C reation  o f p lasm in
Finally, we model the conversion of PL G  to  plasmin. W hen tPA  and PL G  are bound 
to  the same doublet, tPA  converts PLG  to plasmin at rate  . Therefore, tPA -m ediated
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conversion is modeled by kCa-s1,2 (for specific doublets) and k ^ n 1,2 (for nonspecific dou­
blets).
2.1 .6  Sam ple equation
We now write out one model equation in its entirety. For the full model, see Appendix
B. Combining the pieces described above gives the equation:
ds1,3
_ __ _  kaP s1,2 +  ka,0,3a s0,3
dt =  +  kon ,
tPA converts tPA binds to doublet
PLg to PLi with PLi already bound
— kmove(s 1 ,3s 0,0 +  2 s 1,3n 0,0) —
PLi from s1,3 moves onto s0,0 
or n0,0 at same spatial location
The other model equations are similar.
2.1 .7  In itia l and boundary conditions
An indicator function x(x) is used to  specify where fibrin is found at t  =  0. For the 
homogeneous model, the dom ain is 0 <  x <  300 ^m  (0 <  x <  1 nondimensionally) and x  =  
1 — 0.5(1 +  ta n h ( 001—1x)), which corresponds to  fibrin being nearly uniformly distributed over 
the interval 30 ^m  <  x <  300 ^m . For the heterogeneous model, the fibrin concentration 
varies as indicated in Equation (2.3). The fibrin concentration is high at locations occupied 
by a fiber, and zero between fibers, w ith transitions smoothed for numerical simulation. 
The nonzero fibrin concentration is chosen so th a t the fibrin concentration averaged over 
the whole dom ain is 6 ^M . The dom ain is 100 ^m  long, w ith the first 10 ^m  free of fibrin 
(Figure 2.2). Using an average fiber diam eter from experiments [?] and an average pore size 
(gap between fibers), we calculate the num ber of fibers in the clot. For example, in a fine 
clot (pore size 1 ^m ) made of th in  fibers (diam eter 299 nm), there are ^ ^ m - /10nMm ~  69 
fibers in the clot domain. Constraints on com putational tim e m otivate the use of a variable 
space step th a t ranges in nondimensional size from 2- 1 0  to  2- 1 4  (Figure 2.2).
We assume th a t bound plasminogen is initially in equilibrium with the plasm a plas­
minogen at concentration p0 =  0.5 ^M , and th a t only specific doublets are exposed. A 
quasi-steady sta te  analysis for s 0,0 and s0,2 in the presence of this free plasminogen gives 
initial conditions
ka,1 ,3s 1,3 k i,1 ,3s 1,3
koff s koff s
tPA (1st term) or PLi 
(2nd term) unbind
kcat^S1,3




F ig u re  2.2. Fibrin  concentration in a region of the heterogeneous model containing one 
fiber. Position along the clot, m easured in microns, is indicated on the horizontal axis. The 
to ta l clot length is 100 ^m . F iber w idth is indicated by the nonzero region of the black 
curve. x L denotes the left edge of the fiber, x R denotes the right edge, and H  denotes the 
fibrin concentration w ithin the fiber. Tick marks on the horizontal axis correspond to  the 
numerical grid spacing used in solving the equations. A coarse step, hc, is used in fiber-free 
regions of the domain. A fine step, h f , is used in regions of the dom ain containing fibers. 
Four progressively smaller steps are used to  transition  from hc to  h f , and those same steps 
are used in ascending order to  transition  from h f to  hc. Inset: A portion of the clot domain 
before lysis begins. Axes are the same as in main figure. The first fiber is the same one 
shown in the large figure, and is the first fiber in the clot -  there is no fibrin to  the left of 
this fiber. The pa tte rn  of fibers continues in this m anner to  fill the rest of the domain.
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f f s * *
(kPn0’0 P0 +  C 0’2)
s° 0(x  0) ^ | p 00off 0p 0 2\ • X, and (2^
s0 ’ 2(x, 0) =  (stot — s 0 ’ 0(x, 0)) • X, (2.2)
where s tot is the to ta l specific binding site density, taken to  be 1 ^M . Because fibrin is 
concentrated in fibers, the initial conditions involve X, the initial clot indicator function:
' s f f  (x — x L(i)) if x L(i) <  x <  x L(i) +  5h/
X =  < s f f (x — x R(i)) if x R(i) — 5h/  <  x <  x R(i) (2 3)
H  if x L(i) +  5h / <  x <  x R(i) — 5h/
0 otherwise,
for i =  1 ,2 , . . . ,  N / (total fiber num ber), where H  is the height of the trapezoid, h /  is the 
finest numerical space step, and x L(i), x R(i) are the left-most and right-m ost points in 
fiber i, respectively (Figure 2 .2 ). All other specific and nonspecific doublets are initially 
zero. Fibers are aggregates of protofibrils, 2-stranded fibrin polymers in which each strand 
is composed of 3 chains: a , ^ , and 7  [?]. We assume th a t degradation of a single protofibril 
requires six cuts (one for each chain), and we take the to ta l fibrin concentration to  be 6 
^M . This means the concentration of potential, unexposed binding doublets is 5 times the 
concentration of specific doublets, n(x , 0) =  5 • stot • x . At the s ta rt of each experiment, a
5 x 10- 3  ^M  bolus of tPA  is added in the fibrin free region to  the left of the clot (smoothed 
using a hyperbolic tangent function). The boundary conditions for tPA  and PLG at x =  0 
and x =  1 (nondimensional end of the domain) are:
d a (0 ,t)  =  0 
dx ,
p ( 0 , t ) =  P0, (2.4)
d a ( 1 ,t)  dp (1 ,t)
dx dx
0 .
The initial and boundary conditions described above (Equations (2.1), (2.2) and (2.4)), 
along w ith Equations (B.1) - (B.19) (Appendix B), comprise the entire model. These 
equations hold regardless of clot heterogeneity, which requires only a different definition of 
the clot function, X.
17
2.2 Results
The model equations are nondimensionalized and solved numerically using a fractional 
step m ethod with a Crank-Nicholson scheme for the diffusion and a second-order Runge- 
K u tta  m ethod for the reactions. For the param eter values in Table 2.2, the homogeneous 
model predicts th a t lysis proceeds as a front (Figure 2.3). Free PLG concentrations remain 
roughly constant and bound concentrations of tPA, PLG, and plasm in are all elevated at 
the lysis front, in qualitative agreement w ith experiments [?, ?]. Bound PLG concentrations 
are predicted to  be five tim es higher a t the lysis front compared to  the initial bound 
concentration, w ith elevated concentrations over an average distance of 34.2 ^m , about 
one-tenth of the dom ain length.
The homogeneous fibrin model displays im portant features of lysis, bu t is unable to
F ig u re  2.3. Dynamics of the homogeneous fibrin model. Total run tim e is 30 minutes, 
with successive traces moving right each separated by 3 minutes. In the bottom  panel, the 
dotted  line indicates the initial clot function. The vertical axes are concentrations measured 
in ^M . “B d” means “bound” .
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predict the degradation of different types of clots. Based on the observation th a t blood 
clots contain highly concentrated fibrin fibers (and not uniform concentrations of fibrin 
throughout the clot volume), we study a heterogeneous fibrin model. We investigate differ­
ences in the lysis speeds of coarse and fine clots by using the same to tal fibrin concentration, 
w ith several different fiber configurations: a fine clot made of 69 299-nm-wide fibers spaced
0.976 ^m  apart; a coarse clot made of 42 476-nm-wide fibers spaced 1.66 ^m  apart; and as 
an extrem e case, a very coarse clot made of ten  1886-nm-wide fibers spaced 7.03 ^m  apart. 
In each of these cases, the initial fibrin concentration per fiber (i.e., H , the value of the 
nonzero part of the piecewise clot indicator function) is 29.16 ^M .
Since the model is one-dimensional, we m ust choose fiber w idths in a way th a t reflects 
the two-dimensional geometry of the fibrin fibers. The am ount of fibrin in a cross section 
of a th in  fiber is the product of fiber cross sectional area, n ( r thin)2, and the concentration 
of fibrin in a th in  fiber, cthin. Likewise, the am ount of fibrin in a cross section of a thick 
fiber is cthickn ( r thick)2. If we assume the concentration of fibrin in a single fiber is the same 
regardless of fiber thickness, then cthin =  cthick and the am ount of fibrin in a thick fiber 
is related to  the am ount of fibrin in a th in  fiber by the factor ( rthick)2. Taking WA? (therthin Him
w idth of a 1-D th in  fiber) to  be equal to  r thin gives the following equation for the 1-D width 
of a thick fiber:
The am ount of fibrin in a fiber cross section does not scale linearly with radius, so rather 
th an  simply use the 2-D radius as our 1-D fiber thickness, we com pute the 1-D thickness 
using Equation (2.5). Using experim entally m easured radii [?], Equation (2.5) gives a 1-D 
thick fiber w idth of 476 nm.
We explore the effect of fibrin concentration per fiber on lysis speed using two simulated 
clot structures: a coarse clot w ith 42 376-nm-wide fibers spaced 1.86 ^m  apart and fibrin 
concentration per fiber 37.32 ^M  (henceforth referred to  as a “thick, ta ll” clot because 
a higher fibrin concentration results in a taller trapezoid); and a very coarse clot with 
ten  751-nm-wide fibers spaced 8.2 ^m  apart and fibrin concentration per fiber 75.06 ^M  
(henceforth referred to  as a “very thick, ta ll” clot). These concentrations are calculated by 
keeping the to ta l num ber of fibers constant and adjusting the fiber w idths and pores sizes. 
For the coarse clot, the fiber diam eter is taken from experiments [?], and for the very coarse 
clot, the fiber diam eter is back-calculated using Equation (2.5). Once we know the number
(2.5)
19
T a b le  2.3. Heterogeneous model results. Unless otherwise noted, param eters from Table 
2.2 were used. Each sim ulation was run for one diffusion tim e (200 seconds). After 200 
seconds, the to ta l remaining am ount of fibrin was calculated to  obtain the percent of 
clot remaining. “Published kD” means kg =  0.36 ^M , kg =  38 ^M ; “small kD” means 
kg =  0.0036 ^M , kg =  0.38 ^M .






C o n c e n t r a t io n  
o f  f ib r in  p e r  
f ib e r  (^M )
P e rc e n t  
re m a in in g  
(p u b lis h e d  k o )
P e rc e n t  
re m a in in g  
(sm a ll kD)
thin 299 0.976 29.16 61.3% 39.3%
thick 476 1 .6 6 29.16 61.8% 36.7%
very thick 1886 7.03 29.16 60.8% 26.2%
th ick ,“ta ll” 376 1 .8 6 37.32 62.2% 33.8%
very thick ,“ta ll” 751 8.2 75.06 60.6% 7.1%
of fibers and fiber diam eter, we calculate the pore size and choose the fibrin concentration 
per fiber such th a t the to ta l fibrin concentration in the clot is 6 ^M .
C ontrary to  experim ental evidence [?], this model predicts no appreciable difference in 
the lysis rates for the different clot types (columns 1-5 of Table 2.3). W ith  dissociation 
constants from the literature, the lysis front moves a t the same speed regardless of clot 
structure  (Figure 2.4, gray lines). The model does, however, exhibit a wave-like m otion 
of lysis and higher concentrations of bound enzymes at the lysis front compared to  bound 
enzymes elsewhere in the clot (Figure 2.5).
To test if the model can produce different lysis rates for different clot structures, we 
increase the binding rates of tPA  and PLG by two orders of m agnitude while keeping the 
unbinding rates fixed. This gives dissociation constants th a t are 100 tim es smaller than  
those presented in the literature, and also reflects a stronger binding of proteins to  fibrin. 
Stronger binding reduces the effective diffusion of molecules into the clot, and as a result, 
bound enzymes localize near the lysis front (Figures 2.6 and 2.7), and lysis rates vary for 
different clot structures (Table 2.3, column 6 and Figure 2.4, black lines). Concentrations 
of free enzymes also peak near the clot front (Figure 2.8). The representation of 2-D fiber 
geometry in the 1-D model affects lysis speed; the thick, tall fibers (which have a higher 
fibrin concentration per fiber th an  the th in  fibers), result in coarse clots lysing approxim ately 
1.2-times faster than  fine. In the very coarse, tall clot, w ith thicker fibers and wider pores, 
lysis speeds increase even more (up to  1 .6 -times the fine speed).
W ith  the smaller dissociation constants (kg =  0.0036 ^M  and kg =  0.38 ^M ), the 
fibrin-bound concentration of PLG is roughly an order of m agnitude higher th an  the initial
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F ig u re  2.4. Comparison of lysis front velocities in different clot geometries, for published 
(kD =  0.36 ^M , kD =  38.0 ^M , gray lines) and small (kD =  0.0036 ^M  and kD =  0.38 
^M , black lines) dissociation constants. The first location in the clot where the fibrin 
concentration remains a t least 50% of the maximum concentration is plotted versus time. 
The lysis front velocities are the slopes of the lines fitted to  the above data. The step-like 
appearance is due to  the gaps between fibers. The lysis front m ust move across the fibrin-free 
space between the fibers before degradation begins on the next fiber, hence the step-like 
regions where the location of the front is not moving in tim e. The clots w ith thicker fibers 
have wider pores, so the steps are longer in these cases.
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bound concentration in a small region at the front of the lysing clot (about 8.35 ^m  for 
fine clots and 11.4 ^m  for coarse clots, on average). The lysis front is much sharper than  
when dissociation constants from the literature are used, with almost an entire fiber being 
degraded before any lysis begins on the next fiber (Figure 2.6).
To m easure the lysis rate  of individual fibers we focus on the first fiber in the domain. 
Recording the tim e at which the average fibrin concentration in this fiber first reaches 10% 
of its initial concentration gives a m easure of lysis time. Because the first fiber in the 
different clot types begins at the same position in the dom ain and we initialize tPA  the 
same way regardless of clot type, we can compare the times it takes the first fiber to  lyse for 
each case. W ith  dissociation constants from the literature, a single th in  fiber lyses slightly 
faster than  a thick fiber, which lyses slightly faster th an  a very thick fiber: 72.5, 74.0, and 
78.85 seconds, respectively (Table 2.4). W ith  small dissociation constants there is more of 
an increase in lysis tim e with increasing diam eter, bu t the predicted tim es are not physical 
(6.065, 7.415, and 20.415 seconds for thin, thick, and very thick fibers, respectively).
2.3 Discussion
The existence of a front of lysis moving through a clot when plasminogen activator is 
introduced at the clot edge is well supported in the experim ental literature [?, ?, ?, ?]. W ith 
both  spatially homogeneous and heterogeneous fibrin concentrations, our model predicts 
th a t lysis moves as a front w ith peaks in the concentrations of lytic proteins a t the front. 
This confirms results from earlier modeling efforts [?, ?], although consistent w ith W ootton 
et al. [?], we find th a t a ttain ing realistic lysis profiles necessitates using larger binding 
rates than  those proposed by Diamond and Anand [?]. Even with adjusted binding rates, 
however, neither our homogeneous nor heterogeneous fibrin models, w ith dissociation con­
stants taken from the literature, can quantitatively reproduce the protein concentration and
T a b le  2.4. Heterogeneous model single fiber results. Unless otherwise noted, param eters 
from Table 2.2 were used. The lysis tim e is defined as the tim e at which the average fibrin 
concentration in the fiber first reaches 10% of its initial concentration. “Published ko” 
means kD =  0.36 ^M , kD =  38 ^M ; “small kD” means kD =  0.0036 ^M , kD =  0.38 ^M .
T y p e  o f  f ib e rs F ib e r
w id th
L ysis  t im e  (s) 
(p u b lis h e d  k o )
L ysis  t im e  (s) 
(sm a ll kD)
th in 299 nm 72.5 6.065
thick 476 nm 74.0 7.415
very thick 1886 nm 78.85 20.415
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F ig u re  2.5. Average bound PLG and fibrin concentrations (^M) for the heterogeneous 
model in a fine clot with th in  fibers and dissociation constants from the literature (kD =  0.36 
^M , kD =  38.0 ^M ). Averages are plotted a t the fiber midpoints. The open symbols denote 
the initial average concentration, and each successively lighter gray line is 20 seconds later 
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F ig u re  2.6. Average bound PLG and fibrin concentrations (^M) for the heterogeneous 
model in a fine clot with th in  fibers and small dissociation constants (kg =  0.0036 ^M , 
kg =  0.38 ^M ). Averages are plotted at the fiber m idpoints. The open symbols denote the 
initial average concentration, and each successively lighter gray line is 20  seconds later than  





















F ig u re  2.7. Bound lytic protein concentrations for the heterogeneous model of a fine clot 
with th in  fibers and small dissociation constants (fcg =  0.0036 and &D =  0.38 ^M ).
(a) Bound tPA  concentration. (b) Bound PLG  plus plasmin concentration. In each plot, 
the dashed line denotes the initial condition, and each successively lighter shade of gray 
describes the given spatial distribution 20 seconds after the previous plot, for a to ta l of 
200 seconds. The peaks are different heights because the times th a t are plotted do not 
necessarily correspond to  the lysis front speed. All concentrations are in ^M .
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F ig u re  2.8. Free lytic protein concentrations for the heterogeneous model of a fine clot 
with th in  fibers and small dissociation constants (kD =  0.0036 ^M  and kD =  0.38 ^M ). (a) 
Free tPA  concentration. (b) Free PLG  concentration. In each plot, the dashed line denotes 
the initial condition, and each successively lighter shade of gray describes the given spatial 
distribution 20 seconds after the previous plot, for a to ta l of 200 seconds. The peaks are 
different heights because the tim es th a t are plotted do not necessarily correspond to  the 
lysis front speed. All concentrations are in ^M .
distribution results from Sakharov et al. [?]. There the authors report PLG  concentrations 
in fibrin agglomerates on the lysis front to  be 30 times higher th an  the concentration in the 
surrounding plasma, PLG concentrations in the 3-^m  region comprising the lysis front to 
be 9 times higher th an  the plasm a concentration, and PLG concentrations in a 20-^m-wide 
region adjacent to  the front to  be at least 2 times higher th an  the plasm a concentration. The 
“peaks” of PLG  in Figures 2.3 and 2.5 are wider (about 34.2 ^m  and 51 ^m , respectively), 
and are barely higher th an  the free concentration (0.5 ^M ), bu t nonetheless are qualitatively 
similar to  the Sakharov et al. results [?]. In reasonable quantitative agreement with 
Sakharov et al., the heterogeneous model w ith small dissociation constants results in peaks 
of PLG occurring in an 8-12 ^m  region at the lysis front, w ith a concentration almost 
50 times higher th an  the plasm a-phase concentration (Figures 2.7 and 2.8). These results 
are more consistent w ith Sakharov et a l.’s d a ta  th an  any previous models. W ootton et al. 
show increases in plasm a-phase enzyme concentrations a t the lysis front, across distances of 
about 25-50 ^m , but give no results for bound concentrations [?]. Diamond and Anand, in a 
model w ith perm eation of proteins, find a high concentration of bound plasmin at the lysis 
front over a distance of about 2000  ^m , with an increased concentration th a t is lower than  
the plasm a-phase PLG concentration [?]. Our heterogeneous model accurately predicts the 
width of the region of accum ulating proteins (8 - 1 2  ^m ), and is w ithin a factor of 2 of the 
largest measured PLG  increase (50 tim es higher than  surrounding plasm a concentration in 
our model vs. 30 tim es higher in the experiments by Sakharov et al. [?]).
In addition to  using our model to  investigate concentration profiles, we aim to explain 
why coarse clots lyse more quickly th an  fine clots, even when the to ta l fibrin concentration 
is constant. W hen spatial heterogeneity of the clot structure is taken into account and 
param eter values from the literature are used, fine clots degrade at the same speed as 
coarse clots (Figure 2.4, Table 2.3). By lowering the tPA  and PLG dissociation constants 
from the literature by two orders of m agnitude, we observe localization of lytic enzymes at 
the front and variation in lysis rates for different clot structures (Figures 2.4, 2.6, 2.7, and 
2.8). Stronger binding results in a decrease in the effective diffusion constant; molecules 
bind to  fibrin and thus are prevented from diffusing farther into the clot. The tPA  molecules 
rem ain bound until the fiber degrades, and it is only then  th a t they  can diffuse to  the next 
fiber and initiate lysis. This localization of tPA  results in sequential degradation of fibers, 
with one fiber degrading before degradation of the next fiber begins. Taking into account 












0 50 100 
Time (ms)
150 200
F ig u re  2.9. Delay in lysis after tPA  binds. Average concentrations of tPA  (solid black) and 
plasmin (dashed) bound to  a single th in  fiber in a fine clot are shown as functions of time. 
The change in fibrin concentration in the fiber (concentration at tim e 0 minus concentration 
at tim e t) is p lotted in gray. There is a delay after tPA  binds before plasmin is produced, and 
another delay after plasmin production before lysis begins, i.e., before the change in fibrin 
concentration is nonzero. These results were obtained using small dissociation constants 
(kD =  0.0036 and kD =  0.38 ^M ).
(Figure 2.9), we see how coarse clots can lyse faster th an  fine. W hen lysis is sequential 
(as when the smaller dissociation constants are used), the num ber of fibers in the clot is 
im portant; w ith fewer fibers, lysis needs to  be started  fewer times, and therefore there are 
fewer delays while plasmin is created. In this situation, a coarse clot with fewer fibers can 
lyse more quickly th an  a fine clot.
The large accum ulation of lytic proteins appears to  be the cause of the variation in lysis 
rates. Using dissociation constants from the literature, the increase in enzyme concentra­
tions, and therefore lysis, occur over a larger region which contains multiple fibers. W ith 
smaller dissociation constants, almost complete lysis of one fiber occurs before degradation 
of any other fiber begins. This suggests th a t the num ber of fibers in a clot (and not their 
thickness) is the main determ inant of lysis rate; w ith fewer fibers, the lytic process must 
be started  fewer times, which outweighs the longer tim e required to  degrade individual 
thick fibers. Lysis is slower in the thick and very thick clots compared to  their “ta ll”
clot counterparts, because the num ber of fibers are the same, bu t fibers are th inner in the 
“ta ll” clots, allowing them  to lyse more quickly. We cannot explain why it is necessary to 
have dissociation constants th a t are 10 0  tim es smaller th an  m easured values in order for 
the model to  predict th a t coarse and fine clots lyse a t different rates. E ither the meaning 
of the dissociation constant is different in the 1-D model compared to  the experimental 
quantity, or a 1-D model is simply incapable of distinguishing between lysis of fine clots and 
lysis of coarse clots w ithout significant assum ptions (like rate  constants th a t are orders of 
m agnitude different th an  m easured values). The challenge of determ ining w hether either of 
these options explains our results remains to  be resolved.
The heterogeneous fibrin model poorly predicts single fiber lysis -  not only are the lysis 
times too fast, bu t the relative lysis times between fibers of varying diam eter are too small. 
Experim ents show th a t, on average, a th in  fiber takes 3.1 m inutes to  degrade, while a thick 
fiber degrades in 5.4 m inutes [?]. Therefore, a th in  fiber lyses about 1.74 tim es faster than  
a thick fiber. W ith  dissociation constants from the literature (kD =  0.36 ^M  and kD =  38 
^M ), our model predicts th in  fibers lyse 1.021 times faster th an  thick fibers (74 s/72.5 s) 
and only 1.086 times faster th an  very thick fibers (78.75 s/72.5 s); essentially all fibers lyse 
in the same am ount of time. W ith  smaller dissociation constants (kD =  0.0036 ^M  and 
kD =  0.38 ^M ) the relative speeds increase, bu t the individual lysis times are unrealistically 
fast: th in  fibers lyse 1.22 times faster th an  thick fibers (7.415 s/6.065 s) and 3.37 times 
faster th an  very thick fibers (20.415 s/6.065 s).
W hile model results for single fibers are qualitatively correct and show th a t th in  fibers 
lyse faster than  thick fibers, the results are not quantitatively accurate, perhaps for several 
reasons. F irst, our single fiber fibrin concentration may be too small. The fibrin concentra­
tion per fiber has been estim ated to  be about 824 ^M  [?, ?], significantly higher th an  the 
29 ^M  we use. Second, the definition of lysis is likely different experim entally th an  it is in 
the model. We consider a fiber to  be lysed when 90% of its initial fibrin concentration has 
degraded. Experimentally, lysis of a fiber is simply the tim e at which the fiber is no longer 
visible through the microscope. It is unclear how this relates to  relative fibrin concentration. 
Finally, a 1-D model cannot account for transverse cutting. Real lysis seems to  proceed 
by transverse cu tting  across fibers, bu t w ith only one dimension there is no way to  model 
plasmin crawling across a fiber. We believe a higher dimensional model is required to  study 
lysis of individual fibers.
An im portant feature of blood clots is the mesh  of fibers. Fine clots contain more
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fibers and have a higher density of branch points th an  coarse clots [?], which could affect 
the num ber of times lytic enzymes m ust initiate lysis. A 1-D model cannot capture the 
complicated geometry of a blood clot. This lim itation of a 1-D model is dem onstrated 
by the inability of the model to  produce different fine and coarse front velocities upon 
inclusion of a more realistic, spatially varying fibrin concentration. Because clot structure 
plays an im portant role in the effectiveness of lysis, higher dimensional models are likely to 
be required in order to  answer questions about the patterns and rates of lysis of different 
clot configurations.
Using a continuum  model to  investigate the fibrinolytic system may also be problem atic 
because of the extremely low concentration of tPA. Even in experiments th a t inject a bolus 
of tPA  at concentration 5 nM (much higher than  the plasm a concentration of 70 pM), 
there are only 3 tPA  molecules per cubic micron in the clot. Assuming a pore size of 1 
^m  in a fine clot, the volume enclosed by nearest-neighbor fibers is on the order of 1 ^ m 3. 
This observation may partially  explain why fibers are cut laterally, ra ther th an  uniformly 
degraded [?]. W ith  3 tPA  molecules per cubic micron, there is a d istinct possibility th a t a 
particular fiber will encounter only a single tPA  molecule. T ha t tPA  molecule will facilitate 
the local creation of plasmin, but will not contribute to  plasmin production outside of this 
local region. Thus, plasmin activity on the fibrin fiber will be concentrated to  a narrow 
segment of the fiber length.
If there are only 3 tPA  molecules in a characteristic volume of clot, it is not valid 
to  trea t tPA  as a continuum. This observation, coupled w ith the conclusion th a t higher 
dimensional models are necessary to  study lysis of individual fibers and of varying clot 






We want to  elucidate the factors th a t influence lysis speeds in clots of varying structure, 
in an effort to  suggest targets for the design of new therapeutics aimed at breaking up 
blood clots. If plasmin cuts across fibers, a coarse clot w ith fewer fibers to  transect will 
presum ably be degraded faster th an  a fine clot w ith a higher fiber density because fewer 
“cuts” have to  be made. This explanation seems intuitive, however it is difficult to  confirm 
both  experim entally and w ith one-dimensional m athem atical models (see C hapter 2). In 
the current chapter we use a multiscale m athem atical model of fibrinolysis to  show th a t 
fiber num ber im pacts lysis speed, but so does the num ber of tPA  molecules relative to  the 
surface area of the clot exposed to  those molecules. Depending on the values of these two 
quantities (tPA num ber and surface area), coarse clots lyse faster or slower th an  fine clots.
O ur microscale model of single fiber lysis is described in detail in Section 3.1.1, and our 
macroscale model of full clot lysis is described in Section 3.1.2. Results from both  models 
are presented in Section 3.2, and implications of these results are discussed in Section 3.3.
3.1 The model
In C hapter 2, we included spatial heterogeneity in a determ inistic 1-D reaction diffusion 
model in an a ttem p t study lysis of fine and coarse clots. We concluded th a t these types 
of models are insufficient, both  qualitatively and quantitatively, to  explore lysis speeds for 
varying clot structures. Here we develop a three-dimensional (3-D), stochastic, multiscale 
model of fibrinolysis of a fibrin clot formed in plasma. Because tPA  appears in such 
low concentration (70 pM in plasm a [?], but even the 5 nM concentration used in some 
experiments is only 3 m olecules/^m 3 [?]), a determ inistic model (based on reaction diffusion 
PD Es) is not appropriate; our stochastic model tracks individual tPA  molecules ra ther than  
tPA  concentrations. In contrast, the plasm a concentration of PLG is 2 ^M  [?]. How the
model tracks PLG, as well as plasmin and fibrin, is described in detail below. The microscale 
model represents an individual fiber cross section, while the macroscale model represents 
the full, 3-D fibrin clot. D ata  collected from the microscale model is used in the macroscale 
model.
Experim ental evidence suggests fibers are cut transversely [?, ?, ?], so we assume th a t 
lysis of a fiber can be approxim ated by the degradation of fibrin w ithin a single cross section. 
Furtherm ore, we assume the cross section is an arrangem ent of protofibril cross sections. 
Each strand  of a two-stranded protofibril has three chains, a , ft, and y (Figure 3.1), which 
m ust be cleaved by plasmin, for a to ta l of six chains requiring cu tting  [?].
Terminology used from this point forward is as follows. A “binding site” is a structure 
on fibrin to  which one of the proteins tPA, PLG, or plasmin can bind. A “binding doublet” 
is a pair of adjacent binding sites. A “binding location” is a physical region on a fiber where 
binding doublets are located. “Exposed binding doublets” are doublets to  which proteins 
can bind. “Cryptic (or unexposed) binding doublets” are doublets th a t m ust be exposed 
by plasm in-m ediated degradation before they are able to  bind proteins. “Available binding 
sites” refers to  all the binding sites on the surface of a fiber, which we assume are the 




F ig u re  3.1. Schematic of a two-stranded protofibril. A protofibril is a linear aggregation 
of fibrin monomers. Each fibrin monomer has two pairs of three chains, a, ft, and 7 . Since 
a protofibril consists of two strands of half-staggered fibrin monomers, there are a to ta l of
6 chains (two each of a, ft, and 7 ) th a t m ust be cut by plasmin to  degrade the protofibril.
3.1.1 M icroscale m odel
Biochemical reactions th a t occur in a fiber cross section are considered in the microscale 
model. To simplify the numerics, the dom ain is a square of equal area to  a circular fiber 
cross section. A th in  cylindrical fiber w ith diam eter 100 nm has cross sectional area A =  
n (5 0 n m )2 «  (90 nm )2, so we use a square dom ain with side 90 nm. Plasm inogen and tPA  
binding sites are located 6 nm apart across a fiber [?], yielding 15 binding locations along 
a distance of 90 nm. This gives a to ta l of 152 equally-spaced binding locations w ithin the 
square dom ain (Figure 3.2(c)). A thick fiber (200 nm diam eter) has 302 binding locations. 
Each binding location is a physical region containing a specified num ber of binding doublets 
(Figure 3.2(d)), which are pairs of binding sites to  which tPA, PLG, or plasmin can bind. 
Initially each binding location contains one exposed doublet, w ith five other cryptic doublets 
th a t can be exposed by plasm in-m ediated cleavage. We th ink of a binding location as a 
cross section of a protofibril, and th a t the 6 binding doublets represent the 6 protofibril 
chains.
Several different reactions are included in the microscale model (Figure 3.3). The 
enzymes tPA, PLG, and plasmin bind to, and unbind from, binding doublets distributed 
throughout the domain. W hen tPA  and PLG are bound to  the same doublet, tPA  can 
activate PLG to  plasmin. It is believed th a t PLG molecules are small enough to  diffuse 
freely through pores in the fiber [?], so we assume th a t PLG from the plasm a phase can bind 
anywhere w ithin a fiber cross section. Our calculation in Appendix A seems to  contradict 
the idea th a t PLG can diffuse through a fiber; however, since PLG  is present while fibrin 
fibers form, it is still reasonable to  assume th a t PLG can be bound anywhere in a fiber 
cross section. We assume th a t the binding affinity of tPA  to  fibrin is so strong th a t tPA  
only binds to  doublets on the fiber surface, even though it is capable of diffusing through 
the fiber (kDPA =  0.36 ^M  [?]). W hen plasminogen and tPA  unbind from doublets, they 
return  to  the plasm a phase. W hen plasmin unbinds, we imagine it is preparing to  crawl to 
a neighboring binding site or binding location (i.e., w ithin a protofibril or to  a neighboring 
protofibril), as proposed in Weisel et al. [?], ra ther th an  entering the plasm a phase. This 
protects the plasmin from strong plasm a-phase inhibitors, and consequently prevents the 
loss of plasmin molecules from the system. Plasm in crawling will be discussed in more detail 
in the following paragraph.
A binding doublet, which represents a portion of a fibrin monomer, can be degraded 
by a bound plasmin molecule. W hen a doublet is degraded, all proteins bound to  it are
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F ig u re  3.2. Schematic of multiscale model. (a) D iagram  of macroscale clot. The clot is 
formed in a chamber w ith a fibrin-free region in which tPA  is added. W hen we simulate 
the model, we only consider a 1 0 0 -^m  x 1 0 0 -^m  x p.s. (pore size) periodic slab of the clot, 
denoted by the dashed line. We consider fibrin-free regions of different sizes, so H  (height of 
fibrin-free region) varies. (b) Macroscale diffusion of tPA  on a lattice. W hite circles indicate 
the fibers th a t the tPA  molecule (black circle) can reach in one tim e step. The tPA  molecule 
can diffuse to  the four neighboring edges in the plane of the page, diffuse out of the page to 
the two neighboring solid edges (which each represent half of a fiber extending out of the 
plane), or diffuse into the page to  the two neighboring dotted  edges (which represent half 
of the fibers extending into the plane). Boundary conditions are periodic in the z-direction, 
and reflecting in the other two dimensions. (c) Microscale dom ain for th in  fiber. This is a 
90 nm x 90 nm square dom ain w ith 225 binding locations (gray squares) spaced 6 nm  apart 
(not draw n to scale). One tPA  molecule (black dot) is random ly placed on a doublet in the 
first row of the domain, which represents the fiber surface. (d) One binding location. Each 
binding location initially contains one exposed doublet (white boxes) and five unexposed 






F ig u re  3.3. Microscale model reaction diagram . The arrows show the possible reactions 
for each tim e step. Solid arrows indicate binding and unbinding of enzymes, with letters 
identifying which enzyme is involved (T is tPA, P  is plasmin, and Plg is plasminogen). 
Dashed arrow indicates activation of plasminogen to  plasmin, and dotted  arrows indicate 
plasm in-m ediated degradation of doublets or exposure of cryptic binding sites. A note on 
notation: N j  is a doublet with species i and j  bound, for i, j= 0  (nothing), 1 (tPA ), 2 (PLG), 
or 3 (plasmin). N  is a cryptic doublet, and N p lg  is a doublet w ith only plasminogen or 
nothing bound (N 22, N02, or Noo). 0 is a degraded doublet, and 03 is a degraded doublet 
w ith a bound plasmin molecule.
imm ediately released and treated  as if they had unbound. We assume th a t PLG  and tPA  
are no longer able to  bind to  this degraded doublet. However, because we assume th a t 
plasmin is never entirely unbound, bu t ra ther crawls to  neighboring doublets in the cross 
section, we allow plasmin to  move anywhere in the domain, regardless of w hether or not 
the doublets are degraded. We imagine plasmin cuts a “groove” in the fiber, w ith frayed 
ends of protofibrils on either end of the groove. By assuming th a t there are always frayed 
ends of fiber to  which plasmin can crawl, we allow plasmin to  occupy a doublet th a t has 
been degraded, but do not allow it to  degrade th a t doublet any further. However, bound
plasmin can expose initially cryptic doublets a t whatever binding location it occupies, even 
if it is bound to  a degraded doublet. We assume th a t only one plasmin molecule can be 
bound to  a particular degraded doublet.
Our sim ulation of the lytic process begins with one tPA  molecule placed random ly 
on the surface of the fiber (the first row of the com putational domain, Figure 3.2(c)). 
Because tPA  is found at low concentrations, we consider only cross sections w ith a single 
tPA  molecule. We apply the Gillespie algorithm  [?, ?] to  find the event tim es for the various 
microscale reactions depicted in Figure 3.3. The Gillespie algorithm  gives a statistically 
exact realization of the process described by the m aster equation,
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d P
—- (x, t \x 0, to) =  /  [a?(x — v?)P(x — v ?, t |x 0, t0) — a?(x)P(x,  t\x0, to)].
dt
j = 1
Here P (x, t \x 0, t 0) is the probability th a t the system is in sta te  x  a t tim e t having been in 
sta te  x 0 a t tim e t0. Given the current sta te  x  at tim e t, and the set of possible reactions 
and reaction rates as described by the stoichiometric vectors v? and propensity function
a, the Gillespie algorithm  makes provisional choices of the length of tim e after t  th a t each 
possible reaction will happen. (See Appendix C for details about the Gillespie algorithm, 
x, Vj , a.) The next tim e step (and associated event) is chosen to  be the minimum of the 
Gillespie provisional reaction times.
We explicitly model only the doublets th a t contain tPA  or plasmin. Em pty doublets 
and doublets w ith only PLG bound are grouped into one sta te  called N PLG (see Figure 3.3 
caption for explanation of notation). Assuming th a t PLG  binding is in quasi-steady state  
gives us probabilities of PLG being on doublets. We do not model individual PLG molecules. 
The dissociation constant for PLG binding to  fibrin changes depending on w hether fibrin 
is intact or “nicked” (partially degraded): kDtact =  38 ^M , kDcked =  2.2 ^M  [?, ?]. In the 
model, any doublet th a t was cryptic initially and became exposed is considered to  be on 
nicked fibrin. The probability of a nicked or in tact N PLG being in sta te  N 00, N 02, or N 22 is 
calculated using the quasi-steady sta te  assum ption for PLG (Appendix D).
W hen a reaction releases the tPA  molecule (either by unbinding or degradation of the 
doublet to  which it was bound), we calculate the probability of the molecule rebinding to 
the same cross section, ra ther than  diffusing away. If the tPA  rebinds, we assume it binds 
to  an available binding site on a doublet a t most two binding locations away from where
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it unbound. If the molecule does not rebind, we assume it has diffused away from the 
cross section, and is removed from the system, and th a t no more plasmin can be produced. 
We calculated the rebinding probability by solving a 3-D escape problem as described 
in Appendix E, and found th a t for the situation and param eters of relevance here, tPA  
essentially never rebinds.
We define lysis to  be complete (i.e., the fiber to  be cleaved) when a specific fraction 
(typically 2/3) of the to ta l num ber of binding doublets (exposed plus unexposed) have 
been degraded by plasmin. We assume fibers are under tension [?], hence fibers snap after 
a percentage of binding doublets are degraded. Our assum ption th a t both  th in  and thick 
fibers lyse when 2/3 of the doublets are degraded is reasonable if we assume th a t thick fibers 
are under four tim es as much tension as th in  fibers. We present an intuitive justification for 
this assum ption. Imagine we pull on a fine and on a coarse clot (described in the following 
section) w ith a fixed force in a fixed direction. The cross sectional areas of the two clots are 
the same, bu t there are different numbers of fibers in each area. In fact, there are about 
four times as many th in  fibers in a given area as there are thick. So, if the same load is 
distributed among the given fibers, a single thick fiber must bear four times the load of a 
single th in  fiber.
In summary, the microscale model is w ritten algorithm ically as follows:
1. Initialize the system, set final1 (a prescribed final tim e), and random ly place one tPA  
molecule on the first row of binding locations.
2. Determ ine w hether the tPA-containing doublet is N 10 or N 12 using the quasi-steady 
sta te  approxim ation for PLG.
3. W hile t <  final:
a. apply Gillespie algorithm  to  each doublet containing a tPA  or plasmin molecule 
to  determ ine the next reaction event and associated time.
b . assign the smallest tim e from step a  as the next tim e step. U pdate t and use the 
corresponding event to  update  the system.
i. If the event results in the unbinding of tPA, calculate the rebinding proba­
bility to  determ ine whether tPA  rebinds or is removed. For our param eters, 
tPA  is always removed.
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1tflnai is sufficiently large so that it does not interrupt degradation of a fiber undergoing lysis
ii. If the event results in the unbinding (i.e., crawling) of plasmin, random ly 
assign plasmin to  an available binding site on a neighboring binding location 
(it is allowed to  stay on its current binding location), and update the state  
of the new doublet.
d . calculate the percentage of degraded doublets.
i. If degradation <  2/3, return  to  step a.
ii. If degradation >  2/3, stop the algorithm  because lysis is complete.
4. If t  > tflnai, algorithm  term inates and lysis fails.
From the microscale model we save the tim e tPA  unbound from the cross section (the 
tPA  leaving tim e), the num ber of plasmin molecules th a t were created, and the tim e at which 
lysis completed (the lysis tim e). We use this information from hundreds of microscale model 
simulations to  create distributions th a t we use in the macroscale model.
3.1.2 M acroscale m odel
D ata  generated from the microscale model are used in a macroscale model of clot lysis. 
We make the simplifying assum ption th a t the clot is a 3-D square lattice (ra ther th an  a 
tangled mesh of fibers), w ith each lattice edge representing one fiber. Pore size, defined 
as the distance between fibers, is the length of one fiber. To mimic experiments, the clot 
is assumed to  be contained in a small chamber w ith volume V =  depth  x w idth x height 
(Figure 3.2(a)). We assume the w idth and height of the chamber are equal, and th a t 
the depth  of the chamber is of the same order of m agnitude. R ather th an  model the full 
3-dimensional system, we consider a periodic slice of clot, w ith depth  equal to  a single 
pore size. We th ink of this slice as running between edge midpoints, so the 1-fiber-depth is 
actually composed of two halves of two separate fibers. To obtain the lattice dimensions we 
fix the fibrin concentration per fiber a t 824 ^M  [?, ?], the fibrin concentration in the clot 
a t 8.8  ^M  [?], and the height and w idth of the chamber a t 10 0  ^m  (to assure the system is 
big enough to  avoid boundary effects). Then using the radii of the fibers, we calculate the 
pore size and the num ber of fibers required to  keep the concentrations a t their fixed values. 
This results in a fine clot w ith 13,333 fibers and pore size 1.42 ^m , and a coarse clot with 
3,400 fibers and pore size 2.84 ^m . N , the num ber of nodes in one row of the lattice, is 
thus equal to  67 for a fine clot and 34 for a coarse clot.
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A fibrin-free space of height H  extends above the clot chamber (Figure 3.2(a)). We fill 
this fibrin-free volume with a tPA  solution to  mimic a therapeutic  bolus of tPA  adm inistered 
at the edge of a clot (this also mimics many in vitro experim ents). We prescribe the initial 
tPA  concentration in the fibrin-free space and we can vary the bolus size by changing H . 
The tPA  molecules are uniformly d istributed on ghost lattice edges in this fibrin-free volume. 
These edges are arranged in the same square lattice form ation as the clot, bu t they  do not 
contain fibrin and hence cannot be degraded.
Since our aim is to  compare macroscale lysis velocities between two different clots, it is 
necessary to  use the same to ta l fibrin concentration in both  fine and coarse clots, and to  use 
the same relative am ount of tPA  to  initiate lysis. We imagine the coarse and fine clots are 
formed in the same size chamber, so their volumes are equal. Since we only model a periodic 
slab of each clot, of depth  equal to  pore size, and because the pore size is twice as big in the 
coarse clot, the volume of clot (as well as the volume of the fibrin-free region) is also twice 
as big. Therefore, we put twice as many tPA  molecules in the fibrin-free region abu tting  the 
coarse clot as we do in the fine clot. This assures th a t the to ta l tPA  concentration averaged 
over the fibrin-free volume is conserved.
Detailed biochem istry was considered in the microscale model, so the macroscale model 
includes only tPA  binding, unbinding, and diffusion, as well as degradation of fibers. W hen 
a tPA  molecule binds to  a fiber it initiates the lytic cascade on the microscale. The molecule 
is assigned a leaving tim e using the microscale model leaving-time distribution. W hen the 
current tim e is greater th an  or equal to  the leaving time, the tPA  molecule unbinds. Using 
microscale data , the tPA  leaving tim e determines the num ber of plasmin molecules th a t will 
be created in th a t particular cross section. The num ber of plasmin molecules determines 
the tim e it will take the fiber to  be cut (see Section 3.2.1.3 for more details). In this way, 
every edge to  which tPA  binds has an associated degradation time. W hen the current tim e 
is greater th an  or equal to  an edge’s degradation time, the edge is degraded and any tPA  
still bound to  it is released.
D uring each fixed tim e step, we allow tPA  to bind or unbind and any unbound tPA  to 
move by diffusion to  a neighboring fiber. tPA  in the fibrin-free region can only diffuse, as 
there is no fibrin to  which it may bind. Reflecting boundary conditions are imposed on the 
four sides of the clot adjacent to  the walls of the microchamber, and periodic boundary 
conditions are imposed in the small th ird  dimension since we consider a periodic slab of 
clot.
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The size of the fixed tim e step used in the macroscale model is the typical tim e needed for 
one molecule to  diffuse to  one of the eight neighboring edges. In the simulations, we associate 
every tPA  molecule with a particular edge so th a t all the macroscale events happen on the 
lattice edges. By associating each tPA  molecule with one edge, we approxim ate the 3-D 
diffusion problem by having tPA  hop on the lattice (Figure 3.2(b)). In this approxim ation, 
we th ink  of an unbound molecule associated w ith an edge as being anywhere w ithin a small 
distance of th a t edge, not necessarily directly on the fiber. A bound tPA  molecule is bound 
directly to  the edge on which it resides, bu t we do not model the exact location of tPA  on 
a fiber, only which fiber tPA  occupies. For simplicity in deriving the macroscale diffusion 
rules, we assume th a t molecules associated with a particular edge are located at the fiber 
m idpoint (white circles in Figure 3.2(b)). W hen multiple tPA  molecules are bound to  the 
same fiber, we assume they are bound to  different binding sites along the length of the 
entire fiber (and therefore capable of starting  lysis in different cross sections), but for the 
purpose of diffusion we still consider them  to  be a t fiber m idpoints. The degradation tim e 
for an edge with multiple bound tPA  molecules is the minimum of the tim es obtained for 
each molecule. Since tPA  can still diffuse in the whole dom ain regardless of degradation 
sta tus of edges, tPA  molecules may be associated w ith degraded edges, but cannot bind to 
them .
To derive the tim e it takes a molecule to  diffuse to  a neighboring fiber, consider a tPA  
molecule on one of the horizontal edges (Figure 3.2(b)). A neighboring edge is defined 
as one of the eight closest edges, as m easured diagonally from the edge m idpoint. So 
the neighboring edges of a fiber oriented in the x-direction will be oriented in the y- and 
z-directions, since these are closer, diagonally, than  any other x-direction edges. Let P j  k 
be the probability of a tPA  molecule being at edge i, j ,  k at tim e n. Let q be the probability 
of its moving to  a neighboring edge. Then
=  ( 1  -  q)Pi,j,k +  8  {P i-1,j+1,k +  Pi+1,j+1,k +  Pi+1,j—1,k +  p - i j - i , k  
_ L  pn I -pn _ |_  -pn . -pn \
+  P i — 1,j,k+1 +  P i+1,j,k+1 +  P i+1,j,k—1 +  P i —1,j,k-1 J
d  P  q
= ^  A t—  ~  8 ^P (x  -  ^ x ,y  +  Ay, z) +  P (x  +  Ax, y +  A y , z ) +  P (x  +  A x ,y  -  A y ,z)
+  P  (x — Ax, y — Ay, z) +  P  (x — Ax, y, z +  Az) +  P  (x +  Ax, y, z +  Az)
+  P  (x +  Ax, y, z — Az) +  P  (x — Ax, y, z — Az) — 8P  (x, y, z ) }.
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Expanding the right hand side gives
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A d P  q /  A 2 d2P  , 2 d 2P  . 2 d 2P \  . .
A t m  =  8  ( 4A x? f t ?  +  2 A y2 w  +  2A ‘  8 5 2 )  ■ (3' 1)
where A x =  Ay =  A z =  ? (pore size). Doing this derivation for a molecule on an edge in 
the y-direction results in the equation
A d P  q (  A 2 d2P  „ A 2 d 2P  A 2 3 2P \  , .
A t rn = 8  ( 2 A x 2 dX 2  +  4 A y2^  +  2 A z 2 - d j ? ) . (3 .2)
while the derivation for a molecule on an edge in the z-direction results in the equation
d P  q f  \  2d2P  A 2 d 2P  „ A 2 d 2P \  . .
A ti «  = 8  ( 2 A x 2  ^ + 2 A y2 + 4 A z 2 - w ) . (3.3)
Recall th a t if a tPA  molecule moves, it must  move onto an edge oriented in one of the other 
two directions. So there is biased movement away from fibers oriented in the same direction 
as the fiber with tPA. B ut because this is true  for fibers oriented in all three principal 
directions, the overall diffusion is given by the average of Equations (3.1) - (3.3). This gives
d P  =  W 2 P.
dt
where D  =  (pore size) 2 is the diffusion coefficient for tPA. Rearranging gives the macroscale 
tim e step:
A t =  (pore size)2 (3 4)
q =  12D ' ( . )
We do not explicitly know q, the probability of a molecule moving to  a neighboring edge, 
bu t it does not m atter since the ratio  is fixed. As long as we choose a q th a t makes 
A t small enough th a t our m ethod converges, the actual choice of q does not m atter. For 
the macroscale results presented in this chapter we use q=0.2, D  =  5 x 10- 7  cm2/s  so 
A t «  6.72 x 1 0 - 4  s for a fine clot and 2.69x10-3 s for a coarse clot.
Because binding events occur continuously and independently, every tim e a tPA  molecule 
unbinds or diffuses to  a new edge, we use an exponential distribution to  choose the tim e at 
which the molecule will bind to  the edge:
t =  t ln (fi)  A t 
tbind = t kOPAb 2 .
where t is the current time, f  is a random variable uniformly distributed on [0,1] ( f  £ 
U [0,1]), kOpA is the binding rate of tPA to fibrin, and b is the concentration of available tPA 
binding sites. We bind a molecule at time t (a multiple of At) if tbind < t. The subtraction 
of a half time step, ^ , in the definition of tbind eliminates bias in the algorithm and implies 
tha t binding actually occurs at the time t closest to tbind. For the same reason, we also 
subtract ^  from the degradation and unbinding times selected from the microscale model 
distributions.
The macroscale model is expressed algorithmically as follows:
1. Determine the clot geometry and At, set t =  0, fix tfinal (a prescribed final time), and 
initialize the degradation times of all edges to 0.
2. Randomly place a specified number of tPA molecules in the fibrin-free region.
3. For t <  final:
a. set t =  t +  At.
b. degrade any edges with nonzero degradation times < t, and unbind any tPA 
molecules tha t were bound to the degraded edges.
c. check the unbinding times for all bound tPA molecules, unbind any with times
< t.
d. assign each newly unbound molecule a binding time, tbind.
e. for each unbound molecule, pick a random number f  £ U [0, 1] and
i. if f  < (1 — q), the molecule does not move.
A. If tbind > t or the edge has already been degraded, the tPA molecule 
remains unbound.
B . If tbind < t and the edge the molecule is on has not been degraded, 
bind the molecule and use the microscale distributions to find the new 
unbinding time, the number of plasmin molecules produced, and the 
degradation time for tha t fiber.
ii. if f  > (1 — q), the molecule has the opportunity to move, but may bind 
before it can do so.
A. If tbind > t or the edge has already been degraded, randomly move the 
tPA to a neighboring edge and calculate a new binding time for the tPA 
to tha t edge.
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B. If tbind < t and the edge the molecule is on has not been degraded, pick 
a random number, f 2 e  U [0, 1].
I. If f 2 > btnd), then movement happens before the tPA binds. Ran­
domly move the tPA to a neighboring edge and calculate a new binding 
time for the tPA to tha t edge.
II. If f 2 < b;nd), the molecule binds and therefore cannot move. Use 
the microscale model distributions to calculate a new unbinding time, 
the number of plasmin molecules produced, and the degradation time 
for the fiber.
f. return to step a.
3.2 Results
3.2.1 M icroscale m odel results  
To explore the range of model behavior (and because not all parameter values have 
been measured), we use four different parameter sets, shown in Table 3.1. Since this is a 
stochastic model, we report the statistics of many independent simulations. The microscale 
model results presented in this section are given as median (first quartile Q1, third quartile 
Q3) of 600 simulations, and the macroscale model results are mean ±  standard deviation of 
10 simulations. In some instances of the microscale simulation, lysis of an individual fiber 
did not occur because tPA unbound before creating any plasmin. These failed runs are 
excluded from single fiber lysis time data since they would yield an infinite lysis time; the 
microscale results presented are therefore the average lysis times conditional upon successful 
lysis.
3.2 .1 .1  tP A  leaving tim e
From the microscale model we obtain distributions of the tPA leaving time (the time at 
which tPA diffuses away from the cross section), the number of plasmin molecules produced, 
and the single fiber lysis time for thin and thick fibers for all parameter sets (Table 3.2). 
As expected, the thick fiber takes longer to degrade. Unexpectedly, for Case A and B 
parameters, tPA stays bound to the thick fiber slightly longer than it stays bound to the 
thin fiber, even though the same tPA binding and unbinding rates are used. The tPA 
unbinding rate in Cases A and B is small enough tha t tPA rarely unbinds. Instead, tPA
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T able 3.1. Parameter sets used in the model. Case A is the baseline parameter set. 
tPA binding and unbinding rates are changed in Cases C and D, but the dissociation 
constant (ktpA =  kffA/kOnA) remains fixed. The dissociation constant for PLG is different 
depending on whether fibrin is intact or nicked, and the dissociation constant for tPA is 
different depending on whether tPA is bound to a doublet with PLG or without PLG. klon 
and kff are the binding rate of species i to fibrin and the unbinding rate of species i from 
fibrin, respectively, for i= tPA , PLG, or plasmin (PLi). kaPt is the catalytic rate constant 
for activation of PLG to plasmin, knat is the catalytic rate constant for plasmin-mediated 
exposure of cryptic binding doublets, and kdeg is the plasmin-mediated rate of fibrin 
degradation. We know the dissociation constants for tPA and PLG, but not the individual 
rates, so references in the table are for kD. * Estimated.
P a ra m e te rs C ase A C ase B C ase C C ase D R eference
1­sgedk 10 1 10 1
kpffLG (s-1) 3.8 3.8 3.8 3.8 [?, ?]
k ^ 0 , intact (^M - 1s-1 ) 0.1 0.1 0.1 0.1 [?]
kpLG, nicked (^M - 1s-1 ) 1.7273 1.7273 1.7273 1.7273 [?]
kffLi (s-1 ) 38 38 38 38 [?]*
kffA, with PLG (s-1 ) 0.0002 0.0002 0.02 0.02 [?]
kffA, without PLG (s-1 ) 0.0036 0.0036 0.36 0.36 [?]
kOJA (^M - 1s-1 ) 0.01 0.01 1.0 1.0 [?, ?]
-1sk 50 50 50 50
kjat (s-1 ) 10 1 10 1
is released from the fiber when plasmin degrades the doublet to which it is bound. For 
plasmin to force the release of tPA, the two molecules must be sharing a doublet when a 
plasmin-mediated degradation event is chosen by the Gillespie algorithm. W ith the given 
parameter values, plasmin molecules can crawl many times between degradation events. 
Thick fibers have more doublets tha t the plasmin molecules can crawl to, so plasmin shares 
a doublet with tPA less frequently in thick fibers than in thin; this is responsible for the 
increased tPA residence time on thick fibers. W ith Case C and D parameters, the tPA 
unbinding rate is larger than in Cases A and B, and tPA almost always unbinds before it 
encounters plasmin. The tPA leaving times in thin and thick fibers are very similar in these 
cases since the dynamics are dominated by the tPA kinetic rates, which do not depend on 
fiber size.
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T able 3.2. Microscale model results. Entries are median (Q1, Q3) of 600 independent 
simulations, except for lysis time, which is the result of only those simulations tha t produced 
a plasmin molecule. The “Number of PLi” column gives data about the average total 
number of plasmin molecules produced in one run. The column labeled “Runs with PLi” 
gives the number of runs, out of 600, tha t resulted in production of plasmin. f Q1 and the 
median are both 0 because the majority of the runs generated no plasmin. * To generate 
enough lysis time data, 1800 runs were used instead of 600.
P a ra m e te rs F ib e r
d ia m e te r
(nm )
tP A  leaving 
tim e  (s)
N u m b er 
o f P L i




7.98 (3.26, 14.90) 
8.46 (3.34, 16.80)
2 (1, 3) 
2 (1, 3)






37.60 (19.40, 69.39) 
42.35 (17.79, 73.64)
7 (4, 13) 
7 (4, 14)





1.60 (0.64, 3.13) 
1.63 (0.66, 3.19)
0 (0, 1)t 
0 (0, 1)t











1.94 (0.77, 3.87) 
1.90 (0.85, 3.92)
0 (0, 1)t 
0 (0, 1)t




3.2 .1 .2  D egrad ation  and single fiber lysis
Since there are four times as many binding doublets in a thick fiber as a thin fiber, it 
would be reasonable to expect tha t a thick fiber would take four times as long to degrade. 
The model results support this hypothesis (Figure 3.4). Because we do not know the 
exact percentage of doublets that must be degraded before the fiber can be considered 
lysed, we vary our definition of lysis from 1% of total doublets degraded to 95% of total 
doublets degraded and see how median lysis times are affected. As Figure 3.4(a) shows, thin 
fibers lyse four times faster than thick fibers, on average, regardless of how we define lysis. 
Normalized single fiber lysis time distributions for Case C parameters are shown in Figures 
3.4(b), 3.4(c), for lysis defined as degradation of 2/3 of the total doublets. The thick and 
thin single fiber lysis time distributions look very similar when the thin fiber lysis times are 
multiplied by a factor of 4.1. This is close to the factor of 4 tha t relates the medians of the 
data, as seen in Figure 3.4(a).
Insight into how the degradation rate kdeg affects lysis is gained by comparing Case A to 
Case B. W ith baseline parameter values (Case A), plasmin attem pts to degrade a doublet 
10 times per second, on average. In the case with low degradation rate (Case B), plasmin 
does this once per second. For thick fibers, 3.5 times more plasmin is produced in Case B 
than in Case A on average (7 vs. 2 molecules, respectively). While it seems reasonable that
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F ig u re  3.4. Single fiber lysis time data for Case C parameters. (a) Single fiber lysis 
times as a function of the percentage of binding doublets tha t must be degraded for lysis 
to be complete. Black circles denote median lysis time, top error bar (black) represents 
the 95th percentile and bottom error bar (black) represents the 5th percentile, for a thick 
fiber. Red triangles denote 4 x(median lysis time), with top and bottom error bars (red) 
4 x(95th percentile) and 4x(5th  percentile), respectively, for a thin fiber; thick fiber lysis 
times are approximately four times longer than thin fiber lysis times. (b), (c) Normalized 
single fiber lysis time distributions for a thick fiber and a thin fiber, respectively, with lysis 
defined as degradation of 2/3 of the total number of doublets. The thin fiber lysis times are 
scaled by a factor of 4.1, showing tha t the range of the thick fiber lysis time distribution is 
approximately four times larger than the range of the thin fiber lysis time distribution. The 
distributions have several peaks because the lysis times directly correlate to the number 
of plasmin molecules produced, which is discrete. For example, the large, right-most peak 
corresponds to runs when only one plasmin molecule was created.
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more plasmin would result in faster lysis, lysis times are actually about 1.9 times longer 
with lower degradation rates because the plasmin is less efficient (11.38 min for Case B vs. 
5.98 min for Case A). A similar result is seen for thin fibers. If plasmin degrades only once 
per second, approximately ten times more plasmin is needed to get the same lysis time as 
Case A. Clearly lysis depends on plasmin efficiency, not solely on the number of plasmin 
molecules produced.
The degradation rate, kdeg, affects not only the lysis time, but also the pattern of 
lysis. W ith a higher degradation rate, lysis is localized and moves like a wave through 
the cross section (Figure 3.5(a)). Plasmin molecules are created on the doublet with tPA, 
and they cannot move very far between degradation events. Therefore, plasmin degrades 
the area around the tPA doublet first. The plasmin molecules slowly move away from the 
tPA doublet, systematically spreading lysis as they go. Contrast this with Case B, where 
kdeg =  1 s-1 . Here, plasmin can crawl a considerable distance between degradation events 
and start lysis in many locations throughout the cross section (Figure 3.5(b)). Further 
investigation is required to determine whether the pattern of microscale lysis is important, 
or if the single fiber lysis time alone is important for macroscale degradation.
3 .2 .1 .3  M icroscale m odel data  used in m acroscale m odel
The microscale data is incorporated into the macroscale model as follows. Running 600 
independent simulations of the microscale model with each fiber diameter, 100 nm and 200 
nm, generates the data in Figure 3.6. First we obtain an empirical cumulative distribution 
function for tPA leaving times (Figure 3.6(a)). This distribution is used in the macroscale 
model to randomly pick a tPA leaving time every time a tPA molecule binds to a fiber. 
Next, we bin the number of plasmin molecules produced into tPA leaving time intervals. 
For tPA leaving times ranging from 0-30 seconds, we create 5-second intervals in which to 
bin the plasmin data. For tPA leaving times greater than 30 seconds, we create 10-second 
intervals in which to bin the plasmin data. We find the mean of the data in each bin and fit 
a line to these means, weighted by the number of data points in each bin (Figure 3.6(b)). 
In the macroscale model, we use this line to determine the number of plasmin molecules 
produced for a given tPA leaving time. Unsurprisingly, more plasmin is produced for larger 
tPA leaving times. Finally, we fit a power function to the scatter plot of lysis time versus 
plasmin number data and use it to determine the lysis time (Figure 3.6(c)). As expected, 









F ig u re  3.5. Fibrin degradation in a cross section of a 200 nm diameter fiber. Each pixel 
represents a binding location that contains 6 doublets. The color bar indicates level of 
degradation, with lighter colors denoting higher levels of degradation. The pixel ranges 
from black if none of the doublets at a particular binding location have been degraded, 
to white if all 6 binding doublets have been degraded. Top images show cross sections 
with one-tenth of binding doublets degraded, and bottom  images are cross sections with 
one-third of binding doublets degraded. The arrows point to a white star in the top images, 
which indicates the location of tPA. (a) Case A parameters. W ith kdeg =  10 s-1 , lysis is 
localized because plasmin is not able to move very far between degradation events. Top 
image at t =  33.91 s, bottom  image at t =  72.42 s. (b) Case B parameters. W ith kdeg =  1 
s-1 , lysis happens throughout the cross section because plasmin can move a considerable 
distance between degradation events. Top image at t =  84.74 s, bottom  image at t =  188.82 
s.
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is more plasmin. The data displayed in Figure 3.6 is all the microscale model information 
needed for the macroscale model.
3.2.2 M acroscale m odel results  
3.2 .2 .1  Q ualita tive  observations
Depending on the tPA binding site concentration per fiber, macroscale lysis can proceed 
as a front with a high accumulation of tPA molecules at the front (Figure 3.7(a), 3.7(b)), 
or lysis can occur throughout the clot in no particular pattern (Figure 3.7(c), 3.7(d)). We 
imagine that tPA binding sites are distributed throughout the fibrin fibers, but only those 
binding sites on the surface of the fiber are available to tPA as it diffuses through the 
clot. The thick fibers have half as many available binding sites per unit volume as the thin 
fibers. The argument is as follows. The binding site concentration, b, we use to calculate 
macroscale binding of tPA is the number of available binding sites per volume, which is the 
number of fibers per volume times the available binding sites per fiber. The former scales 
like ^3 and the latter is proportional to surface area per fiber, and so scales like r 2.
Because the radius of our thick fiber is twice the radius of our thin fiber, bcoarse =  2fine. 
The average length of time it takes for a tPA molecule to bind to a fiber is (kOnAb)—1. So for a 
given binding rate, kOpA, the time to bind is shorter for a higher b. A long tPA binding time 
means tha t the molecule can diffuse farther between binding events, effectively distributing 
the tPA more evenly throughout the clot. If tPA binds to fibers located throughout the 
clot, then it also initiates lysis on fibers located throughout the clot. Macroscale lysis in 
this case is not front-like (Figure 3.7(c), 3.7(d)). On the other hand, a short binding time 
means that the molecule is not able to diffuse very far between binding events, effectively 
localizing tPA at the clot front. In this case, lysis proceeds as a front (Figure 3.7(a), 3.7(b)).
3.2 .2 .2  Lysis front ve locity  and degradation  rate
Besides the qualitative conclusions drawn above, we also obtain quantitative results 
about macroscale lysis. We use two measures of macroscale lysis: front velocity and 
degradation rate. We measure front velocity of a given column of the lattice by tracking in 
time the y-position (same axes as Figure 3.2(b)) of the first edge oriented in the y-direction 
tha t contains fibrin. This gives position vs. time data from which we can estimate a front 
velocity. We do this for each of the columns extending above the N  nodes on the bottom 




F ig u re  3.6. Microscale model results for 100 nm fiber (red) and for 200 nm fiber (black) 
with Case A parameters. Red triangles indicate thin fiber data, black circles indicate thick 
fiber data. (a) Empirical cumulative distribution function of tPA leaving times. (b) The 
best fit lines of the data relating tPA leaving time to the number of plasmin molecules 
produced. The raw data is binned in 5 second intervals from 0 to 30 s (e.g., 0-5 s, 5-10 
s, etc.), and 10 second intervals from 30 s onward. Means of each bin are plotted at the 
interval midpoint. A line is then fit to the means, weighted by the number of data points in 
each bin. (c) The best fit curves of the data relating number of plasmin molecules to single 
fiber lysis time.
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(c) b = 1 ^M, t = 1 min (d) b = 1 ^M, t = 4 min
F ig u re  3.7. The 3-D distribution of tPA and state of degradation for a coarse clot with Case 
A parameters. Approximately 44,200 tPA molecules (a 5 nM concentration) were randomly 
distributed in the 51.68 x 100 x 3.04 ^m 3 fibrin-free region abutting the clot. Green asterisks 
denote bound tPA; unbound tPA is not plotted. Black segments represent fibrin fibers. The 
dashed lines in (b) and (d) indicate the border of the initial clot. The physical distance 
between lattice nodes is 3.04 ^m. (a), (b) State of the clot approximately 1 min and 4 min, 
respectively, after the introduction of tPA. The tPA binding site concentration per fiber is 
b =  250 ^M. (c), (d) State of the clot approximately 1 min and 4 min, respectively, after 
the introduction of tPA. The tPA binding site concentration per fiber is b =  1 ^M.
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T able 3.3. Macroscale model results for Case A parameters with a 5 nM tPA concentration. 
Entries are mean ±  standard deviation of 10 independent simulations. Front velocity 
calculations do not make sense for simulations in which lysis was not front-like, hence 
the “—” in some entries. b is the concentration of available tPA binding sites and H  is the 
height of the fibrin-free region abutting the clot.
C lo t
t y p e
b (^M ) H  (^m ) F ro n t velocity  
(^ m /m in )
D e g ra d a tio n  ra te  
(% f ib e rs x 10- 1/s )
fine 2 51.68 — 4.29 ±  0.083
coarse 1 51.68 - 4.11 ±  0.101
fine 500 51.68 18.39 ±  0.47 3.03 ±  0.017
coarse 250 51.68 16.83 ±  1.00 2.64 ±  0.048
fine 500 3.04 10.02 ±  0.43 1.69 ±  0.015
coarse 250 3.04 10.76 ±  0.90 1.75 ±  0.025
lysis front velocity for the given simulation. We also calculate the standard deviation. We 
do 10 independent simulations, so the results presented in Table 3.3 are means of the 10 
means ±  means of the 10 standard deviations. Front velocity calculations begin when the 
first fiber degrades, not when the bolus of tPA is added to the fibrin-free region. We could 
instead have tracked how the position of fibers oriented in the z- or x-direction changes in 
time, but results would not be significantly different.
Degradation rate is a useful measure of lysis speed when the pattern of lysis is not 
front-like. To calculate degradation rate, we plot the percentage of fibers degraded as a 
function of time. Lysis begins sometime after the addition of tPA, and lysis of the last few 
fibers takes a bit longer, but the plot is linear in the middle range of times from shortly after 
lysis begins to shortly before lysis ends. Fitting a line to the linear part of this plot allows 
us to estimate a (percent degraded)/s degradation rate. We identify the linear part of the 
plot as the region between the first and last times tha t the slope between consecutive data 
points is >  1 x 10-3 (% degraded)/s. This eliminates the slowly changing initial and final 
data from the degradation rate calculation. Because we do 10 independent simulations, 
results presented in Table 3.3 are means of the 10 independent degradation rates ±  the 
standard deviation of the 10 degradation rates.
The macroscale lysis results presented in Table 3.3 are for Case A parameters with a 
bolus of 5 nM tPA solution added to the fibrin-free region. The volume of 5 nM solution 
added varies, since we change the height of the fibrin-free region in some of the simulations. 
For a fibrin-free region that is approximately half the height of the clot, 51.68 ^m, lysis is 
not front-like and fine clots lyse faster than coarse (as measured by degradation rate) when
b =  2 for the fine clot and 1 for the coarse clot. When b =  500, 250 for fine 
and coarse clots, respectively, lysis proceeds as a front and fine clots lyse faster than coarse 
clots. However, if we keep the larger binding site concentrations and simply change the 
height of the fibrin-free region to 3.04 ^m  (i.e., change the volume of tPA solution we add), 
then lysis is still front-like, but coarse clots lyse faster than fine.
3 .2 .2 .3  Effect o f tP A  on lysis front velocity
It is not simply the number of fibers tha t determines which type of clot lyses faster; 
the number of tPA molecules in the system relative to the surface area of the clot abutting 
the fibrin-free region has a strong influence on lysis speeds. Figure 3.8 shows fine and 
coarse front velocities as a function of this tPA-to-surface-area ratio for Case A parameters. 
Several different tPA concentrations and fibrin-free volumes were used, but these values on
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# of tPA molecules per area
F ig u re  3.8. Lysis front velocity for fine clot (red triangles) and coarse clot (black circles) 
as functions of the ratio of number of tPA molecules to surface area of clot exposed to the 
fibrin-free region. Symbols are means of 10 runs. Dashed line indicates 3 runs with fixed 
tPA-to-surface-area ratio. Velocities are measured in ^m /m in. 15 different experiments were 
run with tPA-to-surface-area ratios varying from 5 to 175 molecules/^m2, and corresponding 
front velocities were calculated.
their own do not matter; it is the total number of tPA molecules relative to the surface area 
(which we fix at 100 ^m  x pore size) tha t affects lysis rate. As the tPA-to-surface-area 
ratio increases, so does the front velocity. Since we keep the surface area of the clot fixed, 
we can only increase the ratio by increasing the number of tPA molecules in the system. 
The way we do so, however, does not matter, as long at the fibrin-free region is not too 
big. We can keep the size of the fibrin-free region fixed and use a larger tPA concentration, 
or we can fix the tPA concentration and increase the size of the fibrin-free region. Both 
methods increase the number of tPA molecules used in the simulation. The dotted line 
in Figure 3.8 represents this. We ran three different simulations of the macroscale model 
using the same number of tPA molecules, but three different fibrin-free volumes and tPA 
concentrations. For a fine clot, the two upper triangles are almost indistinguishable -  they 
look like one triangle. For these two runs, we used tPA concentrations of 19.12 nM and 6.37 
nM, and fibrin-free heights of 3.04 ^m  and 9.12 ^m, respectively. This shows tha t the same 
tPA-to-surface-area ratio produces the same front velocity, as long as the fibrin-free region is 
not too big. When we took a fibrin-free height of 51.68 ^m  and a 1.12 nM tPA concentration 
(the lower triangle), we got a slightly slower front velocity, even though the ratio was the 
same as in the other two simulations. This is because there is so much fibrin-free space into 
which the tPA molecules can diffuse, tha t they encounter the clot, and consequently begin 
lysis, less frequently.
The coarse front velocities respond similarly to the tPA-to-surface-area ratio (Figure 
3.8). By fitting a line to the data for both coarse and fine front velocities and calculating 
the point at which the two lines intersect, we estimate 25.09 molecules/^m2 to be the 
tPA-to-surface-area ratio below which coarse clots lyse faster than fine. As the tPA-to- 
surface-area ratio increases, so does the fine-to-coarse front velocity ratio. W ith a fixed 
surface area, this means that as the number of tPA molecules increases, so does the fine 
front velocity relative to the coarse. This makes sense, because if the system were to contain 
enough tPA to bind to all the fibers at the front of the fine clot, the disadvantage of having 
more fibers would be erased. Lysis would be started on all the fibers at the lysis front, and 
since individual thin fibers lyse faster than thick fibers, the fine clot would degrade more 
quickly. On the other hand, if there are sufficiently few tPA molecules, then lysis could 
not begin on all thin fibers at once. In this case, coarse clots would have the advantage of 
containing fewer fibers. There would be more tPA molecules per fiber in the coarse clots, 
and there would be fewer fibers. Lysis would begin on a higher percentage of thick fibers
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than thin and, if tha t percentage were sufficiently high, this would cause the coarse clot to 
lyse faster than the fine one.
3.3 Discussion
In this chapter we have described a model of fibrinolysis tha t includes several new 
and important features: multiple dimensions, multiple scales, and stochasticity. Detailed 
treatm ent of the biochemistry of lysis occurs in a microscale model of a single fiber cross 
section. Treatment of the overall clot lysis, including transport of the lysis-initiating 
enzyme tPA, occurs in a macroscale model which uses data obtained from microscale model 
simulations. We have shown tha t our 3-dimensional, stochastic model exhibits behavior 
tha t is qualitatively consistent with the literature. Lysis proceeds as a front, with a high 
accumulation of tPA at the front. Individual thin fibers lyse more quickly than individual 
thick fibers, and under certain conditions coarse clots composed of thick fibers lyse more 
quickly than fine clots composed of thin fibers. The faster degradation of coarse clots is 
based on the number of tPA molecules relative to the surface area of the clot, and the fact 
tha t in a given clot volume there are fewer fibers to cut. When the tPA-to-surface-area ratio 
is small enough (for our parameters and clot geometries, < 25.09 molecules/^m2), there is 
not enough tPA to start lysis on all the thin fibers at the front of the fine clot. However, 
there is enough tPA to start lysis on all the thick fibers at the front of the coarse clot 
because there are fewer fibers. Despite the longer single fiber lysis times, coarse clots made 
of thick fibers lyse faster than fine clots in these situations because lysis must be started 
fewer times. However, for the same parameters and clot structures, if there is enough tPA 
at the clot edge to bind to all the thin fibers at the front of the fine clot, fine clots lyse 
faster than coarse. So it is not simply fiber number that determines relative front velocities, 
but rather fiber number in conjunction with the number of tPA molecules exposed to the 
clot. For any tPA concentration, if the height of the fibrin-free region is small enough, then 
almost all the tPA molecules bind to fibers at the clot front within the first minute. Hence, 
the number of tPA molecules added to the system, and not the tPA concentration, matters. 
The overall lysis time is determined by the combination of individual fiber lysis time, the 
number of fibers in the clot needing to be cut, and the number of tPA molecules per unit 
surface area of the clot front (which influences how many individual fiber lysis processes 
occur concurrently).
Rigorous comparisons of our multiscale model with published quantitative data remain
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a challenge. Comparing our results to experiments, we appear to get reasonable single fiber 
lysis times. The lysis times for our baseline parameters (Case A) are on the same order 
as experimentally observed times: the model predicts thin fibers lyse in 1.59 minutes and 
thick fibers lyse in 5.98 minutes, while Collet et al. measure thin fibers to lyse in 3.1 ±  1.1 
minutes, and thick fibers to lyse in 5.4 ±  1.4 minutes [?]. The definition of single fiber lysis 
in the Collet et al. experiment is unclear, however. Presumably the fiber is considered lysed 
when it is no longer visible by the confocal microscope, but this is obviously different than 
our definition in which the fiber is lysed when it is cut by plasmin-mediated degradation 
of fibrin within a cross section. Further, it is not clear when the experimental clock starts 
to run because it is not possible to see when a tPA molecule binds to a fibrin fiber. More 
similar to the criterion in our model, Blinc et al. use atomic force microscopy (AFM) to 
obtain single fiber transection times of 7.6 ±  3.7 and 6.4 ±  4.2 minutes for thin and thick 
fibers, respectively, which according to the authors do not differ significantly [?]. A fiber 
tha t was continuous in the previous AFM image but laterally split in the current image is 
considered lysed, but a single image takes 2-8 minutes to acquire so time resolution is a 
serious issue. Additional data are necessary to verify our single fiber lysis results, but our 
numbers appear to be in a reasonable range.
The predicted lysis front velocities in fine and coarse clots are not as different as the 
measured rates. Collet et al. find coarse clots lyse at a rate of 31 ^m /m in and fine clots lyse 
at a rate of 2.15 ^m /m in [?]. The fastest coarse front velocity we obtain is 17.27 ^m /m in, 
the slowest fine front velocity is 8.15 ^m /m in, and the largest coarse-to-fine front velocity 
ratio is about 1.15. Wootton et al. measure lysis speeds ranging from 8.4 ^m /m in to 18.6 
^m /m in, under various flow conditions (which we do not include in the model), but do not 
distinguish between clot structures [?]. In a different experiment where 10 nM urokinase (a 
plasminogen activator tha t unlike tPA can activate unbound PLG) was added to the edge of 
a fibrin clot formed in buffer, the fine front velocity was about 12 ^m /m in while the coarse 
front velocity was about 25 ^m /m in [?]. If PLG is not pre-equilibrated with a fibrin clot, 
and instead is first introduced to the clot with the bolus of tPA (tPA 69.4 nM, PLG 2.4 
^M), lysis speed is slower: 2.92 ±  0.57 ^m /m in for an unspecified clot structure [?]. Not 
only are all these experiments (with the exception of Collet et al. [?]) different from the 
situation we model, it also is unclear how the experimental front velocities are measured, 
which makes comparisons to our model difficult. We measure front velocities from the time 
the first fiber degrades, but measurements could also be taken from the time tPA is first
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introduced into the system or from some arbitrary time after lysis begins. Due to the wide 
range of lysis rates measured experimentally, it will be beneficial to have additional data 
with which to compare our model.
In a recent study, Longstaff et al. showed tha t when tPA variant delF-tPA was added to 
the edge of a clot, after an initial transient front of lysis with localized delF-tPA, delF-tPA 
diffused ahead of the front and was distributed throughout a larger region of the clot [?]. 
Lysis rates, estimated from changes in clot turbidity, were slower for lysis initiated by 
delF-tPA than by normal tPA. By lowering the concentration of available tPA binding 
sites in our model, we can eliminate the accumulation of tPA at the clot edge and the 
resulting front-like pattern of lysis. However, unlike Longstaff et al., distribution of tPA 
throughout the clot yields significantly faster lysis than tPA localized at the front. This 
suggests tha t therapeutics should be aimed at preventing tPA from accumulating at the lysis 
front. However, dispersal of tPA throughout the clot should be accomplished by minimal 
change to tPA structure, as Longstaff et al. showed tha t a tPA variant missing a key binding 
domain results in slower lysis [?].
The microscale model is able to predict the efficiency of individual molecules -  something 
tha t is currently unattainable experimentally, since single molecules cannot be counted. 
Figure 3.6 nicely illustrates how many plasmin molecules can be produced by a single 
tPA molecule, and how the number of plasmin molecules determines lysis time. The 
microscale model predicts tha t for small tPA unbinding rates, a tPA molecule stays bound 
to a thick fiber slightly longer than it does to a thin fiber because plasmin is slower to 
encounter and degrade the doublet with tPA. We are not aware of any single-molecule 
experiments addressing this phenomenon (or if the experiments are even possible with 
current technology); this is an example of how mathematical models can be used to propose 
new avenues of research for laboratory scientists. Our prediction is a product of the 
assumptions we made about microscale degradation and movement of plasmin (i.e., that 
tPA is released when plasmin degrades the fibrin to which tPA is bound, and that plasmin 
crawls to neighboring binding sites inside a fiber); an experiment to measure the length of 
time tPA stays bound to fibers of varying thickness would be worthwhile. If tPA stays bound 
to thick fibers longer, our model provides a hypothesis for why; if tPA does not stay bound 
to thick fibers longer, this suggests tha t either the physiological rate of tPA unbinding is 
large (Case C, D) or tha t one or more of our model assumptions needs modification. For 
instance, perhaps tPA remains bound to the fiber, even after the doublet has been degraded.
56
Either way, we obtain useful information by comparing the model to experiments.
We find tha t the degradation rate affects both the time and pattern of single fiber 
lysis. Lower degradation rates produce slower lysis times and lead to degradation occurring 
throughout the cross section. Higher degradation rates result in faster lysis that moves as 
a wave across the fiber cross section.
Macroscale model results depend on single fiber lysis times, but we do not know what 
the lysis criteria for a single fiber should be. We assume tha t the fiber is cut when 2/3 
of the binding doublets in a cross section are degraded. We justify this assumption with 
a plausible argument about fibers under tension. However, we could also have defined 
lysis to occur when a given number of doublets remain. If a fiber is cut when all but 100 
binding doublets are degraded, lysis of the thick fiber will take longer, relative to lysis of 
the thin fiber, because the thick fiber has four times as many binding doublets. Even if 
lysis is dependent on percentage of doublets degraded rather than number, macroscale front 
velocities differ for varying values of this percentage. As Figure 3.4(a) shows, single fiber 
lysis times increase nonlinearly as the percentage of doublets required for lysis increases from 
1% to 95%. Choosing a percentage other than 66.67% changes the magnitude of the thin 
and thick lysis times, but the thin-to-thick lysis time ratio remains unchanged. Until there 
is more evidence for a “correct” criterion for single fiber lysis, we believe our assumption is 
reasonable.
Analysis of our model results suggests several possible experiments. The hypothesis 
tha t the number of tPA molecules relative to the surface area of the clot exposed to those 
molecules determines which clot structure lyses faster should be testable in the lab. Also, 
current technology is such tha t individual fibrin fibers can be isolated and observed at 
shorter time intervals, meaning tha t more accurate single fiber lysis experiments should 
now be possible. The prediction of the model is that a thick fiber with diameter twice the 
thin fiber diameter will take four times longer to degrade. If the thick fiber experimental 
degradation time is longer than four times the thin fiber degradation time, this could suggest 
tha t the criteria for complete lysis is not that a certain percentage of doublets are lysed, but 
rather tha t a given to ta l number of doublets remains, below which lysis is almost certain 
to occur. On the other hand, if the thick fiber lysis time is less than four times the thin 
fiber lysis time, this suggests that the unbinding of tPA by plasmin has a significant effect; 
tPA could be forced to unbind by plasmin-mediated degradation less frequently in thick 
fibers because of the additional space for plasmin to crawl. If tPA stays bound longer to
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a thick fiber than a thin fiber, more plasmin can be produced, and lysis can happen faster 
than expected. As explained above, an experiment tha t tests the length of time tPA stays 
bound to fibers of various diameters would be interesting, but we are unsure if this type 
of experiment is currently feasible. Finally, our modeling suggests tha t a potential target 
for new therapeutics should be a tPA variant that has much of the same structure as tPA, 
but binds less strongly to the clot front. Understanding conditions which increase the lysis 
rates of clots of varying structure is important for improved blood clot therapies. The 
broad question of how to safely increase lysis rates clinically is ongoing motivation for our 
work. Our multiscale model is one step toward a better understanding of what influences 
fibrinolysis rates. Laboratory experiments to test our hypotheses will provide even more 
insight, and direct future modeling efforts.
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CHAPTER 4
APPLICATIONS OF A MODIFIED 
MULTISCALE MODEL
In this chapter we present modifications of the stochastic multiscale model (described in 
Chapter 3) tha t make it more amenable to biologically meaningful experimentation. Model 
modifications are explained in detail in Section 4.1 and results are presented in Section 4.2 
and discussed in Section 4.3.
4.1 Model modifications
We make several modifications to the multiscale model presented in Chapter 3. Many 
of these changes are motivated by biology: the microscale and macroscale domains are 
adjusted so tha t model fibrin concentrations are similar to physiological fibrin concentrations 
(Section 4.1.1); the physical size of PLG is taken into account so tha t tPA-mediated 
activation of PLG and plasmin-mediated degradation of fibrin occur on a more biologically 
reasonable spatial scale (Section 4.1.2); and additional published parameter values are used 
(Section 4.1.3). Finally, the microscale data are input into the macroscale model in a more 
appropriate way (Section 4.1.4).
4.1 .1  G eom etry
The first major change to the model presented in Chapter 3 is to adjust the microscale 
model domain to better reflect biologically realistic fibrin volumes and concentrations within 
a fiber. Fibrin fibers are approximately 20% protein and 80% water and have a fibrin 
concentration of about 824 ^M [?, ?]. Consider a thin fiber with diameter 97.5 nm and a 
thick fiber with diameter 195 nm (in Chapter 3 the diameters were 100 nm and 200 nm, 
respectively). For the thin fiber, instead of using 15 binding locations along one row of 
the square cross section, we now use 9 (calculations in Appendix A). For the thick fiber 
we now use 18 binding locations along one row instead of 30. This results in 19.63% of 
the fiber being protein (Equation 4.1), and an 800.95 ^M  fibrin concentration per fiber
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(Equation 4.2).
Percent protein per fiber =
92 protofibrils 22.5n(2.4)2 nm3 
22.5n(48.75)2 nm3 X 1 protofibril 
Fibrin concentration per fiber =
=  19.63%. (4.1)
92 monomers 106 umol 1024 nm3  ^r
X ------------ 2f --------------  X ------------=  800.95 uM. (4.2)
22.5n(48.75)2 nm3 6.02 X 1023 monomers 1L
In performing these calculations, each binding location is assumed to represent a protofibril. 
The calculations require volumes, so we assume tha t the “length” of a cross section is 22.5 
nm -  the distance between binding sites along a fiber. In a 22.5 nm length of protofibril 
there is 1 fibrin monomer, because the half-staggering arrangement of monomers results in 
one half of two separate fibrin monomers coming together to form the protofibril.
The new microscale domain is more accurate with respect to fibrin volume and concentra­
tion, and also with respect to protofibril spacing. When we calculated tha t 15 protofibrils 
would fit in one row of the thin fiber cross section in Section 3.1.1, we measured from 
one protofibril midpoint to the neighboring protofibril midpoint, and essentially packed 
protofibrils very close together. The new geometry, with protofibrils spaced 4.8 nm apart, is 
more realistic than abutting protofibrils and results in a far more accurate protein percentage 
(about 20% vs. 56%).
Because the microscale model domain is different, we must also adjust the macroscale 
model geometry. We take the fibrin concentration per fiber to be 800.95 uM (Equation 4.2) 
and the fibrin concentration averaged over the clot to be 8.8 uM [?]. Given a fixed fiber 
diameter and assuming the clot is formed in a small chamber with dimensions 100 um x 100 
um x depth um, we find the number of lattice nodes and pore size necessary to keep these 
concentrations fixed. The new number of nodes in one row of the fine (coarse) lattice is 69 
(35), with pore size 1.37 um (2.74 um). This results in a fine (coarse) clot with 14145 (3605) 
fibers. To calculate the node number, N , notice tha t the number of edges in a 3-D square 
lattice (that is one fiber deep in one direction) is N 2+ 2 N (N  — 1). To enforce concentrations, 
node number and pore size (p.s.) are found by solving the system of equations given by 
Equations 4.3 and 4.4.
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volume of fibers
Fibrin conc. in clot = ---- ----------— ---- x fibrin conc. per fiber
volume of clot
8.8 ^M =  [N2 +  2N ^  g1)]nr2 p .s. x 800.95 ^M. (4.3)
Length of lattice =  (nodes in one row) x diameter +  (pores in one row) x p.s.
100 ^m  =  N  x  diameter +  (N  — 1) x p.s. (4.4)
The final change to the macroscale model is the parameter which describes the concen­
tration of fibrin on the fiber surface available for tPA binding, b. The number of protofibrils 
on the fiber surface is the number of binding locations along the edge of the square cross 
section. For a thin (thick) fiber, 32 (68) of the 81 (324) protofibrils are on the surface of 
the fiber, or 39.51% (20.99%) of the total fibrin. This means that the fibrin concentration 
on the surface of a fiber available for tPA binding is b =  316 ^M  in fine clots, and b =  168 
^M in coarse clots. As before, the time tha t tPA binds to a fiber in the macroscale model 
is calculated from an exponential distribution with rate parameter b ■ kOJA.
4.1 .2  tP A  activation  and p lasm in -m ediated  degradation
In the microscale model described in Section 3.1.1, tPA could only convert PLG to 
plasmin if tPA and PLG were bound to the same doublet. Physiologically, however, the 
size of PLG (9-11 nm in diameter) suggests that a PLG molecule bound anywhere in a 
5-nm diameter protofibril cross section should be accessible to a tPA molecule in the same 
cross section. Therefore, we relax the constraint tha t tPA and PLG must share a doublet 
for conversion to plasmin to occur, and instead allow tPA to convert any PLG at the same 
binding location to plasmin. In practice, this amounts to the consideration of additional 
reactions in the Gillespie algorithm: now tPA can convert PLG on any of the 6 doublets 
at its location to plasmin (Appendix F). Similarly, we now allow plasmin to degrade any 
doublet at the same binding location, not just the doublet it occupies. This implies that 
plasmin is large enough to reach, and degrade, any of the 6 chains of the protofibril to which 
it is bound. If there is more than one degradable doublet at the same binding location as 
plasmin, we assume the rate of degradation for each doublet is the same, so there is no 
bias in which doublet is chosen for degradation. Similarly, the rate of conversion of PLG to 
plasmin is the same for each PLG molecule at the binding location containing tPA.
4 .1 .3  P aram eter values
We adjust multiscale model parameters to reflect additional references from the litera­
ture. Table 4.1 contains the new Case A parameters with the corresponding references. We 
still have not found experimental measures of tPA and PLG binding and unbinding rates, 
only dissociation constants. We use binding rates from the modeling paper by Wootton 
et al. [?], and choose unbinding rates to satisfy the measured dissociation constants. In 
section 4.2.3 we allow plasmin to unbind from the microscale model, so we now have a 
rate of plasmin crawling (kPLWi, which was kp^ 1 in Chapter 3) and a rate of plasmin fully 
unbinding (Cbind).
The rates of plasmin unbinding from fibrin presented in the literature range from 0.05 
s-1 to 57.6 s-1 [?, ?]. In our simulations we use k^bmd =  0.05 s-1 as the unbinding rate and
T able 4.1. Baseline (Case A) parameter set used in the modified microscale model. k p ^  
and kPLG are the binding rate of PLG to fibrin and the unbinding rate of PLG from fibrin, 
respectively, with dissociation constant k^LG =  kpff^/kp^0 . The tPA rates have similar 
meanings. kpLG is different depending on whether fibrin is intact or nicked, and ktpA is 
different depending on whether tPA is bound to a doublet with PLG or without PLG. 
k^ jpt is the catalytic rate constant for activation of PLG to plasmin, kj?at is the catalytic 
rate constant for plasmin-mediated exposure of cryptic binding doublets, and kdeg is the 
plasmin-mediated rate of fibrin degradation. kPLWi and kpLj1nd are the crawling rate and 
unbinding rate of plasmin, respectively. We know the dissociation constants for tPA and 
PLG, but not the individual rates, so references in the table are for kD. We assume that 
kcnat =  kdeg, since we have not found any references for the rate of plasmin-mediated exposure 
of binding sites.
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P a ra m e te rs C ase A R eference
kdeg (s 1) 5 [?, ?]
kpLG (s-1) 3.8 [?, ?]
kpn^, intact (^M - 1s-1 ) 0.1 [?]
kPnLG, nicked (^M - 1s-1 ) 1.7273 [?]
kPL1 (s-1 ) kcrawl (s ) 57.6 [?]
kunbind (s-1) 0.05 [?]
kOpA, with PLG (s-1 ) 0.0002 [?]
kOpA, without PLG (s-1 ) 0.0036 [?]
kOpA (^M - 1s-1 ) 0.01 [?, ?]
kaat (s-1 ) 0.1 [?, ?]
kcat (s-1) 5
krawi =  57.6 s-1 as the crawling rate. In order for plasmin to crawl, the rate of unbinding 
must be much less than the rate of crawling (Appendix G).
4 .1 .4  U sin g  m icroscale d ata  in th e  m acroscale m odel
In Section 3.2.1.3 we described how the microscale data was incorporated in the macroscale 
model. Briefly, when a tPA molecule bound to a fiber in the macroscale model we generated 
a random number and used it with the empirical CDF of tPA leaving times to determine 
when to unbind the tPA molecule. We then found the mean number of plasmin molecules 
generated in the chosen tPA leaving time. Finally, we used a power function fit to a scatter 
plot of the lysis time vs. plasmin number data to determine the lysis time associated with 
the given number of plasmin molecules.
W ith the modifications made to the microscale model, we no longer have nice relation­
ships (between tPA leaving time and number of plasmin molecules produced, and between 
number of plasmin molecules produced and lysis time) to exploit in the macroscale model. 
Instead of approximating relationships by simple linear or power functions, we now directly 
use distributions. We record the tPA leaving times and lysis times from 10,000 microscale 
model simulations. If lysis does not occur in a given run, a placeholder lysis time of 9000 
seconds is assigned. The tPA leaving time data are sorted in ascending order, and the lysis 
time data are rearranged accordingly to keep the lysis times in the same position as their 
corresponding tPA leaving times. We represent the 10,000 tPA leaving times by 100 discrete 
times (corresponding to the 100 percentiles of the original 10,000 tPA leaving times) and 
use this data to make an empirical tPA leaving time CDF. When a tPA molecule binds to 
a fiber in the macroscale model, a uniformly distributed random number, r 1, is generated 
and used to interpolate a tPA leaving time from the CDF.
To determine when the fiber will degrade based on the tPA leaving time, we put the 
sorted 10,000 lysis times into 100 bins and select the [r1 x 100 — 0.5]th bin. Sorting the 
entries of this bin allows us to generate an empirical lysis time CDF for the chosen tPA 
leaving time. We then generate a second uniformly distributed random number and use it 
to interpolate a lysis time from the CDF. During the interpolation, if we access a lysis time 
of 9000 s (the placeholder time for when lysis does not occur), then tPA does not initiate 
lysis. The fiber to which tPA is bound will not degrade until another tPA molecule binds 
and a lysis time less than 9000 seconds is chosen from the CDF.
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4.2 Results
The microscale model results presented in this section are given as median (first quartile 
Q1, third quartile Q3) of 10,000 simulations, and the macroscale model results are mean 
±  standard deviation of 10 simulations. Unless otherwise stated, macroscale simulations 
were run for 30 minutes of simulation time. We start by verifying tha t the main result 
from Chapter 3 -  tha t the number of tPA molecules exposed to the surface of the clot 
determines relative lysis speeds -  still holds following the model adjustments described in 
Section 4.1. Using Case A parameters (Table 4.1), we set up 10 macroscale experiments with 
tPA-to-surface-area ratios varying from 8 to 450 molecules/^m2. We obtain these ratios by 
varying both the tPA concentration and the height of the fibrin-free region. As in Figure 3.8, 
we find tha t the number of tPA molecules in the system relative to the surface area of the 
clot abutting the fibrin-free region has a strong influence on lysis speeds. Figure 4.1 shows 
front velocities in fine and coarse clots as a function of the tPA-to-surface-area ratio for Case
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# of tPA molecules per area
F ig u re  4.1. Lysis front velocity of a fine clot (red triangles) and a coarse clot (black circles) 
as a function of the ratio of the number of tPA molecules to the surface area of clot exposed 
to the fibrin-free region. Experiments were run with ten different tPA-to-surface-area 
ratios varying from 8 to 450 molecules/^m2. Each symbol is the mean of ten independent 
simulations.
A parameters. As the tPA-to-surface-area ratio increases, so does the front velocity. By 
fitting a line to the data for both coarse and fine front velocities and calculating the point at 
which the two lines intersect, we estimate 287 molecules/^m2 to be the tPA-to-surface-area 
ratio below which coarse clots lyse faster than fine. This number is much higher than 
the estimate of 25 molecules/^m2 tha t we found in Chapter 3, indicating tha t with these 
modifications, there is a wider range of conditions for which coarse clots will lyse more 
quickly than fine.
4.2 .1  P aram eter variation
Many of the parameter values the multiscale model requires have been characterized ex­
perimentally (Table 4.1). However, there are no reliable estimates of binding and unbinding 
rates for lytic proteins. Moreover, it is possible to engineer tPA variants tha t have different 
dissociation constants. To test these unknown and adjustable parameters, we experiment 
with different parameter values. We either vary tPA and PLG binding and unbinding rates 
while keeping the dissociation constants fixed (Section 4.2.1.1) or vary the tPA dissociation 
constant (Section 4.2.1.2).
4.2 .1 .1  V arying b inding and unbinding rates
It is not simply the tPA and PLG dissociation constants that affect the multiscale 
model (and physiological lysis); the individual binding and unbinding rates also play a 
role, but are much harder to measure experimentally. The only estimates in the literature, 
kffA =  6.658 x 10-5 s-1 , C A =  1.148 x 10-4 ^M - 1s-1 , k f f  =  4.131 x 10-3 s-1 , and 
k i^^0 =  1.087 x 10-4 ^M - 1s-1 , are from Diamond and Anand [?]. However, a more recent 
paper claims tha t measuring binding and unbinding rates is very hard to do and tha t no 
good estimates have been made for these rates [?]. We use our model to investigate how lysis 
depends on binding and unbinding rates (for fixed dissociation constants) and to estimate a 
range of plausible parameter values. The different parameter cases we study are displayed 
in Table 4.2.
• C a s e  B  First, consider Case B parameters, which are identical to the baseline 
parameters (Case A) except tha t the tPA binding and unbinding rates are two orders of 
magnitude smaller (and therefore similar to Diamond and Anand's values). The smaller 
rates cause an increase in tPA leaving time and the number of runs tha t result in lysis 
(Table 4.3). The longer tPA leaving time makes sense since tPA has a much smaller 
unbinding rate. In fact, only about 0.8% of the runs result in tPA unbinding on its own; tPA
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T able 4.2. Parameter sets with varying binding and unbinding rates. Parameter values that differ from baseline Case A parameter 
values are underlined. k ^ G and k ^ G are the binding rate of PLG to fibrin and the unbinding rate of PLG from fibrin, respectively, 
with dissociation constant =  k ^ G/ k ^ G. The tPA rates have similar meanings. is different depending on whether fibrin 
is intact or nicked, and k ^ A is different depending on whether tPA is bound to a doublet with PLG or without PLG. k ^ t is the 
catalytic rate constant for activation of PLG to plasmin (PLi), A£at is the catalytic rate constant for plasmin-mediated exposure of 
cryptic binding doublets, and fcdeg is the plasmin-mediated rate of fibrin degradation. Crawl and Cnbind are the crawling rate and 
unbinding rate of plasmin, respectively.
P a ra m e te rs
C ase B 
(sm all tP A  
ra te s)
C ase C 
(large  tP A  
ra te s)
C ase D 
( in te rm e d ia te  
P L G  ra te s)
C ase E 
(sm all P L G  
ra te s)
C ase F  
(sm all tP A  
an d  P L G  ra te s)
^deg (s ) 5 5 5 5 5
C G ( s -1) 3.8 3.8 0.038 0.0038 0.0038
k ^ G, intact (/xM-1 s-1 ) 0.1 0.1 0.001 0.0001 0.0001
k ^ G, nicked (/xM-1 s-1 ) 1.7273 1.7273 0.017273 0.0017273 0.0017273
C a l i  (s_1) 57.6 57.6 57.6 57.6 57.6
Cnbind (S_1) 0.05 0.05 0.05 0.05 0.05
fctPA, with PLG (s” 1) 2 x 10“ 6 0.02 0.0002 0.0002 2 x 10“ 6
C A, without PLG ( s '1) 3.6 x 10-5 0.36 0.0036 0.0036 3.6 x 10-5
k \ ( /x M -V 1) 0.0001 LQ 0.01 0.01 0.0001
K l  ( s -1) 0.1 0.1 0.1 0.1 0.1
Ksh (s_1) 5 5 5 5 5
T able 4.3. Microscale model results for varying binding and unbinding rates. Entries are median (Q l, Q3) of 10,000 independent 
simulations. The column labeled “Time to first PLi” gives data about the time the first plasmin molecule was created. The column 
labeled “Runs with PLi” gives the number of runs, out of 10,000, in which plasmin was produced and single fiber lysis occurred. 
The columns labeled “Forced” and “Unbound” give the number of runs out of 10,000 for which tPA was forced to unbind by plasmin 
and for which tPA unbound on its own, respectively. The “Number of PLi” and “Max PLi” columns give data about the average 
total number of plasmin molecules produced in one run, and the maximum number of plasmin molecules produced in any of the 
10,000 runs, respectively.
P a ra m e te rs F ib e r
d ia m e te r
(nm )
tP A  leav ing  tim e  (s) F orced U n b o u n d T im e to  first P L i (s) N u m b er 
o f P L i
M ax
P L i
R u n s
w ith
P L i
97.5 90.80 (44.01, 173.18) 4760 4383 80.89 (33.88, 159.48) 1 (1, 2) 7 5956
195 104.63 (46.44, 198.31) 4895 4834 84.21 (35.40, 170.07) 2 (1, 3) 10 5892
97.5 161.69 (76.08, 299.69) 8316 74 143.79 (59.27, 283.63) 1 (1, 2) 8 9935
195 193.42 (95.81, 336.88) 9054 80 139.77 (58.23, 278.44) 2 (1, 3) 13 9939
Case C 97.5 2.05 (0.85, 4.09) 37 9963 2.29 (1.02, 4.15) 1 (1, 1) 2 148
195 2.04 (0.86, 4.06) 43 9957 1.73 (0.70, 3.97) 1 (1, 1) 4 145
97.5 133.88 (53.04, 273.79) 2729 6776 104.38 (21.25, 235.06) 1 (1, 2) 6 3406
d i j C  J— 195 139.93 (55.15, 277.77) 2722 7103 92.73 (18.22, 224.67) 1 (1, 2) 10 3369
97.5 155.97 (52.83, 337.87) 1126 8664 14.04 (4.67, 102.48) 1 (1, 2) 6 1413
195 165.36 (62.58, 333.32) 1061 8864 13.44 (4.97, 85.01) 1 (1, 2) 9 1367
97.5 2657.6 (891.11, 5714.6) 7017 1486 2566.6 (796.51, 5649.5) 1 (1, 2) 7 8520
195 2739.7 (891.05, 5682.5) 7555 1412 2649.3 (785.09, 5611.4) 1 (1, 2) 11 8605
is forced to unbind by plasmin-mediated degradation of the doublet to which it is bound 
in the overwhelming majority of runs. W ith Case B parameters, 99% of the runs result in 
lysis, while only about 59% of the Case A runs result in lysis. Because tPA is not likely to 
unbind on its own when Case B parameters are used, longer lysis times can occur than in 
Case A. These long lysis times are a result of slow creation of the first plasmin molecule; 
tPA likely will not unbind unless it is forced to unbind by plasmin, so if the creation of 
plasmin takes a long time, then tPA will stay bound for a long time, and lysis times will 
be long. Figure 4.2 shows lysis time CDFs for the different parameter cases. The Case B 
distribution (red curve) is virtually indistinguishable from the Case A distribution (black 
curve) up to about 6 minutes. The difference in Cases A and B is tha t Case B has more 
long lysis times, resulting in the higher, but otherwise similar, CDF.
Macroscale lysis with Case B parameters (small tPA rates) is not front-like because 
tPA can diffuse through the clot easily due to the small binding rate to fibrin (Table 4.4). 
Figure 4.3 shows the number of successful independent tPA binding events as a function 
of time ( “successful” meaning tha t the binding event resulted in the initiation of lysis, and 
“independent” meaning tha t no other tPA had previously begun lysis on that edge). For 
coarse clots, the enhanced diffusion of tPA through the clot results in faster lysis with 
Case B parameters (red curve), compared to Case A (black curve). For fine clots, Case B 
parameters display slower lysis compared to Case A. This is because of the large number 
of fibers in the fine clot and the longer tPA leaving time for Case B parameters. It takes 
a while for the 1211 tPA molecules to access all 14145 fibers in the fine clot, so when tPA 
leaving times are longer (as in Case B), it will take even longer for the tPA to reach all the 
different fibers. This is not an issue in coarse clots; the 2422 tPA molecules can make it to 
all 3605 fibers without much trouble. Hence, Case B parameters slow down fine clot lysis, 
but speed up coarse clot lysis.
• C a se  C  Increasing baseline tPA binding and unbinding rates by two orders of 
magnitude (Case C), results in tPA quickly unbinding from the fiber cross section and 
lysis only occurring in 1.5% of the runs (Table 4.3). When lysis does occur, single fiber lysis 
times are very short (Figure 4.2, green curve) because degradation requires tPA to create 
plasmin within the first few seconds of the simulation, before the tPA unbinds (Table 4.3). 
In fact, lysis results are very similar to those with only one plasmin molecule (instead of 
one tPA molecule) at the start of the simulation, which gives an estimate of how long it 
takes one plasmin molecule to degrade a single fiber (results not shown). The similarity of
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Case A ------ Case B ------Case C 
Case D ------ Case E ------ Case F
(a) Thick fiber (b) Thin fiber
Lysis time (min) Lysis time (min)
(c) Thick fiber, zoom (d) Thin fiber, zoom
F ig u re  4.2. Lysis time cumulative distribution functions from the microscale model for 
varying binding and unbinding rates. The CDFs do not asymptote to 1 because we define 
“Probability” as the fraction of 10,000 runs. In all simulations, fewer than 10,000 runs 
resulted in lysis, so there are fewer than 10,000 lysis times. (a) Thick fiber. (b) Thin fiber. 
(c) Zoomed in view of the first 6 minutes of the thick fiber CDF. (d) Zoomed in view of the 




























































F ig u re  4.3. Number of successful tPA binding events as a function of time for varying 
binding and unbinding rates. Plots are averages of 10 independent simulations. (a) Coarse 
clot with 3605 total fibers (and 3605 possible successful binding events). (b) Fine clot with 
14145 total fibers. (c) Zoomed in view of the first 125 seconds of the coarse clot data. (d) 
Zoomed in view of the first 125 seconds of the fine clot data.
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T able 4.4. Macroscale model results for varying binding and unbinding rates. The 
experiments involved a 5 nM tPA concentration added to a fibrin-free region with height 
2.935 ^m. Entries are mean ±  standard deviation of 10 independent simulations. Front 
velocity calculations do not make sense for simulations in which lysis was not front-like, 
hence the “—” in some entries. * Lysis is front-like (tPA strongly binds to the front), but 
so slow that it is computationally challenging to measure front velocity.
P a ra m e te rs C lo t ty p e F ro n t velocity  
(u m /m in )
D e g ra d a tio n  ra te  
(% f ib e rs /m in )
Case A fine 1.97 ±  0.10 1.99 ±  0.016coarse 4.40 ±  0.24 4.22 ±  0.061
Case B fine
_ 1.61 ±  0.007
coarse — 6.11 ±  0.004
Case C fine 1.67 ±  0.09 1.68 ±  0.016coarse 2.43 ±  0.10 2.41 ±  0.017
Case D
fine 0.75 ±  0.28 0.87 ±  0.015
coarse 3.04 ±  0.23 3.06 ±  0.016
Case E fine
0.52 ±  1.38* 0.31 ±  0.011
coarse 1.78 ±  0.36 1.89 ±  0.039
Case F
fine _ 0.11 ±  0.007
coarse — 0.95 ±  0.029
the results in the two cases indicates tha t when Case C parameters (large tPA rates) result 
in lysis, plasmin is produced almost immediately. This suggests that the main determinant 
of lysis time is the time it takes for the first plasmin molecule to be created. W ith all of 
the parameter sets tested, only 1-2 plasmin molecules are created, on average. Since the 
plasmin-mediated degradation rate is the same in all cases, once plasmin is formed, it will 
degrade at the same rate. Hence, the difference in lysis times must come from the difference 
in times to first plasmin production. For a given parameter set, the time to produce the 
first plasmin molecule is roughly the same for both thin and thick fibers. This makes sense, 
since fiber diameter does not play a role in the initial production of plasmin.
Despite the fast single fiber lysis times, macroscale lysis with Case C parameters is 
slower than with Case A (Table 4.4) for two main reasons: very rapid binding localizes tPA 
to a narrow region of fibrin at the front of the clot, preventing tPA diffusion farther into 
the clot and initiation of lysis on other fibers; and tPA initiates lysis only 1.5% of the time 
it binds to fibrin. Figure 4.3 illustrates these points; Case C (green curve) results in fewer 
successful tPA binding events as a function of time than Case A (black curve).
• C a se  D  W ith the baseline tPA binding and unbinding rates but with PLG binding 
and unbinding rates two orders of magnitude smaller (Case D), tPA stays bound to the cross
section longer because it is less likely to be forced to unbind by plasmin (Table 4.3). tPA is 
less likely to be forced to unbind by plasmin because it takes longer to create plasmin when 
the PLG binding rate is so low. Unless tPA starts bound to a doublet containing PLG, 
creation of plasmin cannot occur until a PLG molecule binds, which can take a long time 
(0(103 s)). Because of this, lysis times are slower (Figure 4.2, blue curve). Macroscale lysis 
is also slower than Case A (Table 4.4, Figure 4.3), because of the slower single fiber lysis 
times and the fact that only 34% of the time tPA binds will it start lysis (compared to 59% 
in Case A).
• C a s e  E  PLG binding and unbinding rates three orders of magnitude smaller than 
baseline rates (Case E) fall within the range of values presented by Diamond and Anand 
[?]. W ith Case E parameters, we still find tha t tPA stays bound longer than when Case A 
parameters are used, and even fewer simulations result in lysis than in Case D (Table 4.3). 
This is because the majority of runs for which lysis occurs are runs in which tPA starts bound 
to a doublet with PLG. If tPA starts on an empty doublet, it is far more likely to unbind 
before a PLG molecule binds, never initiating lysis. A quasi-steady state approximation 
shows a 9.5% probability tha t an initially exposed doublet contains one bound PLG molecule 
(Appendix D). If the only simulations tha t result in lysis are those for which tPA starts on 
a doublet with PLG, we would expect only about 9.5% of the simulations to result in lysis. 
Since lysis occurred in 14% of the Case E simulations, tPA must occasionally start on an 
empty doublet which later binds a PLG molecule. This results in long lysis times, as tPA 
waits for PLG to bind (Figure 4.2). The CDFs of Case E (cyan curve) and Case A (black 
curve) are similar for very short lysis times (when tPA starts bound to a doublet with PLG 
and quickly creates a plasmin molecule), but ultimately Case E can yield much longer lysis 
times than Case A. For a thin fiber, the largest Case E lysis time is roughly 40 min, while 
the largest Case A lysis time is roughly 20 min. Macroscale lysis is even slower than Case 
D (Table 4.4, Figure 4.3).
• C a s e  F  Finally, when binding and unbinding rates of both tPA and PLG are smaller 
than baseline Case A parameters (Case F, reflecting Diamond and Anand’s estimates), tPA 
stays bound for a very long time. The tPA leaving time is so long because tPA rarely unbinds 
on its own due to a small unbinding rate, and is slow to produce a plasmin molecule to force 
the tPA to unbind (Table 4.3). Single fiber lysis times are very slow (Figure 4.2, magenta 
line) and consequently macroscale lysis is severely retarded. Figure 4.3 shows tha t there 
are many successful tPA binding events early in the simulation when Case F parameters
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are used (magenta line). Yet, due to the incredibly long tPA leaving times, after the first 
round of tPA binding it takes a long time for tPA to unbind and start lysis on a new fiber.
4 .2 .1 .2  V arying tP A  d issociation  constan ts
To test potential therapeutics for lysing blood clots, we experimentally vary the tPA 
dissociation constant, k)p A . It is possible to engineer tPA variants tha t maintain key features 
of tPA-mediated fibrinolysis, but that have different binding or unbinding rates. We conduct 
experiments with kDpA (for tPA binding to fibrin without bound PLG) ranging from 0.036 
to 36 (Table 4.5). The dissociation constant for tPA binding to fibrin in the 
presence of PLG is scaled by the same factor. All other parameter values are kept the same 
as Case A, but either the tPA binding rate or the tPA unbinding rate is changed to alter 
the dissociation constant to some value other than the physiological value of 0.36 ^M.
The value of the dissociation constant does not affect microscale results; only the 
unbinding rate of tPA from fibrin influences microscale lysis (Table 4.6). When the tPA 
dissociation constant is varied by fixing the unbinding rate and varying the binding rate,
T ab le 4.5. Parameter sets with varying kDpA. Parameter values tha t differ from baseline 
Case A parameter values are underlined. Parameter descriptions are the same as in 
Table 4.2.
C ase G C ase H C ase J C ase K
P a ra m e te rs (k;pA= 3 .6 , 
sm all k;pA)
(k ;PA= 3 .6 , 
la rge  k;pA )
(ktPA= 3 6 ) (ktPA= 0 .036 )
kdeg (s ) 5 5 5 5
kpffLG (s-1) 3.8 3.8 3.8 3.8
kpj^0 , intact (^M - 1s- 1) 0.1 0.1 0.1 0.1
kpILG, nicked (^M - 1s“ 1) 1.7273 1.7273 1.7273 1.7273
kcPrLaWi (s-1) 57.6 57.6 57.6 57.6
kunbind (s-1) 0.05 0.05 0.05 0.05
kffA, with PLG (s-1 ) 0.0002 0.002 0.0002 0.0002
kOpA, without PLG (s - 1) 0.0036 0.036 0.0036 0.0036
kOpA (^M - 1s-1 ) 0.001 0.01 0.0001 01
C t  (s-1) 0.1 0.1 0.1 0.1
knat (s-1) 5 5 5 5
T able 4.6. Microscale model results for varying tPA dissociation constants. Baseline Case A parameters are included for comparison. 
Entries are median (Q l, Q3) of 10,000 independent simulations. The column labeled “Time to first PLi” gives data about the time 
the first plasmin molecule was created. The column labeled “Runs with PLi” gives the number of runs, out of 10,000, in which 
plasmin was produced and single fiber lysis occurred. The columns labeled “Forced” and “Unbound” give the number of runs out of 
10,000 for which tPA was forced to unbind by plasmin and for which tPA unbound on its own, respectively. The “Number of PLi” 
and “Max PLi” columns give data about the average total number of plasmin molecules produced in one run, and the maximum 
number of plasmin molecules produced in any of the 10,000 runs, respectively.
P a ra m e te rs F ib e r
d ia m e te r
(nm )
tP A  leav ing  tim e  (s) F orced U n b o u n d T im e to  first P L i (s) N u m b er 
o f P L i
M ax
P L i
R u n s
w ith
P L i
97.5 90.80 (44.01, 173.18) 4760 4383 80.89 (33.88, 159.48) 1 (1, 2) 7 5956
195 104.63 (46.44, 198.31) 4895 4834 84.21 (35.40, 170.07) 2 (1, 3) 10 5892
Case C 97.5 95.87 (45.61, 179.85) 4683 4441 85.11 (36.21, 170.05) 1 (1, 2) 7 5874
195 106.39 (48.55, 195.06) 4807 4933 83.37 (34.32, 163.45) 2 (1, 3) 12 5808
97.5 18.67 (7.93, 36.53) 821 9132 17.32 (7.10, 34.98) 1 (1, 2) 6 1275
195 19.34 (8.18, 38.21) 691 9309 18.04 (7.34, 36.06) 1 (1, 2) 9 1214
97.5 92.53 (43.55, 175.12) 4683 4451 80.56 (33.13, 163.86) 1 (1, 2) 7 5853
d i j C  O 195 107.01 (47.99, 198.05) 4811 4918 86.31 (34.53, 170.25) 2 (1, 3) 11 5820
97.5 95.32 (44.51, 179.71) 4672 4430 83.20 (35.19, 167.38) 1 (1, 2) 7 5883
195 104.23 (47.31, 196.24) 4804 4932 81.18 (33.87, 165.90) 2 (1, 3) 9 5835
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the microscale lysis CDFs are indistinguishable (Figure 4.4, Cases A, G, J and K). The 
CDFs are the same because the simulation begins with tPA bound, so the binding rate only 
enters the model via the rebinding probability calculation. Decreasing the binding rate 
(Cases G and J) decreases the rebinding probability, so tPA does not rebind. Increasing the 
binding rate (Case K) increases the rebinding probability, but only to 0 (1 0 -5 ), so tPA still 
effectively does not rebind. Therefore, microscale results with fixed unbinding rates but 
variable binding rates are no different than results with the baseline Case A parameters.
On the other hand, if the dissociation constant is varied by fixing the binding rate 
and varying the unbinding rate (Case H), there is an effect on microscale lysis. Setting 
k)DA =  3.6 (an order of magnitude bigger than the physiological value) by an order of 
magnitude decrease in binding rate (Case G) had no effect on microscale lysis, but setting 
kDpA =  3.6 ^M  by an order of magnitude increase in unbinding rate (Case H) slows down 
microscale lysis (compare Cases A and G to Case H in Table 4.6 and Figure 4.4). A larger 
unbinding rate results in longer lysis times because tPA unbinds more quickly, produces less 
plasmin, and consequently slows lysis. On the macroscale level, because tPA unbinds more 
quickly with Case H parameters, tPA molecules are able to start lysis on other fibers more 
quickly, resulting in more successful tPA binding events as a function of time (compare red
------ Case A ------Case G ------- Case H 
------Case J ------- Case K
(a) Thick fiber (b) Thin fiber
F ig u re  4.4. Lysis time cumulative distribution functions from the microscale model for 
varying tPA dissociation constants. The CDFs do not asymptote to 1 because we define 
“Probability” as the fraction of 10,000 runs. In all simulations, fewer than 10,000 runs 
resulted in lysis, so there are fewer than 10,000 lysis times. (a) Thick fiber. (b) Thin fiber.
dashed curve to black solid curve in Figure 4.5). Degradation is faster but less front-like 
than with Case A parameters (Table 4.7).
For the simulations in which k^pA is changed by varying the binding rate (Cases G, J, 
and K), differences become evident on the macroscale. The macroscale degradation rate is 
faster with Case G parameters than with Case A because the smaller binding rate means 
tha t tPA binds less readily to the clot front (Table 4.7). Relative to a larger binding rate, 
tPA diffuses farther into the clot, where it can start lysis on the interior fibers earlier; 
there are more successful independent tPA binding events at any given time when Case 
G parameters are used (Figure 4.5, dashed black curve), compared to Case A parameters 
(Figure 4.5, solid black curve).
Increasing the dissociation constant an additional order of magnitude (to k^pA =  36 
^M) by decreasing the binding rate (Case J), has a similar effect on clot lysis as Case B 
(small tPA rates): lysis of a fine clot is slower than with Case A parameters, but lysis of a 
coarse clot is faster (Table 4.7). Successful independent tPA binding events occur earlier in 
coarse clots with Case J parameters (Figure 4.5, dashed green curve) compared to Case A 
(solid black curve), but the opposite is true in fine clots. As with Case B, this is due to the 
number of fibers in the different clots. W ith such a low tPA binding rate, it is difficult for
T able 4.7. Macroscale model results for varying tPA dissociation constants (Cases G-K). 
Baseline Case A parameters are included for comparison. The experiments involved a 5 nM 
tPA concentration added to a fibrin-free region with height 2.935 ^m. Entries are mean 
±  standard deviation of 10 independent simulations. Front velocity calculations do not 
make sense for simulations in which lysis was not front-like, hence the “—” in some entries. 
*Lysis is front-like (tPA strongly binds to the front), but so slow that it is computationally 
challenging to measure front velocity.
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P a ra m e te rs C lo t ty p e F ro n t velocity  
(^ m /m in )
D e g ra d a tio n  ra te  
(% f ib e rs /m in )
Case A fine 1.97 ±  0.10 1.99 ±  0.016coarse 4.40 ±  0.24 4.22 ±  0.061
Case G
fine _ 2.12 ±  0.027
coarse — 7.10 ±  0.002
Case H fine 1.50 ±  2.35* 2.25 ±  0.018
coarse 5.57 ±  0.66 5.72 ±  0.055
Case J fine
_ 1.70 ±  0.018
coarse — 5.41 ±  0.004
Case K fine 1.43 ±  0.06 1.43 ±  0.016
coarse 2.21 ±  0.08 2.18 ±  0.021
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------ Case A - -
------Case J - -
(a) Coarse clot
Time (s)



















(d) Fine clot, zoom
0
0
F ig u re  4.5. Number of successful tPA binding events as a function of time for varying 
tPA dissociation constants. Plots are averages of 10 independent simulations. (a) Coarse 
clot with 3605 total fibers (and 3605 possible successful binding events). (b) Fine clot with 
14145 total fibers. (c) Zoomed in view of the first 125 seconds of the coarse clot data. (d) 
Zoomed in view of the first 125 seconds of the fine clot data.
tPA to start lysis ( “successfully” bind) on all the thin fibers in the fine clot, but this is less 
of an issue in a coarse clot where there are fewer fibers. This appears to be another instance 
in which the number of fibers in a clot affects lysis rates. In fact, if we look at the raw 
number of tPA bindings (whether or not they successfully started lysis), we find tha t about 
10000 bindings occur in 1800 seconds in both types of clots (results not shown). These are 
a sufficient number of binding events to degrade the 3605 thick fibers in the coarse clot, 
but not nearly enough to degrade the 14145 thin fibers in the fine clot. Lastly, with Case 
J parameters, fine and coarse clot lysis rates are slower compared to Cases G and H. This 
suggests there exists a value for the tPA dissociation constant that optimizes lysis speed; 
increasing k ^ A from 0.36 ^M  (physiological) to 3.6 ^M speeds up lysis, but increasing it 
further to 36 ^M  begins to slow lysis down.
W ith a dissociation constant an order of magnitude sm aller than physiological (k tpA =
0.036 ^M), obtained by using an order of magnitude larger tPA binding rate (Case K), 
the lysis front velocity is slower than with Case A (Table 4.7). This is because tPA binds 
more readily to fibrin, and is therefore prevented from diffusing farther into the clot and 
beginning lysis on internal fibers. As a function of time, there are far fewer successful tPA 
binding events for Case K (Figure 4.5, dashed blue curve) than for Case A (black solid 
curve).
4 .2 .2  tP A  rebinding
Given the very low tPA rebinding probability calculated in Appendix E, we conclude 
tha t tPA essentially never rebinds to the fiber cross section. The absence of tPA rebinding 
eliminates the positive feedback caused by plasmin-mediated exposure of new binding sites. 
Since tPA can never rebind, it does not m atter how many new binding sites are exposed -  
no additional plasmin can be created. It would be possible for a different tPA molecule to 
bind to one of the newly exposed sites. However, due to the low tPA concentration (only 3 
tPA molecules/^m3 in a 5 nM tPA concentration), this is very unlikely. It is often stated in 
the literature tha t there is positive feedback, but direct evidence for this is lacking. In order 
to explore the effect that positive feedback would have in the model, we must allow tPA to 
rebind. The microscale model is adjusted so tha t tPA rebinds with 100% probability if there 
is an available doublet within two binding locations of the doublet from which it unbound. 
The constraint tha t tPA can only rebind up to two binding locations away from where it 
unbound is motivated by the idea tha t tPA is more likely to rebind nearby, since the binding
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rate for tPA to fibrin is large. If there are multiple doublets available for tPA rebinding, the 
doublet to which tPA binds is chosen randomly using a uniform distribution. We study tPA 
rebinding using three representative parameter sets from Section 4.2.1.1: baseline (Case A), 
small tPA binding and unbinding rates (Case B), and small PLG binding and unbinding 
rates (Case D).
Results from microscale model simulations with tPA rebinding are presented in Table 4.8 
and Figure 4.6. Comparing data from runs with tPA rebinding (Table 4.8) to data from 
runs without tPA rebinding (Table 4.3) provides insight into how the presence of tPA affects 
lysis. Unsurprisingly, for a given set of parameters, tPA stays bound to the cross section for 
a longer total amount of time when tPA can rebind. In fact, in many cases tPA stays bound 
for the whole simulation, producing a tPA leaving time equal to the lysis time. Figure 4.6 
shows tha t single fiber lysis is faster when tPA can rebind, but a wider range of lysis times 
is also possible. The dashed curves represent runs with tPA rebinding, and the solid curves 
represent runs without tPA rebinding. We see that for all cases, the dashed curves are 
above the solid curves. W ith tPA rebinding, 100% of the microscale runs result in lysis, 
so some longer lysis times are achieved compared to runs without tPA rebinding. These 
longer lysis times correspond to situations in which tPA unbinds before creating a plasmin 
molecule (so in the runs without rebinding, these would be failed attem pts at lysis), but 
then rebinds and later produces plasmin.
Adding positive feedback via tPA rebinding to the microscale model increases macroscale 
lysis rates in coarse clots with Case A or Case D parameters (compare Table 4.9 to
T able 4.8. Microscale model results for tPA rebinding. Entries are median (Q1, Q3) of 
10,000 independent simulations. The column labeled “Time to first PLi” gives data about 
the time the first plasmin molecule was created. The column labeled “Runs with PLi” gives 
the number of runs, out of 10,000, in which plasmin was produced and single fiber lysis 
occurred.
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P a ra m e te rs F ib e r
d ia m e te r
(nm )
tP A  leav ing  tim e  (s) T im e to  firs t P L i (s) R u n s
w ith
PL i
Case A (tPA) 97.5
195
183.50 (98.46, 323.93) 
260.06 (161.02, 406.11)




Case B (tPA) 97.5
195
180.00 (96.78, 320.86) 
251.83 (156.15, 388.91)




Case D (tPA) 97.5
195
419.07 (172.81, 814.58) 
481.51 (244.08, 905.58)





------  Case A ------  Case B ------ Case D 
------Case A (tP A )--------Case B (tP A )--------Case D(tPA)
(a) Thick fiber (b) Thin fiber
Lysis time (min) Lysis time (min)
(c) Thick fiber, zoom (d) Thin fiber, zoom
F ig u re  4.6. Lysis time cumulative distribution functions from the microscale model with 
tPA rebinding. Dashed curves denote simulations with tPA rebinding. For comparison, solid 
curves represent simulations without tPA rebinding. The solid curves do not asymptote to 1 
because we define “Probability” as the fraction of 10,000 runs. In those simulations, fewer 
than 10,000 runs resulted in lysis, so there are fewer than 10,000 lysis times. (a) Thick 
fiber. (b) Thin fiber. (c) Zoomed in view of the first 8 minutes of the thick fiber CDF. (d) 
Zoomed in view of the first 7 minutes of the thin fiber CDF.
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T able 4.9. Macroscale model results for tPA rebinding. The experiments involved a 5 nM 
tPA concentration added to a fibrin-free region with height 2.935 ^m. Fine clots were run 
for 60 minutes of simulation time, coarse clots for 30 minutes. Entries are mean ±  standard 
deviation of 10 independent simulations. Front velocity calculations do not make sense for 
simulations in which lysis was not front-like, hence the “—” in some entries.
P a ra m e te rs C lo t ty p e F ro n t velocity  
(^ m /m in )
D e g ra d a tio n  r a te  
(% fib e rs /m in )
Case A (tPA) fine 1.77 ±  0.07 1.77 ±  0.009
coarse 4.78 ±  0.22 4.70 ±  0.024
Case B (tPA) fine - 1.57 ±  0.006
coarse — 6.09 ±  0.28
Case D (tPA) fine 0.82 ±  0.09 0.85 ±  0.005
coarse 3.49 ±  0.17 3.47 ±  0.024
Table 4.4). The number of successful binding events as a function of time is greater when 
tPA can rebind (blue and black dashed curves are above the solid curves in Figure 4.7), 
increasing lysis rates. For these parameter cases, allowing tPA to rebind greatly increases 
the probability that tPA initiates lysis when it binds on the macroscale. For example, with 
Case A parameters, tPA rebinding increases the likelihood of lysis on the microscale from 
59% to 100%. Hence, macroscale lysis rates are increased because tPA is more efficient -  
every time tPA binds to a fiber, it starts lysis. W ith Case B parameters, however, macroscale 
lysis of a coarse clot is virtually unchanged whether or not tPA can rebind. In this case, 
the plots of the number of successful binding events are almost indistinguishable (solid and 
dashed red curves in Figure 4.7). Because more than 99% of Case B microscale runs result 
in lysis even when tPA does not rebind (Table 4.3), allowing tPA to rebind has little effect 
on macroscale lysis.
Fine clots also have more efficient tPA when tPA can rebind to the fiber cross section 
(compare “Runs with PLi” columns in Table 4.8 and Table 4.3), but unlike in coarse clots, 
macroscale lysis is not faster. W ith tPA rebinding, the higher percentage of successful tPA 
bindings is outweighed by the longer residence time of tPA on fibers; when tPA is bound, 
it cannot diffuse and therefore initiation of lysis on other fibers is delayed. The very large 
ratio of fibers to tPA molecules in a fine clot (14145/1211 «  11.68 fibers/molecule) means 
tha t each tPA molecule must start lysis on many different fibers in order for macroscale 
degradation to occur. Contrast this with a coarse clot, where the fiber-to-tPA ratio is 
3605/2422 «  1.49 fibers/molecule. The longer tPA leaving times are not an issue in coarse 
clots because there are enough tPA molecules to efficiently start lysis on all fibers. However,
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------  Case A ------  Case B ------ Case D 
------Case A (tP A )--------Case B (tP A )--------Case D(tPA)
(a) Coarse clot (b) Fine clot
F ig u re  4.7. Number of successful tPA binding events as a function of time for tPA 
rebinding. The dashed curves represent runs with tPA rebinding, and the solid curves 
represent runs without tPA rebinding. Plots are averages of 10 independent simulations. 
(a) Coarse clot with 3605 total fibers (and 3605 possible successful binding events). (b) 
Fine clot with 14145 total fibers.
in fine clots, where each tPA molecule must start lysis on many fibers, preventing tPA from 
diffusing to new fibers (by keeping it bound longer) can slow lysis. We see this with Case A 
parameters. Allowing tPA to rebind results in fewer successful binding events as a function 
of time (dotted black curve is below solid black curve in Figure 4.7), and consequently in 
slower lysis rates (Table 4.9 and Table 4.4). W ith Case B and Case D parameters, tPA 
rebinding does not appreciably change the macroscale lysis rates. As in coarse clots, the 
reason tPA rebinding does not have an effect with Case B parameters is that every tPA 
binding event almost certainly initiates lysis, even when tPA cannot rebind. We believe it 
is serendipitous tha t tPA rebinding does not have an effect on fine clot lysis with Case D 
parameters; the prolonged tPA leaving times prevent tPA from diffusing as quickly through 
the clot, but this is balanced by the higher percentage of successful tPA bindings.
4 .2 .3  P lasm in  unbinding
We now study the effect of the plasmin inhibitor, a 2-antiplasmin (a 2-AP), on our 
multiscale model. a 2-AP exists in the plasma at a concentration of about 1 and 
binds to plasmin with an association constant of 2 x 107 M-1 s-1 [?], one of the fastest 
biological reactions ever characterized [?]. It is believed tha t plasma-phase a 2-AP directly
inhibits free plasmin. When cross-linked to fibrin, a 2-AP has been shown to inhibit plasmin 
generated on fibrin [?, ?]. It is believed that a 2-AP inhibits the plasmin once the plasmin 
unbinds from fibrin; bound plasmin is protected from a 2-AP. Some biological experiments 
suggest tha t both fibrin-associated and plasma-phase a 2-AP affect fibrinolysis [?]. However, 
other experiments seem to imply tha t free a 2-AP has little effect on clot lysis time [?]. In 
these experiments, uncross-linked clots showed very little variation in lysis rate, regardless 
of the a 2-AP concentration in the clotting plasma. Because we do not distinguish between 
cross-linked and uncross-linked fibrin in our model, we focus on plasma-phase a 2-AP.
To study the effect of a 2-AP on lysis, we allow plasmin to unbind in the microscale 
model. We assume that unbound plasmin is immediately inhibited by a 2-AP and removed 
from the system. In this way, we model the effect of a 2-AP without directly adding it 
to the model. We adjust the microscale model by adding plasmin unbinding reactions to 
the Gillespie algorithm; now plasmin can crawl, degrade fibrin, expose binding sites, and 
unbind from the cross section.
As expected, allowing plasmin to unbind has no effect on the time required to produce 
the first plasmin molecule (compare Table 4.10 to Tables 4.9 and 4.3). The tPA leaving 
time is increased when tPA is usually forced to unbind by plasmin (Case B) relative to when 
tPA usually unbinds on its own (Cases A and D). Also, single fiber lysis times are slower for 
all parameters when plasmin is allowed to unbind, with Case B being the most drastically 
affected (Figure 4.8). Thick fibers degrade less than 1% of the time (0.05-0.89%) when 
plasmin can unbind, so it is virtually impossible to see the corresponding lysis time CDFs 
in Figure 4.8(a). Because lysis of thin fibers requires fewer plasmin-mediated degradation 
events than lysis of thick fibers, a larger percentage of thin fiber simulations result in 
degradation (6.9-33.61%), but all of these percentages are still lower than when plasmin 
does not unbind.
Fine clots lyse faster than coarse clots, even though the number of tPA molecules exposed 
to the clot front is less than 287 molecules/um2 (and hence in the range where coarse clots 
should lyse faster than fine (Figure 4.1)). The fine clots lyse faster because of the drastic 
difference in successful tPA binding (0.05-0.89% success rate for thick, 6.9-33.61% for thin). 
This suggests that the number of fibers in the clot, the number of tPA molecules exposed to 
the clot front, and the likelihood of tPA initiating lysis when it binds contribute to relative 
lysis rates in fine and coarse clots.
When plasmin can unbind and tPA can rebind, single fiber lysis times are slower (for
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T able 4.10. Microscale model results for plasmin unbinding. D ata descriptions are the 
same as Table 4.8. In the parameter names, “PLi” means that plasmin was allowed to 
unbind, and “tPA” means tha t tPA was allowed to rebind.
P a ra m e te rs F ib e r
d ia m e te r
(nm )
tP A  leaving  tim e  (s) T im e to  first 
P L i (s)
R u n s
w ith
P L i
Case A (PLi) 97.5
195
105.47 (46.08, 209.25) 
111.63 (48.49, 222.27)




Case B (PLi) 97.5
195
216.08 (93.52, 416.47) 
246.97 (109.44, 489.67)




Case D (PLi) 97.5
195
144.69 (57.74, 302.73) 
148.77 (58.62, 307.57)




Case A (tPA,PLi) 97.5
195
272.24 (145.21, 475.42) 
502.01 (309.67, 783.48)




Case B (tPA,PLi) 97.5
195
301.05 (150.21, 541.42) 
565.81 (332.00, 945.75)




Case D (tPA,PLi) 97.5
195
619.18 (292.63, 1109.3) 
1009.7 (574.94, 1637.9)






—  Case B
-  -  Case B(PLi)





F ig u re  4.8. Lysis time cumulative distribution functions from the microscale model 
with plasmin unbinding. Dashed curves denote simulations with plasmin unbinding. For 
comparison, solid curves represent simulations without plasmin unbinding. The CDFs do 
not asymptote to 1 because we define “Probability” as the fraction of 10,000 runs. (a) 
Thick fiber. Due to the very low number of runs resulting in lysis when plasmin unbinds, 
the dashed curves are not visible on this scale. (b) Thin fiber.
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all parameter cases tested) than in runs for which plasmin cannot unbind and tPA does not 
rebind, but lysis occurs more frequently (Figure 4.9(a)). These single fiber lysis times are 
also slower than those produced by simulations in which plasmin cannot unbind but tPA 
can rebind (results not shown).
Unsurprisingly, compared to runs in which plasmin does not unbind, clot lysis rates 
are drastically reduced when plasmin is allowed to unbind, whether or not tPA rebinds 
(Table 4.11). The number of successful tPA binding events as a function of time is much 
lower as well (which contributes to the slower lysis rates), since the probability of tPA 
initiating lysis when it binds is so low (Figures 4.10 and 4.11).
4.3 Discussion
In this chapter we describe biologically motivated modifications of our multiscale model 
of fibrinolysis. The microscale domain is adjusted so that the fibrin concentration in a single 
fiber is approximately 800 ^M, and the amount of fibrin protein in a fiber is approximately 
20% of the fiber volume. The physical size of PLG is accounted for by allowing tPA to 
activate to plasmin any PLG molecule on the same protofibril, and by allowing plasmin to
------Case A ------ Case B ------  Case D 
------Case A (tP A ,P L i)--------Case B (tP A ,P L i)--------Case D(tPA,PLi)
(a) Thick fiber (b) Thin fiber
F ig u re  4.9. Lysis time cumulative distribution functions from the microscale model with 
plasmin unbinding and tPA rebinding. Dashed curves denote simulations with plasmin 
unbinding and tPA rebinding. For comparison, solid curves represent simulations without 
plasmin unbinding and tPA rebinding. The CDFs do not asymptote to 1 because we define 




—  Case B
















(a) Coarse clot (b) Fine clot
F ig u re  4.10. Number of successful tPA binding events as a function of time for plasmin 
unbinding. The dashed curves represent runs with plasmin unbinding, and the solid curves 
represent runs without plasmin unbinding. Plots are averages of 10 independent simulations. 
(a) Coarse clot with 3605 total fibers (and 3605 possible successful binding events). (b) Fine 
clot with 14145 total fibers.
T ab le 4.11. Macroscale model results for plasmin unbinding. D ata descriptions are the 
same as Table 4.4. In the parameter names, “PLi” means that plasmin was allowed to 
unbind, and “tPA ” means that tPA was allowed to rebind. * Lysis is front-like (tPA 
strongly binds to the front), but so slow tha t it is computationally challenging to measure 
front velocity.
P a ra m e te rs C lo t ty p e F ro n t velocity  
(^ m /m in )
D e g ra d a tio n  ra te  
(% f ib e rs /m in )
Case A (PLi) fine
coarse
0.66 ±  1.60* 
0.04 ±  0.19*
0.49 ±  0.012 
0.045 ±  0.006
Case B (PLi) fine
coarse
— 0.50 ±  0.014 
0.064 ±  0.007
Case D (PLi) fine
coarse
0.25 ±  0.55* 
0.001 ±  0.008*
0.16 ±  0.006 
0.008 ±  0.003
Case A (tPA,PLi) fine
coarse
1.17 ±  0.23 
2.20 ±  0.21
1.24 ±  0.019 
2.21 ±  0.019
Case B (tPA,PLi) fine
coarse
— 1.13 ±  0.014 
2.96 ±  0.030
Case D (tPA,PLi) fine
coarse
0.91 ±  2.52* 
1.25 ±  0.33
0.56 ±  0.014 




—  Case B






























(a) Coarse clot (b) Fine clot
0 00 0
F ig u re  4.11. Number of successful tPA binding events as a function of time for plasmin 
unbinding and tPA rebinding. The dashed curves represent runs with plasmin unbinding 
and tPA rebinding, and the solid curves represent runs without plasmin unbinding or tPA 
rebinding. Plots are averages of 10 independent simulations. (a) Coarse clot with 3605 total 
fibers (and 3605 possible successful binding events). (b) Fine clot with 14145 total fibers.
degrade any doublet on the same protofibril. Since a protofibril is about 5 nm in diameter 
and a plasminogen (and therefore plasmin) molecule is about 9-11 nm in diameter, it is 
reasonable that a PLG (or plasmin) molecule bound to one chain of a protofibril would be 
able to contact the other five protofibril chains.
W ith model modifications and baseline parameters (Case A), coarse clots lyse faster 
than fine clots for a wide range of conditions (Figure 4.1). The individual quantities of 
tPA concentration and volume of fibrin-free region do not matter; as long as the number of 
tPA molecules exposed to the surface of the clot is less than 287/^m 2, coarse clots will lyse 
faster than fine. Many experiments show coarse clots lyse faster than fine clots, so this new 
estimate seems more reasonable than the 25 molecules/^m2 obtained earlier in Chapter 3; 
if the threshold number of tPA molecules is larger, presumably many biological experiments 
will show coarse clots lysing faster than fine.
Since individual binding and unbinding rates for lytic proteins are difficult to measure, 
we use the multiscale model to hypothesize reasonable ranges for these values. The tPA 
and PLG binding rates to fibrin in the baseline parameter set (Case A) were suggested
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in an earlier mathematical model [?]. The Case A unbinding rates are chosen to enforce 
the measured dissociation constants. The incredibly slow single fiber and whole clot lysis 
times for Case F parameters (Figure 4.2, Table 4.4) suggest tha t the binding and unbinding 
rates of tPA and PLG should be bigger than those cited in Diamond and Anand [?]. W ith 
small tPA rates and baseline PLG rates (Case B), single fiber lysis seems reasonable, but 
macroscale lysis is not front-like (Figure 4.2, Table 4.4). Since lysis has been observed 
experimentally to be front-like, tPA (un)binding rates in the absence of PLG are likely 
larger than these values (kOpA =  1 x 10-4 ^M - 1s-1 , k f f  =  3.6 x 10-5 s-1 ). Increasing 
the tPA rates so kOpA =  1 ^M - 1s-1 (Case C) results in infrequent microscale lysis, but 
produces reasonable macroscale lysis due to the strong binding of tPA to the clot front 
(Figure 4.2, Table 4.4). W ith small PLG rates and baseline tPA rates (Cases D and E), 
only a small fraction of the time tPA binds to fibrin does it start lysis (Table 4.3). Because 
tPA rarely initiates lysis when it binds and because once bound it remains bound for a 
very long time, macroscale lysis is slowed to what seem to be biologically unreasonable 
rates (Table 4.4). We conclude that binding rates of tPA and PLG should be in the range 
kOnA e  (1 x 10- 2, 1) ^M - 1s-1 , k^ 0 e  (1 x 10-3 , 1 x 10-1 ) ^M - 1s-1 , with unbinding rates 
such that the measured dissociation constants are achieved.
To suggest potential targets for new therapeutics aimed at lysing blood clots, we studied 
model results with varying tPA dissociation constants. The physiological tPA dissociation 
constant for tPA binding to fibrin in the absence of PLG is 0.36 ^M  [?]. Decreasing 
ktpA (Case K) slows down macroscale lysis and increasing ktpA (Cases G, H, J) speeds up 
lysis (Table 4.7). It appears that there is an optimum dissociation constant, since lysis is 
reduced at the highest dissociation constant tested (k)pA  =  36 ^M displays slower lysis than 
k)pA  =  3.6 ^M). The way that we increase the dissociation constant (either by decreasing 
the binding rate or increasing the unbinding rate) has a quantitative effect on lysis speed, 
but lysis is still faster than when the physiological dissociation constant is used. The reason 
a larger dissociation constant results in faster lysis is because tPA does not bind as strongly 
to the front and can start lysis on more fibers throughout the clot. So a tPA variant that 
bound less strongly to fibrin, but retained the full ability to convert PLG to plasmin, would 
be an ideal target for drug design.
In general, we find tha t lysis rates are increased when tPA binds less frequently to fibrin. 
In this case, tPA diffuses more easily and starts lysis on fibers throughout the clot, so lysis 
is not front-like. The front-like behavior of lysis is dependent on strong binding of tPA to
fibers at the lysis front. If the binding rate of tPA to fibrin is small (Cases B and F in 
Section 4.2.1.1, Cases G and J in Section 4.2.1.2), or if the concentration of binding sites 
on fibrin available to tPA is low (Table 3.3 in Section 3.2.2.2), lysis does not proceed as a 
front. We conclude tha t in order for a lysis front to exist, tPA must bind strongly to fibrin; 
the binding rate of tPA to fibrin and the concentration of binding sites available to tPA on 
fibrin determine whether or not lysis is front-like.
Positive feedback, attained in the model by allowing tPA to rebind to the fiber cross 
section, has only a small effect on clot lysis. Depending on parameters, positive feedback 
may or may not affect fine clot lysis rates. Coarse clot lysis rates are increased by positive 
feedback for all parameter sets that result in inefficient tPA (Cases A and D). If tPA initiates 
lysis essentially every time it binds to a fiber, then positive feedback has no effect on lysis 
rates (Case B). The differing effect of positive feedback on the two types of clots is due to 
the tradeoff between the higher percentage of successful tPA bindings and the longer tPA 
leaving times. tPA is more efficient on the macroscale when we allow it to rebind on the 
microscale, but it is also less mobile on the macroscale because it stays bound to fibers 
for a longer time. In a fine clot with 14145 fibers, the hindered movement of tPA through 
the clot outweighs the increased efficiency of tPA in starting lysis, and therefore results in 
slower lysis rates. In a coarse clot with 3605 fibers, the longer tPA leaving times are less 
important, and the higher efficiency of tPA results in faster lysis rates. In the future, we 
will more closely examine the potential role of positive feedback in fibrinolysis.
We allow plasmin to unbind from the microscale model to study the effect of a 2-AP 
on lysis. When plasmin can unbind, there is a significant reduction in the number of 
microscale runs tha t result in lysis (Table 4.10). On the macroscale, this results in inefficient 
tPA (very few of the tPA binding events initiate lysis), and consequently in extremely 
slow clot lysis rates. The predicted lysis front velocities from the macroscale model (Ta­
ble 4.11) are up to three orders of magnitude smaller than published experimental lysis 
front velocities [?, ?, ?]. The slow lysis rates predicted by the model when plasmin unbinds 
are physiologically unrealistic, though we should not conclude from this observation that 
plasmin does not unbind. On the contrary, it is highly likely tha t plasmin unbinds under 
physiological conditions, so we instead conclude that tPA must rebind. Since whole clot 
degradation rates increase to more reasonable values if plasmin unbinds and tPA is allowed 
to rebind to the cross section (Table 4.11), we hypothesize that tPA does rebind to fiber 
cross sections under physiological conditions. This suggests that our rebinding probability
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calculation (Appendix E) is not appropriate. The calculation is based on a highly idealized 
geometry with an idealized definition of binding. Future work will involve a more thorough 




As discussed in Chapter 4, a 2-antiplasmin is a strong inhibitor of plasmin, and con­
sequently of fibrinolysis. In this chapter we discuss two additional fibrinolytic inhibitors: 
plasminogen activator inhibitor-1 (PAI-1) and thrombin activatable fibrinolysis inhibitor 
(TAFI). We include these inhibitors in the multiscale model framework described in Chap­
ters 3 and 4 to gain insight into the regulation of fibrinolysis.
5.1 Plasminogen activator inhibitor-1
Plasminogen activator inhibitor-1 (PAI-1) is a potent inhibitor of tPA. The plasma 
concentration of PAI-1 is about 0.4 nM [?, ?], but continuous production of PAI-1 by 
activated platelets could greatly increase the PAI-1 concentration in platelet-rich blood clots 
[?]. PAI-1 binds stoichiometrically to tPA with second order rate constant 35 ^M -1 s-1 and 
is consumed during the inhibition process [?]. Fibrin-bound tPA is inaccessible to PAI-1 
[?], providing a mechanism for PAI-1 regulation of fibrinolysis: PAI-1 inhibits plasma-phase 
tPA, preventing systemic lysis, but developing blood clots provide protection for tPA, 
leading to the initiation of fibrinolysis.
PAI-1 is present in the blood in both active and latent states [?]. The active state, 
which interacts with tPA, is unstable (half-life of «  10 min) and spontaneously converts 
into the latent form. However, active PAI-1 may bind to the protein vitronectin, increasing 
its half-life 2-10-fold while retaining its inhibitory ability [?]. Almost all active PAI-1 in 
plasma circulates in this vitronectin complex [?].
In this section we investigate the effect of platelets and PAI-1 on clot lysis. The 
microscale model is unchanged and the macroscale model is adjusted to include the physical 
presence of platelets and the inhibitory effect of PAI-1. We focus our investigation on coarse 
clots, but similar results are obtained for fine clots.
5.1.1 M od el m odifications
Plasma concentrations of PAI-1 are about 0.4 nM, but platelets trapped in the fibrin 
mesh of blood clots release PAI-1 locally. Measuring the PAI-1 concentration released by 
platelets is difficult, but an experiment with platelet-rich plasma (in which the platelets 
had been lysed) showed a concentration of about 5 nM [?]. Another experiment measured 
a PAI-1 concentration of 210 nM in a whole blood clot reconstituted with 1010 purified 
platelets/mL [?]. In the macroscale model, we assume tha t regions of clot containing 
platelets also contain PAI-1 at concentration 5 nM or, for an extreme experiment, 1 ^M. 
The presence of platelets in the macroscale clot is modeled by defining a 9 ^m  x 9 ^m  x 
2.74 ^m  region of the clot to be undegradable fibrin (we call this undegradable region an 
“obstacle”). This small region is about the size of a 3 x 3 clump of platelets. tPA can diffuse 
into such obstacles, but cannot bind and therefore cannot initiate lysis. We retain the lattice 
edges in the obstacles for ease of computation, but since the edges are undegradable and 
tPA cannot bind to them, we can imagine tha t there are platelets in this region instead of 
fibrin.
To mimic the inhibitory effect of PAI-1, we remove tPA that enters the obstacles with 
a probability dependent on the PAI-1 concentration. The second order rate constant for 
PAI-1 complexing with tPA is 35 ^M - 1s-1 [?], and the time step used in the macroscale 
model is about 0.0025 s. We derive the probability of tPA removal during one time step in 
a region of clot containing 5 nM PAI-1 by,
Premoval =  35 ^M - 1s-1 x 0.005 ^M x 0.0025 s =  4.375 x 10-4 .
Similarly, the probability of tPA removal in one time step is 0.0875 if the local PAI-1 
concentration is 1 ^M. This information is included in the macroscale model by checking 
the location of each tPA molecule at each time step. If a tPA molecule is in a region of 
clot containing platelets, we generate a uniformly distributed random number, r  € U [0, 1]. 
If r  < premoval, then the tPA molecule is removed from the simulation. If r  > premoval, 
then the tPA molecule is not removed and instead remains unbound at the current edge or 
diffuses to a neighboring fiber. Because platelets continually produce PAI-1, we assume the 
PAI-1 concentration remains fixed, even though PAI-1 is consumed as it inhibits tPA. The 
macroscale algorithm described in Section 3.1.2 is modified as follows (changes in italics):
1. Determine the clot geometry and At, set t =  0, fix tfinal (a prescribed final time), fix
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the tPA rem oval probability p removal, and initialize the degradation times of all edges 
to 0.
2. Randomly place a specified number of tPA molecules in the fibrin-free region.
3. For t  <  final:
a. set t =  t +  At.
b. degrade any edges with nonzero degradation times < t, and unbind any tPA 
molecules tha t were bound to the degraded edges.
c. check the unbinding times for all bound tPA molecules, unbind any with times
< t.
d. assign each newly unbound molecule a binding time, tbind.
e. for each unbound molecule, pick a random number r  e  U [0, 1] and
i. if r  < (1 — q), the molecule does not move.
A. If the tPA molecule is on a degradable edge, the molecule can bind.
I. If tbind > t or the edge has already been degraded, the molecule 
remains unbound.
II. If tbind < t and the edge the molecule is on has not been degraded, 
bind the molecule and use the microscale distributions to find the new 
unbinding time and the degradation time for tha t fiber.
B . If the tPA molecule is on an undegradable edge, the molecule can be 
removed. Pick a random number r 2 e  U [0,1].
I. I f  r 2 < p removai, rem ove the tPA molecule from  the simulation.
II. I f  r 2 > p removal, the tPA molecule rem ains on its current edge.
ii. if r  > (1 — q), the molecule has the opportunity to move, but may bind 
before it can do so.
A. If the tPA molecule is on a degradable edge, the molecule can bind.
I. If tbind > t or the edge has already been degraded, randomly move the 
tPA to a neighboring edge and calculate a new binding time for the 
tPA to tha t edge.
II. If tbind < t and the edge the molecule is on has not been degraded, 
pick a random number, r  3 e  U [0, 1].
aa. If f 3 >  (t-^ nd), then movement happens before the tPA binds. 
Randomly move the tPA to a neighboring edge and calculate a new 
binding time for the tPA to that edge. 
bb. If ^3 <  (t ^tmd), the molecule binds and therefore cannot move. Use 
the microscale model distributions to calculate a new unbinding time 
and the degradation time for the fiber.
B. If the tPA molecule is on an undegradable edge, the molecule can be 
removed. Pick a random number f 4 e U [0,1].
I. I f f 4 <  premoval, remove the tPA molecule from the simulation.
II. I f 4^ >  premovai, randomly move the tPA to a neighboring edge and 
calculate a new binding time for the tPA to that edge.
f. return to step a.
5.1.2 Results
We use the modified macroscale model described above to study the effect of platelets 
and PAI-1 on lysis. We experiment with different numbers of obstacles in the clot, as well 
as different distributions of obstacles throughout the clot. Baseline Case A parameters 
(Table 4.1) without tPA rebinding or plasmin unbinding are used in all experiments, and 
the investigation is limited to lysis of coarse clots (although we find similar results for fine 
clots). Unless otherwise noted, experiments were run with fibrin-free height H  =  2.935 ^m. 
Sets of experiments are run in pairs: once with a tPA removal probability corresponding to 
a 5 nM PAI-1 concentration (premovai =  4.375 x 10-4 ) and another time with a 1 uM PAI-1 
concentration (premoval =  0.0875). We use “platelet region” and “obstacle” interchangeably 
to refer to the region of clot containing undegradable fibrin.
5.1.2.1 Fraction of clot composed of obstacles
We start with one obstacle (9 ^m x 9 ^m x 2.74 ^m clump of platelets) in the middle 
of the coarse clot, corresponding to 0.8% of the domain being undegradable fibrin. A 5 
nM tPA concentration is introduced into the fibrin-free region, which has height H  =  2.935 
^m (Figure 3.2). Lysis proceeds more quickly when the tPA removal probability is small 
(premoval =  4.375 x 10-4 ) compared to when the removal probability is larger (premoval =  
0.0875) (Figure 5.1). In both cases, however, all the tPA molecules are inhibited eventually. 
The pattern of lysis is also affected when the removal probability is high (premoval =  0.0875);
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lysis is slowed behind the obstacle compared to the rate of lysis away from the obstacle 
(Figure 5.1). The reduction in lysis behind the obstacle is due to inhibition of tPA as 
it diffuses through the platelet region. Some of the tPA molecules are removed from the 
region, hence fewer tPA molecules arrive at the rear edge of the obstacle. This effect is not 
seen when premoval =  4.375 x 10-4 .
We also study the effect of the number of obstacles on clot lysis. Initially, we evenly space 
four 9 ^m x 9 ^m x 2.74 ^m obstacles throughout the domain (3.2% of the total domain is 
undegradable fibrin in this case). We then increase the number of evenly spaced obstacles 
to 9 (7.3% of domain is undegradable fibrin), 16 (13% of domain is undegradable fibrin), 
and 25 (20.3% of domain is undegradable fibrin) in subsequent experiments. Lysis proceeds 
at about the same rate regardless of number of obstacles when premoval =  4.375 x 10-4 
(Figure 5.2). When premoval =  0.0875, however, systematically increasing the number of 
obstacles results in a systematic reduction in lysis. By the time 20% of the domain is 
undegradable fibrin, hardly any lysis occurs (Figure 5.3).
There is more uninhibited tPA at a given percentage of clot degradation when premoval =  
4.375 x 10-4 than when premoval =  0.0875. However, as a function of time, the number of 
tPA molecules remaining in the experiment depends on the percentage of undegradable 
fibrin in the clot. We expect that tPA will be removed more quickly when premoval =  0.0875 
compared to premoval =  4.375 x 10-4 , and we do see this in experiments with large numbers 
(16 or 25) of equally spaced obstacles. In these experiments, tPA encounters the PAI-1 
regions very quickly and is completely removed from the experiment more quickly when the 
removal probability is large (premoval =  0.0875). Interestingly, when there are small numbers 
(four or nine) of evenly spaced obstacles in the clot, tPA is completely removed from the 
experiment more quickly when the removal probability is small (premoval =  4.375 x 10-4 ), 
because lysis happens faster and the tPA is not protected from PAI-1. When tPA is bound 
to fibrin, it cannot diffuse, so it cannot “wander” into the platelet region. Once all the 
fibrin has been degraded, tPA diffuses and is quickly inhibited.
So far we have considered only situations in which the PAI-1 secreted by platelets remains 
in the vicinity of the platelets and does not diffuse. We can model diffused, plasma-phase 
PAI-1 by including in the model the effect of the stable PAI-1-vitronectin complex. We 
model this effect by assuming a low level of tPA removal on all the edges: we take premoval =  
3.675 x 10-5 (which corresponds to a 0.42 nM PAI-1 concentration) on non-obstacle edges 
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(b) t = 31 min
Figure 5.1. Coarse clot lysis around a single obstacle. Figures on left have 
premoval =  4.375 x 10-4 , and figures on right have premoval =  0.0875. Figures are 2-D 
projections of the 3-D clot; black lines indicate fibrin fibers in the plane of the page, and 
blue dots represent fibers extending out of the page. Green asterisks represent bound tPA, 
and black asterisks represent unbound tPA. Numbers on axes correspond to lattice node 
number, with a physical distance between lattice nodes of 2.74 ^m. (a) Macroscale clot 24 
minutes after introduction of the 5nM bolus of tPA. (b) Macroscale clot 31 minutes after 
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(b) t = 27 min
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Figure 5.2. Coarse clot lysis around different numbers of obstacles, with tPA removal 
probability premoval =  4.375 x 10-4 . The clot on the left contains one obstacle, taking up 
0.8% of the domain. The clot on the right contains 25 obstacles, accounting for 20% of the 
domain. Symbols and interpretations are the same as in Figure 5.1. (a) Macroscale clot 7 
minutes after introduction of the 5nM bolus of tPA. (b) Macroscale clot 27 minutes after 
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(b) t = 27 min
Figure 5.3. Coarse clot lysis around different numbers of obstacles, with tPA removal 
probability premoval =  0.0875. The clot on the left contains one obstacle, taking up 0.8% 
of the domain. The clot on the right contains 25 obstacles, accounting for 20% of the 
domain. Symbols and interpretations are the same as in Figure 5.1. (a) Macroscale clot 7 
minutes after introduction of the 5nM bolus of tPA. (b) Macroscale clot 27 minutes after 
introduction of the 5nM bolus of tPA.
remain undegradable, but all other edges can be degraded. As before, tPA can only be 
inhibited if it is unbound. We find that the fibrin protects tPA from inhibition; even when 
tPA can be removed at any edge, lysis proceeds at about the same rate as it does in the 
case with inhibition only in platelet regions (Figures 5.4(a) and 5.4(b)). However, if there 
is a low level of tPA removal on all edges and bound tPA is accessible to PAI-1, then all 
tPA is inhibited very quickly and virtually no lysis occurs (Figure 5.4(c)).
5.1.2.2 Distribution of obstacles
As seen in Section 5.1.2.1, the fraction of clot containing platelets has an effect on 
macroscale lysis with a large tPA removal probability (premoval =  0.0875) and obstacles that 
are evenly spaced throughout the clot. Here we show how the distribution of these obstacles 
within the clot affects lysis. We use nine obstacles, and distribute them throughout the clot 
in two distinct ways: in the first configuration, obstacles are evenly spaces as in the previous 
section; in the second configuration, all nine obstacles are placed one fiber-length apart, and 
this mass of tightly-packed obstacles is centered in the clot.
When premoval =  4.375 x 10-4 , lysis occurs at about the same rate regardless of how the 
nine obstacles are distributed (results not shown). When premoval =  0.0875, lysis is faster 
and more complete when the obstacles are placed close together as compared to when the 
obstacles are evenly spaced throughout the clot (Figure 5.5). When the obstacles are placed 
only one fiber-length apart, most of the clot is degraded except for the fibers connecting 
the nine obstacles. The explanation for why the two distinct obstacle configurations (that 
have the same percentage of total platelets) produce such different lysis patterns involves 
the surface area of obstacles abutting the rest of the clot, which is very different in the two 
configurations. The surface area of a single obstacle that contacts the surrounding clot is 
36 ^m x 2.74 um =  98.64 um2, so when there are nine evenly spaced obstacles, 9 x 98.64 
=  887.76 um2 is directly exposed to the bulk fibrin clot. However, when the obstacles are 
closely packed together, only 108 um x 2.74 um =  295.92 um2 of platelet region is directly 
exposed to the bulk clot. With a smaller surface area exposed to the rest of the clot, tPA 
is less likely to contact the platelet region and be inhibited. With more tPA around, more 
lysis can occur, which is why we see a greater extent of lysis in the clot with closely packed 
obstacles.
When the obstacles are placed close together in the center of the clot, another effect of 
platelets on lysis is observed: when premoval =  4.375 x 10-4 , the tPA binding front moves
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Figure 5.4. Coarse clot lysis around nine obstacles with a low level of tPA removal on 
all edges. Symbols and interpretations are the same as in Figure 5.1. All figures show the 
state of the macroscale clot 27 minutes after introduction of the 5nM bolus of tPA. (a) 
premoval =  4.375 x 10-4 on edges in the obstacles. (b) premoval =  3.675 x 10-5 on all edges in 
the clot, and premoval =  4.375 x 10-4 on edges in the obstacles. Only unbound tPA can be 
inhibited. (c) premoval =  3.675 x 10-5 on all edges in the clot, and premoval =  4.375 x 10-4 
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Figure 5.5. Coarse clot lysis around nine obstacles that are distributed in different ways. 
The figures on the left have the nine obstacles spaced evenly throughout the clot. The 
figures on the right have the nine obstacles spaced one fiber apart in the center of the 
clot. Symbols and interpretations are the same as in Figure 5.1. (a) Macroscale clot 17 
minutes after introduction of the 5nM bolus of tPA. (b) Macroscale clot 47 minutes after 
introduction of the 5nM bolus of tPA.
through the platelet region more quickly than it does in other parts of the clot (Figure 5.6). 
Because tPA cannot bind to fibrin in a platelet region, its diffusion is not impeded. tPA 
freely diffuses through the region and, therefore, travels a greater distance in a given time 
than the tPA molecules away from the obstacle, which bind to fibrin and are prevented 
from diffusing. However, if premoval =  0.0875, the effect is reversed; the tPA binding front 
moves more quickly in regions of the clot away from the obstacles. The removal probability 
is high enough that it is very unlikely that a tPA molecule diffuses through the obstacle 
without being inhibited. The described effect occurs with a 5 nM tPA concentration added 
to a fibrin-free region with height 2.935 ^m (not shown), but is more evident when the 5 
nM tPA concentration is added to a fibrin-free region with height 17.61 ^m (Figure 5.6).
5.2 Thrombin activatable fibrinolysis inhibitor
In this section, we discuss the indirect fibrinolytic inhibitor, TAFIa. Thrombin activat­
able fibrinolysis inhibitor (TAFI) is a carboxypeptidase that cleaves lysine residues when 
activated. Because tPA and PLG bind to lysine residues, TAFI plays a role in fibrinolysis. 
Activated TAFI (TAFIa) cleaves the tPA and PLG binding sites that become exposed as 
lysis progresses, preventing the accumulation of PLG on partially degraded fibrin [?]. PLG
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Figure 5.6. tPA diffusion through the platelet region of coarse clots. The clot on the left 
has premoval =  4.375 x 10-4 and the clot on the right has premoval =  0.0875. Both clots are 
shown 8 minutes after introduction of the 5nM bolus of tPA. Symbols and interpretations 
are the same as in Figure 5.1. The height of the fibrin-free region is H  =  17.61 ^m.
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circulates in plasma in its native form, Glu-PLG, but in the presence of partially degraded 
fibrin can be converted by plasmin to the more active Lys-PLG [?]. Lys-PLG is more 
easily activated to plasmin by tPA (K m =  19 ^M, kcat =  0.2 s-1 for Lys-PLG compared 
to K m =  65 ^M, kcat =  0.06 s-1 for Glu-PLG) [?]. Thus, TAFIa not only slows lysis 
by inhibiting the activation of PLG to plasmin, but also by inhibiting the conversion of 
Glu-PLG to Lys-PLG [?]. TAFIa attenuates lysis in these indirect ways, however, and does 
not directly inhibit plasmin activity [?].
TAFI is activated to TAFIa by plasmin (K m =  55 nM, kcat =  0.00044 s-1 ), thrombin 
(K m =  0.5 — 2.14 ^M, kcat =  0.0021 s-1 ), and the thrombin-thrombomodulin complex 
(K m =  1.01 ^M, kcat =  0.4 — 1.24 s-1 ) [?, ?, ?]. While the thrombin-thrombomodulin 
complex is the fastest activator, activation by plasmin occurs for a more physiological TAFI 
concentration (K m =  55 nM instead of 1.01 ^M). The plasma concentration of TAFI ranges 
from 75-275 nM [?, ?], and plasma levels of TAFIa have been measured to be about 12 
pM [?]. However, local physiological TAFIa concentrations in blood clots during lysis are 
unknown, and are especially hard to measure since TAFIa is unstable (the half-life of TAFIa 
at 37°C is 8-15 minutes [?]). In TAFI-deficient plasma experiments, it is found that the 
peak TAFIa concentration is only about 0.2% of the total added TAFI concentration (e.g., 
when 66 nM TAFI is added, the peak TAFIa concentration is 0.11 nM) [?]. As far as we 
know, this is the only published measurement of TAFIa during lysis. It seems reasonable 
that significantly more TAFIa could be produced since there are so many activators of TAFI 
(plasmin, thrombin, thrombin-thrombomodulin), but we know of no other measurements 
in the literature.
The interplay between the plasmin inhibitor a 2-AP and TAFIa is complicated. The 
observed rate of inhibition of plasmin by a 2-AP is much higher in the presence of TAFIa, 
and the rate increases with increasing initial TAFIa concentrations [?]. This is presumably 
because TAFIa cleaves binding sites, preventing the protection of plasmin by releasing it 
into the plasma where it can be inhibited by a 2-AP. In the absence of a 2-AP, TAFIa does 
not appreciably prolong lysis of a purified fibrin clot; there is virtually no change in the 
lysis time (it remains about 0.2 hours) for TAFIa concentrations ranging from 0-200 nM 
in the absence of a 2-AP, but in the presence of 1 ^M a 2-AP, lysis times increase from 
about 3.8 hours (no TAFIa) to 5 hours (200 nM TAFIa) [?]. The results of this experiment 
are perplexing: why is a 2-AP necessary for TAFIa to prolong lysis? If TAFIa exerts its 
influence mainly by cleaving PLG binding sites, thus preventing both the accumulation of
PLG and the increase in the rate of PLG activation, at what step would the a 2-AP be 
required?
We add TAFIa to the microscale model, with and without the effect of a 2-AP (which 
is modeled by allowing plasmin to unbind, as described in Section 4.2.3), to investigate the 
interplay between TAFIa and a 2-AP. Model results allow us to suggest an explanation for 
how TAFIa is effective in delaying lysis only in the presence of a 2-AP.
5.2.1 Model modifications
For the purpose of our investigation, we assume that TAFI has already been activated 
to TAFIa, and hence we do not model the activation process. TAFIa is included in 
the microscale model (described in Sections 3.1.1 and 4.1), where it is able to cleave 
initially-cryptic doublets when they become exposed. We assume TAFIa is present in high 
enough concentration that we can consider it to be in quasi-steady state, and treat it 
deterministically as we do PLG -  using probabilities of TAFIa being on doublets -  rather 
than explicitly tracking large numbers of individual TAFIa molecules. In the notation of 
Figure 3.3, we use “4” to represent TAFIa. So N 14 is a doublet with one tPA molecule 
and one TAFIa molecule bound. Now NPLG can be N22, N02, N00 (as before), or N04, 
N24, or N44. The probability of NPLG being in any of these 6 states is calculated using the 
quasi-steady state approximation (Appendix H). In addition to the change in NPLG, four 
new states are added to the model: a doublet with tPA and TAFIa bound (N 14), a doublet 
with plasmin and TAFIa bound (N34), a doublet that has been cleaved by TAFIa (C ), and 
a cleaved doublet with a plasmin molecule bound (C3).
With the new states come new reactions, so that now the Gillespie algorithm chooses 
from 54 reactions (Appendix I). The TAFIa rate constants are listed in Table 5.1. For 
all experiments described in this section, we use a 20 nM TAFIa concentration, which 
corresponds to about 10% of the plasma TAFI having been activated to TAFIa. To cleave, 
TAFIa must be bound to a doublet. It is assumed that TAFIa can bind to and cleave only 
exposed doublets that were initially cryptic, and that once a doublet is cleaved, no tPA or 
PLG may bind to it. All bound tPA and PLG molecules on a doublet are released upon 
its cleavage by TAFIa. Plasmin can bind to cleaved doublets for the same reason it can 
bind to degraded doublets: we assume plasmin uses the frayed ends of nearby protofibrils to 
crawl, and therefore can reside on a cleaved doublet by being bound to a frayed protofibril. 
Cleaved doublets, like all undegraded doublets, can be degraded by any plasmin molecule
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at the same binding location.
TAFIa does not directly affect the macroscale model -  it appears indirectly via the 
tPA leaving time and lysis time distributions computed with the microscale model. In 
all macroscale experiments in this section, a 5 nM tPA concentration is introduced into a 
fibrin-free region abutting the clot that is 2.935-^m high. The experiments are run for 30 
minutes of simulation time.
5.2.2 Results
For each experiment, we run the microscale model with TAFIa 10,000 times with Case 
A parameters (Tables 4.1 and 5.1). In one experiment, plasmin is not allowed to unbind and 
therefore is not inhibited by a 2-AP. In another experiment, we model the effect of a 2-AP 
by allowing plasmin to unbind and immediately be inhibited. Finally, we model positive 
feedback by running experiments in which tPA rebinds to the fiber cross section, both with 
and without plasmin unbinding. Microscale model results are presented as median (first 
quartile Q1, third quartile Q3) of 10,000 simulations, and macroscale model results are 
presented as mean ±  standard deviation of 10 simulations.
With no tPA rebinding and no plasmin unbinding, adding TAFIa to the microscale 
model slightly slows down single fiber lysis (compare the dashed and solid black curves in 
Figure 5.7). The median tPA leaving time is about 5 seconds longer, for both thin and thick 
fibers, when TAFIa is included in the model (compare “TAFIa” in Table 5.2 to “Case A” 
in Table 4.3). The time to first plasmin production is very similar for Case A parameters 
with and without TAFIa. Since single fiber lysis is slower when TAFIa is included in the 
model, and because TAFIa does not affect the time it takes to produce the first plasmin 
molecule, TAFIa must reduce the total number of plasmin molecules created. Indeed, we 
find that the median (Q1, Q3) number of plasmin molecules created in a thick fiber drops
Table 5.1. TAFIa parameters. kcleave is the rate at which TAFIa cleaves binding sites.
and are the TAFIa binding rate to fibrin and the TAFIa unbinding rate from
fibrin, respectively. These individual on and off rates have not been measured, but we were 
able to estimate a dissociation constant from [?].
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Param eter Value R eference
kcleave (s ) 2.34 [?]
fcJAFI (^M-1 s-1 ) 54.9 [?]
















Figure 5.7. Empirical lysis time cumulative distribution functions from the TAFIa 
microscale model with Case A parameters. Solid curves denote simulations without TAFIa, 
dashed curves denote simulations with TAFIa. “tPA” means tPA was allowed to rebind 
and “PLi” means plasmin was allowed to unbind. Most of the CDFs do not asymptote to 
1 because we define “Probability” as the fraction of 10,000 runs. In most situations, fewer 
than 10,000 runs resulted in lysis, so there are fewer than 10,000 lysis times. (a) Thick 
fiber. Only 20 runs out of 10,000 resulted in lysis for “Case A (PLi)” simulation, so the 
corresponding CDF is not visible on this scale. For the “TAFIa (PLi)” simulation only 1 
run out of 10,000 resulted in lysis, so there is no corresponding CDF. (b) Thin fiber.
from 2 (1, 3) to 1 (1, 2) in the presence of TAFIa, and the maximum number of plasmin 
molecules produced in any run drops from 10 to 6. Similarly, for a thin fiber with TAFIa, 
the median (Q1, Q3) number of plasmin molecules is 1 (1,1) (down from 1 (1,2) without 
TAFIa), and the maximum number of plasmin molecules produced in any run is 5 (down 
from 7). The reduced plasmin production causes the increased tPA leaving times in runs 
with TAFIa; tPA is less likely to be forced to unbind by plasmin when there are fewer 
plasmin molecules in the cross section, allowing tPA to stay bound longer.
When tPA is allowed to rebind in the TAFIa microscale model but plasmin still does 
not unbind (denoted “TAFI (tPA)” in tables and figures), single fiber lysis is slightly slower 
than in the same situation without TAFIa (solid and dashed red curves Figure 5.7). Also, 
the tPA leaving time is increased and the first plasmin molecule is created at about the 
same time (compare “Case A (tPA)” in Table 4.8 to “TAFIa (tPA)” in Table 5.2). As in the 
case without tPA rebinding, the slower single fiber lysis times and longer tPA leaving times 
are a result of the fewer plasmin molecules that are produced (on average) when TAFIa is
0
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Table 5.2. Microscale model results for Case A parameters with TAFIa. Entries are 
median (Q1, Q3) of 10,000 independent simulations. The column labeled “Time to first 
PLi” gives data about the time the first plasmin molecule was created. The column labeled 
“Runs with PLi” gives the number of runs, out of 10,000, in which plasmin was produced 
and single fiber lysis occurred. Our standard experiment (denoted “TAFIa” in table) does 
not allow plasmin to unbind, nor does tPA ever rebind. In different experiments plasmin 
was allowed to unbind (denoted “PLi” in table), and tPA was allowed to rebind (denoted 
“tPA” in table).
Param eters F iber tP A  leaving tim e (s) T im e to  first R uns
diam eter P L i (s) w ith
(nm ) PLi
TAFIa 97.5 95.38 (44.89, 177.52) 83.02 (35.61, 164.29) 5852195 110.26 (47.83, 209.67) 84.34 (34.39, 174.63) 5887
TAFIa (tPA) 97.5 191.03 (108.54, 334.51) 140.74 (57.75, 284.53) 10000195 310.73 (211.41, 450.75) 139.47 (56.44, 280.12) 10000
TAFIa (PLi) 97.5 114.73 (49.73, 227.07) 83.96 (34.73, 169.50) 708195 121.93 (50.39, 243.49) 84.94 (36.38, 169.06) 1
TAFIa (tPA, PLi) 97.5 583.57 (314.78, 959.90) 139.88 (58.52, 274.80) 8340195 1544.9 (894.75, 2335.4) 140.61 (57.43, 280.81) 2189
present.
To study the effect of a 2-AP we allow plasmin to unbind. When plasmin unbinds it 
is assumed to be inhibited immediately by a 2-AP, and is removed from the simulation. 
If tPA does not rebind, but plasmin can unbind, adding TAFIa to the microscale model 
greatly increases the single fiber lysis times (solid and dashed blue curves Figure 5.7). Lysis 
happens very infrequently; when TAFIa is present and plasmin can unbind, only 1 run out 
of 10,000 results in lysis of a thick fiber, and 708 runs out of 10,000 result in lysis of a thin 
fiber. tPA leaving times are slightly increased when TAFIa is included in the model, and 
the first plasmin molecule is created at about the same time (compare “Case A (PLi)” in 
Table 4.10 to “TAFIa (PLi)” in Table 5.2).
As illustrated in Figure 5.7, adding plasmin unbinding alone (i.e., a 2-AP) has a greater 
effect on lysis time than does adding TAFIa alone. The standard Case A parameter results 
(no TAFIa, no plasmin unbinding) are depicted by the solid black curve. Adding TAFIa 
slightly slows down lysis (dotted black curve is below solid black curve), but adding plasmin 
unbinding noticeably slows lysis (solid blue curve, only visible in Figure 5.7(b)). Including 
TAFIa and plasmin unbinding slows lysis even more (dotted blue curve, only visible in 
Figure 5.7(b)). In fact, adding TAFIa and plasmin unbinding to the microscale model
slows lysis even more than the sum of the effects of adding each alone. For example, with 
no plasmin unbinding and without TAFIa, the median lysis time of a thin fiber is 2.32 
min. Allowing plasmin to unbind increases the median lysis time by 0.17 min (7.33%), 
while adding TAFIa increases the time by 0.07 min (3.02%). Adding plasmin unbinding 
and TAFIa together, however, increases the median lysis time by 0.81 min (35.91%). This 
is because plasmin and TAFIa do not work independently of each other; TAFIa cleaves 
doublets, causing fewer plasmin molecules to be produced. If those fewer plasmin molecules 
can also unbind, the result is a significant increase in lysis time.
For completeness, we study the effect of adding TAFIa to the microscale model when 
tPA can rebind and plasmin can unbind. tPA stays bound over twice as long compared to 
runs without TAFIa, but the first plasmin molecule is still produced at about the same time 
(compare “Case A (tPA,PLi)” in Table 4.10 to “TAFIa (tPA,PLi)” in Table 5.2). Single 
fiber lysis times are much longer (the dotted green curve is substantially below the solid 
green curve in Figure 5.7), for the same reason described above: there is a much greater 
effect when TAFIa and a 2-AP are combined than when either acts independently.
The presence of TAFIa in the microscale model results in slower macroscale lysis in all 
experiments (compare Table 5.3 to Tables 4.4, 4.9, and 4.10). Macroscale lysis proceeds
Table 5.3. Macroscale model results for Case A parameters with TAFIa. The experiments 
involved a 5 nM tPA concentration added to a fibrin-free region with height 2.935 ^m. 
Entries are mean ±  standard deviation of 10 independent simulations. Front velocity 
calculations do not make sense for simulations in which lysis was not front-like, hence 
the “—” in some entries. No lysis occurred in the coarse “TAFIa (PLi)” experiment, hence 
the “—” in both columns. Our standard experiment (denoted in table as “TAFIa” ) does not 
allow plasmin to unbind, nor does tPA ever rebind. In different experiments, plasmin was 
allowed to unbind (denoted in table “PLi” ) and tPA was allowed to rebind (denoted in table 
“tPA” ). Front velocity and degradation rate were calculated as described in Section 3.2.2.2.
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Param eters C lot type Front ve locity  
(^ m /m in )
D egradation  rate 
(%  fib ers /m in )
TAFIa fine 1.74 ±  0.24 1.90 ±  0.018coarse 3.56 ±  0.20 3.55 ±  0.037
TAFIa (tPA) fine 1.61 ±  0.18 1.69 ±  0.010coarse 3.44 ±  0.16 3.42 ±  0.017
TAFIa (PLi) fine — 0.22 ±  0.014coarse — —
TAFIa (tPA, PLi) fine 0.50 ±  0.011coarse — 0.21 ±  0.033
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through the clot as a front, except when plasmin is allowed to unbind. In this case, the 
lack of front-like behavior is likely a result of the very long single fiber lysis times, which 
result in very little macroscale lysis and hinder accurate measurement of a lysis front. 
Comparing the dashed curves to the solid curves in Figure 5.8 shows that for all four of 
the situations tested, TAFIa decreases the number of successful tPA binding events as a 
function of time. This makes sense for the runs in which plasmin unbinds ( “TAFIa (PLi)” 
and “TAFIa (tPA,PLi)” ) because the probability that a tPA molecule initiates lysis when 
it binds in these cases is much lower than the same probability in the runs without TAFIa 
( “runs with PLi” column in Table 5.2). Additionally, since tPA stays bound longer in the 
runs with TAFIa, its progression through the clot is slower, which also decreases the number 
of successful binding events as a function of time. In runs in which plasmin does not unbind 
( “TAFIa” and “TAFIa (tPA)” ), the probability of tPA initiating lysis when it binds is very 
similar in the presence and absence of TAFIa. The decrease in the number of successful 
binding events in these cases is due to the reduced movement of tPA through the clot. tPA 
leaving times are longer in the TAFIa runs, causing tPA to remain on edges for a longer 




































(a) Coarse clot (b) Fine clot
0
0 0
Figure 5.8. Number of successful tPA binding events as a function of time for TAFIa 
runs with Case A parameters. Plots are averages of 10 independent simulations. Solid lines 
indicate runs without TAFIa, dashed lines indicate runs with TAFIa. (a) Coarse clot with 
3605 total fibers (and 3605 possible successful binding events). (b) Fine clot with 14145 
total fibers.
5.3 Discussion
We investigated the effects of inhibitors on single fiber and whole clot lysis. First, the 
tPA inhibitor PAI-1 was included in the macroscale model by prescribing a tPA removal 
probability on fibers in regions of clot containing PAI-1 (Section 5.1). Then the indirect 
fibrinolytic inhibitor TAFIa was included in the microscale model by adding new state 
variables and reactions (Section 5.2 and Appendix I). The plasmin inhibitor a 2-AP was 
modeled indirectly on the microscale by allowing plasmin to unbind, and then immediately 
removing the unbound plasmin from the simulation. We studied the effects of PAI-1, TAFIa, 
and a 2-AP independently, as well as the combined effect of TAFIa and a 2-AP.
In all versions of our model, we assume the clot is a homogeneous 3-dimensional square 
lattice. However, there are many ways inhomogeneity can arise in a clot: varying fiber 
size in different regions of the clot; arrangement of fibers in the clot; the presence (and 
distribution) of cells like platelets; chemistry such as varying concentrations of PAI-1. We 
focus on the latter two causes of clot heterogeneity. The physical presence of platelets 
is modeled by defining regions of the clot to be undegradable. The chemical presence of 
platelets is included via PAI-1, which is modeled indirectly by prescribing a tPA removal 
probability on fibers in regions of the clot containing platelets.
Results of the macroscale model with platelets and PAI-1 suggest that PAI-1 concentra­
tions in the clot must be larger than the measured 5 nM concentration in order to retard 
lysis. If the PAI-1 concentration is only 5 nM, lysis rates are not reduced, even if 20% 
of the clot is composed of platelets (Figure 5.2). However, if platelets can create local 
concentrations of PAI-1 on the order of 1 ^M, lysis can be greatly affected; as the fraction 
of domain composed of platelets increases, lysis is greatly reduced when premoval =  0.0875 
(Figure 5.3).
When the larger tPA removal probability is used, the distribution of platelets in the clot 
has a significant effect on lysis. If the platelet regions are spaced closely together in the 
center of the clot, lysis is much faster and more complete than if they are spaced evenly 
throughout the clot, suggesting that the surface area of the platelet regions is important 
(Figure 5.5). tPA is more likely to be inhibited by PAI-1 if the surface area of platelet 
regions exposed to the rest of the clot is large; tPA is only inhibited in the platelet regions, 
so if the surface area of these regions is large, tPA will be more likely to enter a platelet 
region. Thus, it is not just the amount of platelets in a clot that will determine the ease 
with which the clot can be degraded, but also their distribution within the clot.
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The results described above were obtained under the assumption that PAI-1 only inhibits 
unbound tPA. Also, we assumed that PAI-1 is short-lived and cannot diffuse through the 
whole clot, and therefore is only present in the local vicinity around platelets. However, if 
we imagine that PAI-1 has diffused away from the platelets and we define a low probability 
of tPA removal on all edges in the clot (not just edges in the platelet regions), then we 
can provide support for the hypothesis that PAI-1 regulates lysis. We find that if PAI-1 
can inhibit all tPA, whether or not it is bound, lysis is severely hindered (Figure 5.4). 
However, if PAI-1 only inhibits free tPA, lysis is able to proceed unimpeded (Figure 5.4). 
This suggests that in the presence of low levels of fibrin, PAI-1 can effectively inhibit tPA 
and prevent systemic lysis. When a blood clot develops, tPA binds to fibrin and is protected 
from PAI-1. Lysis begins because the tPA is no longer inhibited.
When we include TAFIa in the microscale model, fewer plasmin molecules are produced 
than when we do not account for TAFIa. There are two consequences of fewer plasmin 
molecules: tPA stays bound longer because it is forced to unbind by plasmin less frequently 
(Table 5.2), and single fiber lysis times increase (Figure 5.7). TAFIa slightly increases single 
fiber lysis times in the absence of a 2-AP, and drastically increases them in the presence of 
a 2-AP (Figure 5.7). In our model without a 2-AP, TAFIa only slows down lysis by 3-8% 
in thin fibers and 8-30% in thick fibers (depending on whether tPA can rebind or not). 
With a 2-AP, however, TAFIa slows down lysis by 35-240% (thin), or 800% to stopping lysis 
almost completely (thick).
In all situations tested, adding TAFIa to the microscale model decreases the macroscale 
lysis front velocity (Table 5.3). Lysis front velocities are slower in the presence of TAFIa for 
three reasons: fewer plasmin molecules are produced, so single fiber lysis times are longer; 
tPA is slower to diffuse to new fibers because tPA leaving times are longer; and, when 
plasmin can unbind, the probability that a bound tPA molecule initiates lysis is smaller. 
When both a 2-AP and TAFIa are present, our model predicts that virtually no lysis of thick 
fibers or coarse clots will occur. However, experiments show that TAFIa cannot completely 
stop lysis, and the effect of TAFIa on clot lysis saturates with a half-maximal effect at 1 nM 
TAFIa [?]. In the future, we plan to use our multiscale model with TAFIa to investigate 
the saturating behavior of TAFIa on clot lysis.
Experimental results suggest that TAFIa has no effect on lysis in the absence of a 2-AP 
[?], inconsistent with our findings. Yet, our results may provide a possible explanation for 
the experimental results. From the model, we find that TAFIa and a 2-AP both individually
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slow down single fiber and full clot lysis. a 2-AP is the more effective inhibitor (compare 
solid blue curves to dashed black curves in Figures 5.7 and 5.8), but the biggest increase in 
single fiber lysis times (and biggest decrease in front velocities) occurs when both a 2-AP 
and TAFIa are present (blue dashed curves in Figures 5.7 and 5.8). Perhaps the effect 
of TAFIa is more apparent in conjunction with a 2-AP because there are fewer plasmin 
molecules. In the absence a 2-AP, there is more plasmin in the system and the continued 
plasmin-mediated degradation of fibrin is able to mask the effects of TAFIa. In the presence 
of a 2-AP, there are fewer plasmin molecules and the plasmin-mediated degradation of fibrin 
is slower, so the effect of TAFIa is more visible.
Also, it is possible that there is very little positive feedback during lysis, contrary to 
general belief. If exposure of new binding sites facilitates the creation of more plasmin, then 
removing those binding sites with TAFIa should reduce the amount of plasmin produced 
and consequently slow lysis, even in the absence of a 2-AP. However, this is not seen 
experimentally, and the model predicts only a small retardation of lysis in the absence 
of a 2-AP. When we do not allow tPA to rebind to the cross section, the model has minimal 
positive feedback; it does not matter how many new binding sites are exposed, additional 
plasmin molecules cannot be created if tPA cannot rebind to the new sites. The only positive 
feedback in the model occurs on the protofibril to which tPA is bound. As the 5 cryptic 
doublets at that binding location are exposed by plasmin, PLG can bind to the new sites 
and tPA can activate the PLG to plasmin. Perhaps it is the TAFIa-mediated inhibition of 
this minimal positive feedback that increases lysis times in the model.
We can study additional positive feedback by allowing tPA to rebind. The exposure 
of binding sites as lysis progresses provides more places for PLG to bind, so when tPA 
rebinds, it is more likely to be on a protofibril that contains PLG. The tPA is therefore 
more likely to create a plasmin molecule, which begins degrading and exposing binding 
sites. In this way, lysis is sped up by the positive feedback achieved by tPA rebinding. We 
see that TAFIa has more of an effect on lysis when tPA can rebind because it prevents the 
positive feedback in that situation; TAFIa slows the coarse clot lysis front velocity by 19% 
without tPA rebinding, and by 28% with tPA rebinding, when plasmin does not unbind. 
So the lack of inhibition of lysis seen in TAFIa experiments without a 2-AP could suggest 
that there is not as much positive feedback in the lytic process as previously assumed. 
Therefore, our model results in comparison to experiments are inconclusive with respect to 
tPA rebinding. Without tPA rebinding, a 2-AP slows lysis to unrealistic levels (Figure 5.8(a),
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solid blue curve) or stops lysis completely in the presence of TAFIa (lack of dashed blue 
curve in Figure 5.8(a)). Adding tPA rebinding to these simulations recovers more reasonable 
lysis rates (Figure 5.8(a), solid and dashed green curves), suggesting that tPA does rebind 
physiologically. However, the experimental observation of no effect of TAFIa alone on lysis 
rates suggests there is little tPA rebinding. Future work will more carefully address and 
explore the presumed positive feedback within the fibrinolytic system.
CHAPTER 6
CONCLUSION
Fibrinolytic rates must be maintained in a tightly regulated range to prevent severe 
health complications such as heart attack, stroke, and excessive bleeding. Clinical research 
is aimed at developing both fibrinolytic and anitfibrinolytic drugs to treat patients with 
abnormally functioning fibrinolytic systems. The goal of our mathematical research is to 
elucidate biochemical mechanisms of the fibrinolytic system to better understand how lysis 
occurs. Our mathematical models can be used to propose useful biological experiments and 
suggest targets for drug development.
We developed a 1-dimensional reaction-diffusion model of fibrinolysis that extended pre­
ceding models by considering more detailed reaction chemistry and the spatial heterogeneity 
of fibrin (Chapter 2). More so than previous models, our model predicts spatial protein 
concentrations at the lysis front that are consistent with experimental data. However, we 
conclude that even with our model improvements, 1-D continuum models are unable to 
accurately describe the observed differences in lysis behavior between fine and coarse clots.
The 1-D model results, along with the observation that a 5 nM tPA concentration 
(typical concentration used in experiments) is only about 3 tPA molecules/^m3, motivated 
the creation of a 3-D stochastic model of fibrinolysis (Chapters 3-5). Our model is the first 3­
dimensional fibrinolysis model, and the first mathematical model to simultaneously consider 
lysis at the single fiber and whole clot scales. It is also the first to acknowledge the low 
protein concentrations by treating tPA and plasmin stochastically. Our model is multiscale 
and involves stochastic and deterministic spatiotemporal dynamics. The microscale model 
represents a fiber cross section and contains detailed biochemical reactions. It provides 
information about single fiber lysis times, the number of plasmin molecules that can be 
activated by a single tPA molecule, and the length of time tPA stays bound to a given fiber 
cross section. Data from the microscale model is used in a macroscale model of the full 
fibrin clot, which gives lysis front velocities and spatial tPA distributions.
Results from the multiscale model suggest that the number of tPA molecules exposed
to the front of the clot determines whether coarse clots lyse faster or slower than fine clots. 
For our clot geometry and parameter values, if there are fewer than 287 tPA molecules/^m2 
at the clot front, coarse clots lyse faster than fine clots because they contain fewer fibers. 
As the number of tPA molecules increases, the advantage of having fewer fibers is erased 
because tPA can start lysis on all fibers at the front of both types of clots (Chapters 3 and
4).
We use the multiscale model to predict ranges of parameter values that have yet to 
be measured experimentally, and to suggest targets for future fibrinolytic drugs. A simple 
model of plasmin unbinding allows us to estimate the relative values of plasmin unbinding 
and crawling rates (Appendix G). We propose that the crawling rate must be much larger 
than the unbinding rate in order for plasmin to crawl effectively; if the rates are similar, 
plasmin will unbind and be inhibited by a 2-AP before it has a chance to crawl. We can 
also hypothesize values of PLG and tPA binding and unbinding rates. Based on our model 
results, we estimate that the binding rate of PLG is in the range fcOn"G e (1 x 10-3 , 1 x 
10-1 ) ^M -1 s-1 , and that the binding rate of tPA is in the range fcOpA e (1 x 10-2 , 1) 
^M -1 s-1 (Chapter 4). PLG and tPA dissociation constants have been measured, so given 
the binding rates estimated above, the unbinding rates are computed as necessary to achieve 
the measured dissociation constants.
If a tPA variant with a different dissociation constant can be engineered, our model 
suggests values for this new dissociation constant that will most effectively increase clot 
lysis rates. Increasing the dissociation constant from its physiological value increases the 
clot lysis rate because tPA binds less strongly to the clot front and consequently starts lysis 
on more fibers throughout the clot. However, there appears to be an optimal value of the 
tPA dissociation constant with respect to the resulting lysis rate (Chapter 4).
We are able to study the effect of inhibitors on fibrinolysis using our multiscale model. 
We find that a 2-AP greatly inhibits single fiber and full clot lysis (Chapter 4). TAFIa 
slightly retards lysis on its own, but is much more effective in the presence of a 2-AP 
(Chapter 5). The presence of a 2-AP likely makes the effect of TAFIa more apparent 
(compared to the effect of TAFIa alone) because it removes plasmin molecules from the 
simulation. When plasmin is more abundant, TAFIa-mediated cleavage of binding sites is 
overwhelmed by plasmin-mediated degradation, and the inhibitory effect of TAFIa is weak. 
At measured physiological concentrations, the tPA inhibitor PAI-1 also seems to have a 
weak inhibitory effect on lysis. The PAI-1 concentration in blood clots must be higher
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than the 5 nM concentration measured in platelet rich plasma in order to retard lysis 
(Chapter 5). If higher PAI-1 concentrations are present, then lysis rates decrease and often 
prevent complete degradation of the clot. In simulations with a 1 ^M PAI-1 concentration, 
the number and distribution of platelets in the clot affects the progression of lysis.
The multiscale model raises questions about some generally accepted beliefs about 
fibrinolysis. It is believed that PLG is able to diffuse through the pores in a single fibrin 
fiber, however our calculation of protofibril spacing in a fiber (coupled with experimental 
estimates of PLG diameters), suggests that PLG is too large to diffuse between protofibrils 
(Appendix A). Also, model results suggest that positive feedback does not have a large effect 
on clot lysis (Chapter 4). It is generally accepted that the plasmin-mediated exposure of new 
binding sites during lysis increases PLG binding, and hence increases plasmin production 
and fibrin degradation. However, model results in the presence and absence of positive 
feedback do not differ greatly. We believe that the low tPA concentration is responsible 
for the lack of expected positive feedback. It does not matter how many additional PLG 
binding sites get exposed during lysis -  if there is no available tPA to bind to those sites, 
additional plasmin cannot be created.
Analysis of our stochastic multiscale model suggests several interesting biological ex­
periments with significance to clinical practice and future mathematical modeling work. 
First, we propose an experiment to test the hypothesis that the number of tPA molecules 
relative to the surface area of clot exposed to the molecules determines whether coarse 
clots lyse faster or slower than fine clots. We imagine many coarse clots formed under 
identical conditions. A different volume and concentration of tPA (i.e., a different number 
of tPA molecules) will be added to the edge of each clot and lysis front velocities will be 
calculated. Then the same tPA concentrations and volumes will be added to the edges of 
fine clots (all formed under identical conditions) and lysis front velocities will be recorded. 
We hypothesize that with fewer tPA molecules, coarse clots will lyse faster than fine clots, 
but as the number of tPA molecules increases, fine clot lysis rates will be faster than coarse 
clot lysis rates. This could help explain why some experiments show faster lysis rates in 
coarse clots [?, ?], while others display little difference in lysis rate or faster rates in fine 
clots [?, ?, ?].
A second experiment driven by results of our model involves engineering tPA variants 
with larger-than-physiological dissociation constants and testing their effectiveness in clot 
lysis. The model predicts that tPA with a dissociation constant one order of magnitude
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bigger than physiological (call this tPA-1) increases lysis rates more than tPA with a 
dissociation constant two orders of magnitude bigger than physiological (call this tPA-2). 
An experiment in which normal tPA, tPA-1, and tPA-2 are used to lyse fibrin clots formed 
under identical conditions should start to elucidate desirable characteristics of fibrinolytic 
drugs. Based on our model, we propose that one such characteristic is weaker binding to 
fibrin; if tPA binds less strongly to fibrin, it can diffuse through the clot more easily and 
initiate lysis on more fibers.
Now that technology has progressed to the point that accurate single fiber experiments 
are possible, we can use our model to suggest single fiber lysis experiments that may be 
worth investigating. Finding a relationship between fiber diameter and the time it takes 
for the fiber to degrade could give us an idea about what “degradation” of a fiber actually 
means. In the model, we assume that degradation occurs when a given percentage of 
binding sites have been lysed. This results in single fiber lysis times scaling quadratically 
with diameter: a thick fiber with twice the diameter of a thin fiber will take four times 
longer to degrade. If single fiber lysis experiments showed a similar relationship between 
diameter and lysis time, we might hypothesize that percentage of degraded fibrin determines 
lysis. However, if a thick fiber with diameter twice the thin fiber takes more than four times 
longer to degrade, we might hypothesize that the raw number of degraded fibrin monomers 
determines lysis.
Finally, we do not know if such experiments are currently possible, but in the future it 
would be interesting to study single molecules. For example, how long does a tPA molecule 
stay bound to a single fiber? Does the length of time it stays bound differ depending on the 
size of the fiber? When the tPA molecule unbinds, does it rebind elsewhere on the fiber? 
The model predicts that if tPA is usually forced to unbind from fibrin by plasmin-mediated 
degradation, then tPA will stay bound to thick fibers longer than to thin fibers. Thick fibers 
have more space for plasmin to crawl, and therefore the plasmin encounters the tPA less 
frequently. If, however, tPA usually unbinds on its own, the model predicts no difference in 
the length of time tPA stays bound to different fibers. Experiments that measure the length 
of time tPA stays bound to a fiber could be used in conjunction with the model to predict 
whether tPA is forced to unbind by plasmin or unbinds on its own. Also, the model predicts 
that very few plasmin molecules (1-2, on average) are responsible for the degradation of a 
single fiber, and that single fiber lysis time is often determined by the amount of time it 
takes tPA to create a plasmin molecule. In the future, it would be interesting if a single
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fiber experiment could determine when, and how much, plasmin is created.
The model framework we created lends itself to future research. We plan on more 
thoroughly investigating the role (and existence) of positive feedback in fibrinolysis. Part 
of this work will involve revisiting the tPA rebinding probability calculation (Appendix E). 
We have only briefly studied the effect of TAFIa on lysis. Future work will address the 
experimental observation that lysis rate saturates as a function of TAFIa [?, ?]. The 
activation of TAFIa from TAFI is also a consideration for future work. Thrombin, plasmin, 
and the thrombin-thrombomodulin complex all convert TAFI to TAFIa, but they all do so 
with wildly different rates [?, ?, ?]. Understanding the relative importance of each activator 
in physiological conditions will provide information about how the TAFIa in a blood clot is 
created. This information can then be used to develop therapeutics that increase fibrinolysis 
rates by preventing TAFIa production.
It will also be important to study lysis of more heterogeneous fibrin clots. So far our 
clots have been 3-dimensional square lattices, with all fibers in a given clot having the same 
diameter. However, the mesh of fibers near platelets is often tightly packed, with thicker 
fibers and a coarser mesh of fibrin in regions of clot away from platelets. Allowing for this 
type of variation in fiber diameter and pore size within our model clot will be necessary 
to study more physiological clots. It could also be interesting (and clinically relevant) to 
study lysis of a thrombus, which often has very thick fibers packed closely together. The 
macroscale model clot geometry will need to be adjusted to accommodate heterogeneous 
clots, but neither the microscale model algorithm nor the macroscale model algorithm will 
require adjustments.
Finally, as more fibrinolysis experiments are conducted (perhaps inspired by our mod­
eling), we acquire new information that can be incorporated into our models. In this 
way, mathematical modeling and biological experimentation complement and motivate each 
other; advances in modeling suggest avenues of research for experimentalists, and new 
experiments provide information that makes models more realistic.
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APPENDIX A
PROTOFIBRIL SPACING IN A FIBRIN 
FIBER
The following calculation can be done for any size fiber, but for concreteness, consider 
a 97.5-nm diameter fibrin fiber. For ease of computation, assume the fiber cross section is 
a square of equal area to the circular cross section (Figure A.1):
Area =  n(48.75 nm)2 =  7466.19 nm2 «  (86.4 nm) x (86.4 nm).
Since a fibrin fiber is approximately 20% protein, 20% of the cross sectional area (or
4.8 nm
86.4 nm
Figure A .1 . Diagram of protofibril spacing in a 97.5-nm diameter fiber cross section. The 
circular fiber cross section is approximated by a square of equal area. Black circles are 
protofibril cross sections, each with diameter 4.8 nm. The distance from the edge of one 
protofibril to the edge of a neighboring protofibril is also 4.8 nm.
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1493.238 nm2) should be protein. The diameter of a protofibril is approximately 4.8 nm. 
We assume that a protofibril is a solid cylinder of protein, so the amount of fibrin in the 
cross section of a single protofibril is n(2.4 nm)2 =  18.09 nm2. This means there should be
1493.238 nm2
---------------- :r - ~  8218.09 nm2
protofibrils in the 97.5-nm diameter fibrin fiber. We can leave out one protofibril (to get a 
square number), without drastically changing the protein concentration (with 81 protofib­
rils, the percentage of fibrin in the fiber is 19.63%). Equally spacing the 81 protofibrils in 9 
rows of 9 in the square cross section results in an edge-to-edge distance between protofibrils 
of 4.8 nm (Figure A.1).
APPENDIX B
1-D MODEL EQUATIONS
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DETAILED DEFINITIONS FOR 
GILLESPIE ALGORITHM
Here we define the specific vectors that appear in the master equation,
22dP  22
(x, t|x0,t0) =  ^ [ a j ( x  -  V j)P(x -  Vj, t|x0,t0) -  a j(x )P (x , t|x0, t0)],
• 1j=1
that describes the microscale model reactions. Using the notation explained in Figure 3.3, 
the state vector is
x = N plg, N 12, N 10, N 13, N03, N23, N33, 0, 03, N  , (C.1)
where x» is the number of molecules of type i in the system. The stoichiometric matrix 
describing the 22 possible reactions that can occur is
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V =
V1 \ 0 - 1 1 0 0 0 0 0 0 0
V2 0 1 - 1 0 0 0 0 0 0 0
V3 0 0 1 - 1 0 0 0 0 0 0
V4 0 0 0 - 1 1 0 0 0 0 0
V5 0 0 0 0 - 1 1 0 0 0 0
V6 0 0 0 0 1 - 1 0 0 0 0
V7 0 0 0 0 1 0 - 1 0 0 0
V8 1 - 1 0 0 0 0 0 0 0 0
Vg 1 0 - 1 0 0 0 0 0 0 0
V10 1 0 0 0 - 1 0 0 0 0 0
V11 1 0 0 0 0 - 1 0 0 0 0
V12 0 - 1 0 1 0 0 0 0 0 0
V13 0 0 0 0 0 0 0 1 - 1 0
V14 0 0 0 - 1 0 0 0 1 0 0
v15 0 0 0 0 - 1 0 0 1 0 0
V16 0 0 0 0 0 - 1 0 1 0 0
V17 0 0 0 0 0 0 - 1 1 0 0
V18 1 0 0 0 0 0 0 0 0 - 1
V19 1 0 0 0 0 0 0 0 0 - 1
V20 1 0 0 0 0 0 0 0 0 - 1
V21 1 0 0 0 0 0 0 0 0 - 1
V22 / 1 0 0 0 0 0 0 0 0 - 1
and the propensity function is
j^ PLG juPLGroy r'llfree P^Li z^ tPA z^ PLG rpT pifree ;lPLG P^Li koff X2, kon [PLG] X3, koff X4, koff X4, kon [PLG] X5, koff X6, koff X7.
ko^AX2, koPAX3, kPLiX5, kPLiX6, k ^ ,  Cff^Xg, kdegX4, kdegX5, kdegX6, kdegX7
kcatnX4. k?atnX5. k?atnX6. k?atnX7. k?atnX9
where n is the number of cryptic doublets at the binding location of interest. We use this 
information in the Gillespie Algorithm as follows:
0. Initialize t =  t0, X =  x0.
1. With the system in state x  at time t, evaluate the propensity function a and the sum
22
ao(x) =  (x ) . 
j=1
2. Choose two independent random variables, r1,r 2 G U [0,1]. Set t =  — ^ - ln  ( —
a0 (x) \ r 1
(when the next reaction happens), and set i to be the smallest integer such that
i
^  a j(x) >  r2a0(x) (which reaction happens next). 
j=1
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3. Carry out reaction i and set t =  t +  t , x  =  x  +  Vj. Return to step 1.
APPENDIX D
QUASI-STEADY STATE CALCULATION 
FOR PLG
Here we describe the quasi-steady state assumption calculation for plasminogen (PLG) 
in the microscale model. Assume we have a system consisting solely of PLG and doublets 
(pairs of binding sites to which PLG can bind). Let p =  free PLG concentration, N j  =  
concentration of N00 doublets of type j ,  N j  =  concentration of N02 doublets of type j,  
and N j  =  concentration of N22 doublets of type j , where j= i  for intact, j= n  for nicked. 
Similarly, let kOn and kOff denote the rates for PLG binding to, and unbinding from, fibrin 
of type j .  Then we have the system of equations
-N  *
- d 00 =  -2kO nPN00 +  kOffN02
-N*
02 =  - k 0ffN02 +  2kOnpN00 -  kOnpN02 +  2kOffN22dt 
N
dt
=  2kO ffN22 +  kO npN02 
-t  - 2 0 N 0 0  +  kSrNS
7 N n
02 =  -knffN02+ 2knnpN s) -  kOnpNn+ 2knffN22 
=  -2knffN ?2+ knnpN02.
Making the quasi-steady state assumption we set the right hand sides of the above 
equations equal to zero. Let the total concentration of binding sites be F , so
F  =  N00 +  N02 +  N22 +  N00 +  N02 +  N22.
Fi Fn
Then doing a bit of algebra gives the probability of having each type of doublet:
128
—(N 00)= ° " kD Fj
P  (N02) =  
P  (N22) =
pY* (Fj +  F „ ) ’ 
F*
Y*(Fi +  Fn) ,
°.5pF* 
k*DYi(Fj +  Fn),
—(N 0 ) =  ° .5kD Fn
P  (N02) =  
P  (N22) =
pYn(Fj +  Fn) ’ 
Fn
Y'n(Fi +  Fn) ,
°.5pFn 
kDYn(F* +  F n ):
.fcj
where Yj =  (1 +  °.5 k f +  °.5 j ), j  =  i or n. For kjD =  38 ^M, kD =  2.2 ^M, p =  2 ^M,
kD
P  (N00) =  °.9°25 
P  (N02) =  °.°95° 
P  (N22) =  °.°°25
F*
Fi +  Fn
F*
F* +  Fn
F*
F* +  Fn
P  W o )  =  °.2744 
P  (N02) =  °.4989
P  (N22) =  °.2268
Fn
F* . Fn 
Fn
F* +  Fn
Fn
F* +  Fn
In the model, we use these probabilities to determine where a plasmin molecule crawls. 
Once we know if the plasmin is moving onto a nicked or intact doublet, then we use the 
above probabilities without the ( F.+F j  factor to determine if the given nicked or intact 
doublet is N00 , N02, or N22.
APPENDIX E
tPA REBINDING PROBABILITY
Consider a molecule that can diffuse in a sphere of radius R 1 and bind to a partially 
absorbing inner sphere of radius R0 <  R 1. We think of R0 as the size of the fiber cross 
section of interest, and R 1 as the distance to the next cross section along the fiber. Let 
n(r) be the probability of binding anywhere within the sphere of radius R0 having started 
at radius r, so
1 d (  2dn\ 
D - , ^ -  r —  -  k0n r2 dr \ or  J
d - -  fr2  —  ^
r2 dr V dr I
=  —k0 for r <  R0 and
=  0 for R0 <  r <  R 1,
(E.1)
(E.2)
where k0 is the binding rate. Assuming that R 1 is an absorbing boundary gives the boundary 
condition n (R 1) =  0.
Solving for n(R 0) gives the rebinding probability, i.e. the probably that a molecule 
starting at R0 rebinds anywhere in the sphere of radius R0:
(
n(R0) =  1 — R0
\
1
1 +  (R 1 — R0W  §  coth ( J D R0
(E.3)
/
where D  =  107 (typical diffusion constant for an enzyme), R 1 =  22.5 nm (the distance 
to the next tPA binding site along the length of a fibrin fiber), R0 =  0.5 nm (the assumed 
“thickness” of the cross section), and k0 =  kOpAB, where kOpA is the binding affinity of tPA 
to fibrin (in units of ), and B  is the concentration of binding sites in the cross section 
(in units of ^M).
When tPA unbinds from a doublet we pick a random number. tPA rebinds if the random 
number is less than the rebinding probability, otherwise we conclude that the tPA molecule 
diffused away. The probability that a molecule will bind in the region r <  R0 is higher when 
there is a high concentration of binding sites and/or a strong binding affinity. The rebinding
probability changes with time because B increases initially as binding sites are exposed, and 
then decreases as degradation proceeds. However, for our parameters, n (R 0) =  0 (1 0 -6 ), 
and we conclude that tPA essentially never rebinds.
To derive Equations (E.1) and (E.2), consider the probability of a molecule being at 
position r2, in state a 2 at time t2 given that it started at position r3, state a 3 at time 
t3, p (r2, a 2, t2, r3, a 3, t3). r  is a continuous variable describing the physical location of the 
molecule, and a» is a discrete variable describing the state of the molecule. a» =  0 indicates 
the molecule is unbound, and a» =  1 means the molecule is bound. When the molecule 
binds it remains bound, so
p(r2,1,t2,r3,1,t3) =  1, (E.4)
p(r2,0,t2,r3,1,t3) =  0. (E.5)
Let
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P(r2,t2,r3,t3) =  p(r2, 0,t2,r3,0,t3),
Q(r2 ,t2,r3,t3) =  p(r2,1,t2,r3,0,t3).
Since the molecule can diffuse and bind, P  and Q  satisfy the differential equations 
dP
Trr(r2,t2,r3,t3) =  Lr2P(r2,t2,r3,t3) -  k0x(r2)P(r2,t2,r3,t3) (E.6)
dt2
dQ
Trr(r2,t2,r3,t3) =  k0 x(r2)P  (r2, t2, r3, t3), (E.7)
dt2
where Lr2 is the diffusion operator on r2, k0 is the binding rate, and x (r2) is an indicator 
function such that
,  \ /1  if r2 <  R0 
X(r2) =  \0 otherwise.
Define g (t i ,r 2) =  j  Q (r i , f i ,r 2,0)dri, the probability the molecule is bound at time ti
given it started at position r2 at time t2 =  0. Then
H  =  /  dt1Q(ri ' r2 ■ ° )-r1
k0% (n)P (n  , t1, r2 , ° ) - n
f  ~  /  d
J  d^"k0X(r 1)P(r1,t1,^2, °)-r1-t1.
We show below that
_d
dt1
— P (n ,t1  ,r2, °) =  [L*2 -  k0x(r2 )]P (n ,tb r2, °).
Accepting this as true and using it in equation (E.9), we obtain 
dg f  “ k0%(n)[L* -  k0x(r2)]P (n ,t1,f2, ° ) -n -t1dt1 / I ■ ^ V 1^ 2
~  /  /• d
=  - [L*2 -  k0x(r2)]^" d^ -Q (n ,t1 ,r2 , ° ) - n )  -t1 
=  [ l ; 2 -  k0x(r2 ) ] ^ J  Q(r1,t1,r2, ° ) - n  -  J  Q (rb TO,r2, ° ) - n  
dgTaking the limit of —— as t1 ^  °  gives (via Equation (E.8)) 
dt1
dg f  lim —— =  lim k0x (r 1)P  (r1,t 1,r 2, °)d r1 
tn-0 dt1 t i^ 0 j
=  J  k0x(^1)^(r1 -  r2 )-n  
=  k0x(r2).
So Equation (E.9) becomes
k0x(r2) =  -  [L*2 -  k 0 x (r 2 )^  Q (n , rc>,f2, ° ) - n .
Let n (r2) =  J  Q (r1, to, r2, ° )d r1, so









Equation (E.14) is equivalent to equations (E.1) and (E.2).
It remains to show equation (E.1°). Because we have discrete and continuous variables, 
the Chapman-Kolmogorov equation is
132
p(r1,a1,t1,r3,a3,t3) =  ^  /  p (n , a1, r2, a2, t2)p(r2, a2, t2, r3, a3, t3)dr2, (E.15)
« 2=0 ,1 '
where the function on the left hand side is independent of t2. Taking derivatives with 
respect to t2 and dropping the terms that evaluate to 0 gives
f  d
0 =  ^ ^ 1 , 0,t1,r2,0,t2)p(r2, 0,t2,r3,0,t3)dr2
f  d
+  / p (n , 0,t1,r2,0,t2)d^P(r2, 0,fi,r3,0,t3)dr2
f  d
=  /  d^"P(r1 ,t1,r2,t2)P(r2,t2,r3,t3)dr2
/■ d
+  I P ( r 1 , t 1 , r 2 , t 2 ) ( r 2 , t 2 , r 3 , t 3 ) d r 2
/  d
=  I d ^ P (r1  ,t1,r2,t2)P(r2,t2,r3,t3)dr2 
+  J  P(r1,t1,r2,t2)[Lr2 — k0X(r2)]P(r2,t2,r3,t3)dr2.
Integrating by parts yields
f  d
0 =  /  d^"P(r1 ,t1,r2,t2)P(r2,t2,r3,t3)dr2
+  J  P(r2,t2,r3,t3)[L*2 — k0X(r2)]P(r1,t1,r2,t2)dr2, (E.16)




— P  (r1,t1,r2,t2) +  [L*2 — k0X(r2)]P (r1,t1,r2 ,£2) =  0. (E.17)
Because this is a time homogeneous process, P (r1,t 1,r 2, 0) =  P (r 1, 0, r2, —12), and
d d
— P(r1, t1, r2, 0) =  —— P (r1 ,0, r2, — fi), (E.18)
which with equation (E.17) gives
_d
dt1
— P  (r1,t1 ,r2,0) =  [l ; 2 — k0X(r2)]P (r1,t1,r2,0).
APPENDIX F
MODIFIED MODEL GILLESPIE 
DEFINITIONS
Here we define the specific vectors that appear in the master equation,
dP  34
(x,t|x0, t0) =  ^ [ a j ( x  -  V j)P(x -  Vj,t|x0,t0) -  a j(x )P (x , t|x0, t0)],
dt • 1J=1
that describes the modified microscale model reactions. In the modified model, tPA can 
convert any PLG at the same binding location to plasmin, plasmin can degrade any doublet 
at the same binding location, and plasmin can unbind (if k ^ ^  =  0). The state vector is
xT









\ N  )
where x» is the number of molecules of type i in the system. Using the notation explained 
in Figure 3.3, N j  denotes a doublet with molecules of type i and j  bound, where i , j  =  0 
(nothing), 1 (tPA), 2 (PLG), 3 (plasmin). N  denotes a cryptic doublet and 0 denotes a 
degraded doublet. The stoichiometric matrix describing the 34 possible reactions that can 
occur is
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V l34 / 0 0
0 0 0 0 0 0 0
0 0 0 0 0 0 0
0 0 0 0 0 0 0
-1 0 0 0 0 0 0
-1 1 0 0 0 0 0
0 -1 1 0 0 0 0
0 1 -1 0 0 0 0
0 1 0 -1 0 0 0
0 0 0 0 0 0 0
0 -1 0 0 0 0 0
0 0 -1 0 0 0 0
0 1 0 0 0 0 0
0 0 0 0 1 -1 0
-1 0 0 0 1 0 0
0 -1 0 0 1 0 0
0 0 -1 0 1 0 0
0 0 0 -1 1 0 0
0 0 0 0 0 0 -1
0 0 0 0 0 0 -1
0 0 0 0 0 0 -1
0 0 0 0 0 0 -1
0 0 0 0 0 0 -1
0 0 -1 0 0 0 0
0 -1 0 0 0 0 0
0 1 0 -1 0 0 0
-1 0 0 0 0 0 0
0 0 0 0 0 1 -1
0 0 0 0 1 0 0
0 0 0 0 1 0 0
0 0 0 0 1 0 0
0 0 0 0 1 0 0
0 0 1 0 0 0 0
1 0 0 0 0 0 0
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where n is the number of cryptic doublets at the binding location of interest, x  =  1 if there 
is a tPA molecule at the current binding location, and x  =  °  if there is no tPA molecule. 
x  appears in the reactions describing tPA-mediated conversion of PLG to plasmin, because 
those reactions are not possible unless tPA is present somewhere on the binding location.
APPENDIX G
PLASMIN CRAWLING AND UNBINDING 
RATES
Consider a plasmin molecule with 2 “feet” it can use to crawl. There are 4 possible 
states this molecule can be in: Sn  (both feet are bound to fibrin), S10 (the first foot is 
bound to fibrin, the second is unbound), S01 (the second foot is bound to fibrin, the first 
is unbound), and S00 (both feet are unbound) (Figure G.1(a)). Plasmin is bound to fibrin 
in all states except S00. The molecule transitions between states according to the reaction 
diagram in Figure G.1(b), where we have grouped the S10 and S01 states into one state 
(also called S10). We imagini that the plasmin molicule crawls by unbinding one foot and
(a)
(b)
F igure G .1. Basic model for plasmin crawling. (a) The 4 possible states a plasmin 
molecule with 2 feet can be in. A filled circle represents fibrin with a plasmin foot bound 
and an open circle represents fibrin without a plasmin foot bound. (b) Reaction diagram 
for a plasmin molecule transitioning between states. The possibility of an unbound plasmin 
(S00) binding is neglected since we are interested in what happens prior to the plasmin 
molecule unbinding.
rebinding it elsewhere, while keeping the other foot bound, so S10 represents the states 
in which plasmin will either step (bind the unbound foot) or unbind completely (unbind 
the bound foot). We are interested in the mean exit time (i.e., the time before plasmin 
totally unbinds and enters the S00 state), and the mean number of transitions that can be 
completed in that time. We leave out the possibility of S00 to S10 transitions since we want 
to know the number of transitions that occur before the plasmin molecule reaches the S00 
state. The rate of transitioning from S11 to S10 is k_, the rate of transitioning from S10 to 
S11 is k+, and the rate of transitioning from S10 to S00 is l_.
In the model depicted in Figure G.1(b), we assume that transition from S10 to S11 is 
an attempted crawling step. We say “attempted” because this model cannot tell us where 
the foot bound, only that it did bind. A true step would be one in which the foot bound to 
a different site than that from which it unbound. So the mean number of transitions (i.e., 
steps) between states S10 and S11 obtained with this model will be an overestimate, since 
not all these transitions will result in a true crawling step. There must be a large number 
of transitions before total unbinding (i.e., before reaching state S00) in order for a plasmin 
molecule to crawl. We calculate the mean number of transitions as follows:
Assume the plasmin molecule is in state S10. The probability the first transition is 
to S11 is -— -, and the probability the first transition is to S00 is ( 1 — +
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k+ + 1_ y + 1_
- — . However, several transitions between states S10 and S11 may occur before plasmin 
unbinds (reaches state S00). Let N  be the number of times plasmin transitions to S11 before 
unbinding and calculate the probability distribution for N,
P [N  = n] =  G + k + i J  ( 1 — k + T Z _ )  • ^
prob. there are n prob. of Sio ^  Soo 
S10 ^  S11 transitions transition
Let A =  -------- — , so
+ 1_
P  [N =  n] =  An(1 — A)
is the probability of n transitions before unbinding. Then the expected number of transitions 
before unbinding is
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E =  ^  nAn(1 -  A)
n=1
=A(1 -  A) ^  nAn-1
n=1
=A(1 -  A ) - d  ( - i ­
v ; dA V 1 -  A
A
=  1 -  A
= k+ 
i -  ■
The intrinsic plasmin unbinding rate from fibrin is l- . We see that this intrinsic 
unbinding rate (or the rate of one foot unbinding when one is already unbound) must 
be small in comparison to k+ (the rate of one foot binding when the other is bound) in 
order for plasmin to make many crawling steps. If the rates are similar, then k+ «  l­
and the molecule only takes 1 step, on average. The rate l-  is comparable to the plasmin 
unbinding rate that we use in the microscale model (kpnbind), and k+ can be thought of as 
a crawling rate (kpLWi). Therefore, if we take kpLbind =  0.05 s-1 and kpLWi =  57.6 s-1 , we 
satisfy the condition l-  < <  and are guaranteed that plasmin will actually crawl. (A 
final note: We see that k-  (the rate of one foot unbinding when both are bound) does not 
affect how many steps occur, but k-  will affect how long it takes a step to occur. That is, 
k-  affects travel time, not distance traveled.)
APPENDIX H
QUASI-STEADY STATE CALCULATION 
FOR PLG AND TAFIa
Assume we have a system consisting solely of plasminogen, TAFIa, and doublets. Let 
p =  free plasminogen concentration, T  =  free TAFIa concentration, N00 =  concentration 
of N00 doublets of type j , N j  =  concentration of N02 doublets of type j , and N j  =  
concentration of N22 doublets of type j ,  where j= i  for intact, j= n  for nicked. Similarly, let 
kOn and kOff denote the rates of plasminogen binding to, and unbinding from, fibrin of type 
j .  Since TAFIa can only bind to nicked doublets, we also have N04, N24, and N44. TAFIa 
binding and unbinding rates are denoted k°n and kff, respectively, with dissociation constant 
kD =  k ff /k L . TAFIa and PLG compete for binding sites on nicked fibrin (Figure H.1), 
which gives the system of equations 
dN*
- - 00 =  -2kO npN00 +  kO ffN02 
dN*
- - P  =  -kOffN02 +  2kOnpN00 -  0 N 0 2  +  2kOffN22 
dN*
- - P  =  -2kO ffN22 +  kO npN02
-N  n
-t00 =  -  2kOnpN00 +  kOffN0n +  k°ffN04 -  2kTnTN 00 
- N n
-t02 =  -  kOffN02 +  2konpN0() -  knnpN02 +  2knffN 22 -  kOnTN (32 +  kTffN24 
- N n
- - P  =  -2kOffN2n2 +  O N S ;
-t  =  2koiiT I^X) -  kOffN04 -  kOiiTN 04 +  2koffN44 -  konpN04 +  kOffN24 
- N l  =  kTnTN0n2 -  kOffN24 -  kTffN24 +
- - 44 =  -2kOffN44 +  kTnTN04.
Making the quasi-steady state assumption we set the right hand sides of the above 






Figure H .1. Reaction diagrams for the PLG and 'TAFIa quasi-steady state approximation. 
a) Reaction diagram for intact doublets. TAFIa cannot bind to intact doublets, so the 
reactions only include PLG. b) Reaction diagram for nicked doublets. TAFIa and PLG 
compete for binding sites.
doublets, respectively, so
v22
Fn =  NO +  N n  +  N22 +  N04 +  N24 +  N44.
(H.1)
(H.2)
Solving the system of equations in Maple gives the probability of having each type of doublet:
P  (N0O) =  0.9025Fi, P  (N0n0) =  0.224804Fn, P  (N04) =  0.089922Fn 
P  (No2) =  0.0950Fi, P  (N02) =  0.408740Fn, P  (N24) =  0.081748Fn 
P  (N22) =  0.0025Fi, P  (N22) =  0.185794Fn, P  (N44) =  0.008992Fn,
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where we have used kD =  38 ^M, kg =  2.2 ^M, k^ =  0.1 ^M, p =  2 ^M, and T  =  20 nM. 
(Note: the symbolic solution to the system of equations involves many messy terms, but 
the on and off rates only appear together in ratios, so we only need to know the kD values.)
APPENDIX I
MODIFIED MODEL GILLESPIE 
DEFINITIONS WITH TAFIa
Here we define the specific vectors that appear in the master equation,
d p  54
(x, t|x0, t0) =  ^ [ a j  (x — Vj )P  (x — Vj, t|x0, t0) — aj (x )P  (x, t|x0, t0)],
• 13 = 1
that describes the modified microscale model reactions. In the modified model, tPA can 
convert any PLG at the same binding location to plasmin, plasmin can degrade any doublet 
at the same binding location, plasmin can unbind (if k^m d =  0), and TAFIa is present. 
The state vector is
xT














where x^  is the number of molecules of type i in the system. Using the notation explained 
in Figure 3.3, N j  denotes a doublet with molecules of type i and j  bound, where i, j  =  
0 (nothing), 1 (tPA), 2 (PLG), 3 (plasmin), 4 (TAFIa). N  denotes a cryptic doublet, C 
denotes a cleaved doublet, and 0 denotes a degraded doublet. The stoichiometric matrix




l l \ / 1 0 -1 0 0 0 0 0 0 0 0 0 0 0
l2 0 -1 1 0 0 0 0 0 0 0 0 0 0 0
l3 0 1 -1 0 0 0 0 0 0 0 0 0 0 0
l4 0 0 1 -1 0 0 0 0 0 0 0 0 0 0
l5 0 0 0 -1 1 0 0 0 0 0 0 0 0 0
l6 0 0 0 0 -1 1 0 0 0 0 0 0 0 0
l7 0 0 0 0 1 -1 0 0 0 0 0 0 0 0
l8 0 0 0 0 1 0 -1 0 0 0 0 0 0 0
l9 1 -1 0 0 0 0 0 0 0 0 0 0 0 0
llO 1 0 0 0 -1 0 0 0 0 0 0 0 0 0
l l l 1 0 0 0 0 -1 0 0 0 0 0 0 0 0
ll2 -1 0 0 0 1 0 0 0 0 0 0 0 0 0
ll3 0 0 0 0 0 0 0 1 -1 0 0 0 0 0
ll4 0 0 0 -1 0 0 0 1 0 0 0 0 0 0
v15 0 0 0 0 -1 0 0 1 0 0 0 0 0 0
ll6 0 0 0 0 0 -1 0 1 0 0 0 0 0 0
V17 0 0 0 0 0 0 -1 1 0 0 0 0 0 0
ll8 1 0 0 0 0 0 0 0 0 -1 0 0 0 0
ll9 1 0 0 0 0 0 0 0 0 -1 0 0 0 0
l20 1 0 0 0 0 0 0 0 0 -1 0 0 0 0
l2l 1 0 0 0 0 0 0 0 0 -1 0 0 0 0l2
1^ 1 0 0 0 0 0 0 0 0 -1 0 0 0 0
l23 = 1 0 0 0 0 0 0 0 0 0 -1 0 0 032
1^ 1 0 0 0 0 0 0 0 0 0 0 -1 0 0
l25 0 0 1 0 0 0 0 0 0 0 -1 0 0 0
l26 0 0 -1 0 0 0 0 0 0 0 1 0 0 0
v27 0 0 0 0 1 0 0 0 0 0 0 -1 0 0
l<2 to 00 0 0 0 0 -1 0 0 0 0 0 0 1 0 0
l29 -1 0 0 0 0 0 0 0 0 0 0 0 1 0
l30 0 0 0 0 0 0 0 0 0 0 0 -1 1 0
l3l 0 0 0 0 0 0 0 0 0 0 -1 0 1 0
l32 0 0 0 0 0 0 0 0 0 0 0 0 1 -1
l33 1 0 0 0 0 -1 0 0 0 0 0 0 0 0
l34 1 0 0 0 -1 0 0 0 0 0 0 0 0 0
l35 0 0 0 0 1 0 -1 0 0 0 0 0 0 0
l36 0 0 1 -1 0 0 0 0 0 0 0 0 0 0
v37 0 0 0 0 0 0 0 0 1 -1 0 0 0 0
l38 1 0 0 0 0 0 0 0 0 0 0 -1 0 083
1^ 0 0 0 0 0 0 0 0 0 0 0 0 1 -1
l40 0 0 0 0 0 0 0 0 1 0 0 -1 0 0
l4l 0 0 0 0 0 0 0 0 1 0 0 0 0 -1
l42 1 0 0 0 0 0 0 0 0 -1 0 0 0 0
l43 1 0 0 0 0 0 0 0 0 -1 0 0 0 0
l44 0 0 0 0 0 0 0 1 0 0 -1 0 0 0
l45 / V 0 0 0 0 0 0 0 1 0 0 0 0 -1 0
145
V46 \ / 0 0 -1 0 0 0 0 1 0 0 0 0 0 0
v47 0 -1 0 0 0 0 0 1 0 0 0 0 0 0
V48 -1 0 0 0 0 0 0 1 0 0 0 0 0 084
1^ -1 0 0 0 0 0 0 1 0 0 0 0 0 0
v50 = -1 0 0 0 0 0 0 0 0 0 0 0 1 0
v51 -1 0 0 0 0 1 0 0 0 0 0 0 0 0
V52 -1 0 0 0 0 0 0 0 0 0 0 1 0 0
V53 0 -1 0 1 0 0 0 0 0 0 0 0 0 0
v54 / V 0 0 0 0 0 -1 1 0 0 0 0 0 0 0
and the propensity function is the 54-component vector
(  a1 \ / koff X2
02 fcPnLG[PLG]free X3
03 kPLlx ^ koff X4

































a34 kPLl x kunblndx5
a35 kpnLllndx 7





a41 = kdegx 14
a42 kCat n x12











a54 V kccptx 6x J
where n is the number of cryptic doublets at the binding location of interest, x  =  1 if there 
is a tPA molecule at the current binding location, and x  =  °  if there is no tPA molecule. 
x  appears in the reactions describing tPA-mediated conversion of PLG to plasmin, because 
those reactions are not possible unless tPA is present somewhere on the binding location.
